# EDGAR Filing Document

**Accession Number:** 0001555127
**File Stem:** 0001555127-25-000006
**Filing Date:** 2025-6
**Character Count:** 440926
**Document Hash:** 1467e308aedeaacd7628d783a075b18e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001555127-25-000006.hdr.sgml**: 20250616

**ACCESSION NUMBER**: 0001555127-25-000006

**CONFORMED SUBMISSION TYPE**: C/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250616

**DATE AS OF CHANGE**: 20250616

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IX Power Clean Water, Inc.
- **CENTRAL INDEX KEY:** 0001555127

**ORGANIZATION NAME:**
- **EIN:** 460658022
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-35753
- **FILM NUMBER:** 251050162

**BUSINESS ADDRESS:**
- **STREET 1:** 17301 WEST COLFAX AVENUE
- **STREET 2:** SUITE 110
- **CITY:** GOLDEN
- **STATE:** CO
- **ZIP:** 80401
- **BUSINESS PHONE:** (505) 661-1000

**MAIL ADDRESS:**
- **STREET 1:** 17301 WEST COLFAX AVENUE, SUITE 110
- **CITY:** GOLDEN
- **STATE:** CO
- **ZIP:** 80401

### Attached PDF Documents

**Attachment 1:** `formca.pdf`

FORM C/A AMENDMENT NO. 2
FILED ON 16 JUNE 2025

ISSUER: IX Power Clean Water, Inc.

Pursuant to this Form C/A Amendment filed on 16 June 2025, the Issuer is extending the end date for this Offering from July 8, 2025 (as previously extended from April 30, 2025) to September 8, 2025.

LIST OF EXHIBITS TO THIS FORM C/A FILED 29 APRIL 2025:

Exhibit A	Offering Memorandum: Part II of Offering Document, including Addendums 1, 2 and 3
Exhibit B*	2024-2024 Audited Financial Statements and Independent Auditor's Report for IX Power Clean Water, Inc.1 and 2023-2022 Audited Financial Statements and Independent Auditor's Report2
Exhibit C	Profile Pages
Exhibit D	Video Transcript
Exhibit E	Investing Process
Exhibit F	Existing Certificate of Incorporation of IX Power Clean Water, Inc.
Exhibit G	Existing Stockholder Agreement of IX Power Clean Water, Inc.

1 Added as an additional Exhibit B attachment pursuant to the Form C/A filed 29 April 2025
2 Filed as the initial Exhibit B attachment pursuant to the Form C filed 8 April 2025

FORM C/A AMENDMENT
FILED ON 29 APRIL 2025

ISSUER: IX Power Clean Water, Inc.

Pursuant to this Form C/A Amendment filed on 29 April 2025, the Offering Statement filed on 8 April 2025 is re-filed with the Issuer’s 2024-2023 Audited Financial Statements and Independent Auditor's Report included as an additional attachment to Exhibit B and the text relating to the pending appointment of Robert C. Rowe as a non-voting board observer is deleted (via strike through text). Due to conflicting commitments, Mr. Rowe has declined such non-voting board observer position.

The Issuer also is extending the end date for this Offering from April 30, 2025 to July 8, 2025.

The Issuer is amending the previously disclosed Time-Based ("Early Bird") Reward, which originally offered 10% Bonus Shares for the first 14 days of the Offering. The amended reward period now extends to 16 days. Accordingly, the Issuer confirms that the 10% Bonus Shares will be honored through the end of day on Thursday, April 24, 2025.

LIST OF EXHIBITS TO THIS FORM C/A FILED 29 APRIL 2025:

Exhibit A	Offering Memorandum: Part II of Offering Document, including Addendums 1, 2 and 3
Exhibit B*	2024-2024 Audited Financial Statements and Independent Auditor's Report for IX Power Clean Water, Inc.1 and 2023-2022 Audited Financial Statements and Independent Auditor's Report2
Exhibit C	Profile Pages
Exhibit D	Video Transcript
Exhibit E	Investing Process
Exhibit F	Existing Certificate of Incorporation of IX Power Clean Water, Inc.
Exhibit G	Existing Stockholder Agreement of IX Power Clean Water, Inc.

1 Added as an additional Exhibit B attachment pursuant to this Form C/A filed 29 April 2025
2 Filed as the initial Exhibit B attachment pursuant to the Form C filed 8 April 2025

Offering Memorandum: Part II of Offering Document
(Exhibit A to the Form C Offering Statement filed on 8 April 2025)

IX Power Clean Water, Inc.
Physical Address:
17301 West Colfax Ave, Suite 110
Golden, CO 80401
Mailing Address:
P.O. Box 16999
Golden, CO 80402
www.IxWater.com

This Offering Memorandum (this "Offering Memorandum")
is dated 8 April 2025

Up to $2,750,000.00 in Series CF Non-Voting Preferred Stock at $2.50
Minimum Target Amount: $20,000.00

NOTICE - OFFERING PERIOD: The initial end date for this Offering is April 30, 2025. This is a temporary end date, pending completion of the Company's financial audit for the fiscal year ended December 31, 2024 (FY24). The Company expects to complete its audited financial statements for FY24 during the month of April 2025, no later than April 30, 2025. Following completion of the audit, the Company intends to file an amendment to this Form C to include the FY24 audited financials and to extend the Offering end date from April 30, 2025 to July 8, 2025.

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment.

In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document.

The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature.

These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

In the event that we become a reporting company under the Securities Exchange Act of 1934, we intend to take advantage of the provisions that relate to "Emerging Growth Companies" under the JOBS Act of 2012, including electing to delay compliance with certain new and revised accounting standards under the Sarbanes-Oxley Act of 2002.

IX Water Offering Memorandum (8 April 2025)
Cover Page

IX Water Offering Memorandum (8 April 2025)

# Company:

Company: IX Power Clean Water, Inc.

Physical Address: 17301 West Colfax Ave, Suite 110, Golden, CO 80401

Mailing Address: P.O. Box 16999, Golden, CO 80402

State of Incorporation: DE

Date Incorporated: September 17, 2014

# Terms:

## Equity

Offering Minimum*: $20,000.00 | 8,000 shares of Series CF Non-Voting Preferred Stock

Offering Maximum*: $2,750,000.00 | 1,100,000 shares of Series CF Non-Voting Preferred Stock

Type of Security Offered: Series CF Non-Voting Preferred Stock (convertible into shares of the Company's Class B Non-Voting Common Stock as described herein)

Purchase Price of Security Offered: $2.50

Minimum Investment Amount (per investor): $250.00

*The Minimum and Maximum Number of Shares Offered each is subject to adjustment for bonus shares. See bonus shares information below. Fractional shares will not be distributed in any case. Shares issued for investment amounts above $250.00 will be determined by rounding down to the nearest whole share.

## Additional Investor Eligibility Criteria for this Offering

In addition to the investor requirements and limitations that are applicable to this Offering pursuant to Regulation Crowdfunding:

**U.S. Investors only:** Only U.S. investors may invest in this Offering. A US investor means any investor who/that is a "United States person," as defined in Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended.

**Verification of US Investor/Taxpayer Status, TIN/W-9 Requirements:** The terms of the Series CF Non-Voting Preferred Stock include a special dividend entitlement as further described herein. While the Company would typically verify U.S. investor/taxpayer status at a future date if and when a taxable event occurs (for example, a sale of the Company that results in distributable cash proceeds), the existence of the special dividend entitlement term in this Offering requires a different approach. To facilitate payment of any future cash dividends arising from the special dividend entitlement term, all investors in this Offering will be required to certify and verify their U.S. investor/taxpayer status as part of the investment subscription (commitment) and closing process. See Exhibit E to the Form C Offering Statement of which this Offering Memorandum forms a part for a description of the investing process for this Offering.

**ONLY PROSPECTIVE INVESTORS ABLE TO SATISFY THESE REQUIREMENTS SHOULD SUBMIT AN INVESTMENT SUBSCRIPTION (COMMITMENT) IN THIS OFFERING.**

Page 1

Terms (continued):

## Live Offering Company Perks and Investment Incentives*

Time-Based ("Early Bird") Rewards (not stackable, except with the 10% StartEngine Venture Club Bonus as further described on the next page):

16
First 44 Days | 10% Bonus Shares

Amount-Based Perks (not stackable, except with the 10% StartEngine Venture Club Bonus as further described on the next page):

$500+ | Investor Community Access

Receive updates about IX Water through our quarterly newsletter &amp; Semi-Annual "Open Mic with IX Force" web call.

$1,000+ | Stream

A free IX Water "Water to Save the World" T-Shirt

$2,500+ | River

5% bonus shares plus "Water to Save the World" T-Shirt and travel mug

$5,000+ | Lake

7% bonus shares plus IX Water tabletop meditation fountain plus IX Water "Water to Save the World" T-Shirt and travel mug

$10,000+ | Sea

10% bonus shares plus invite to tour the Company's facility to meet the IX-Force ("Our Team").

$100,000+ | Ocean

10% bonus shares plus accompany IX Water CEO, John "Grizz" Deal, on a sales &amp; marketing trip (location and details to be determined) to meet customers and/or prospects.

## The 10% StartEngine Venture Club Bonus (stackable):

The 10% StartEngine Venture Club Bonus is the only stackable bonus (perk). See the next page 3 for a full description of this perk.

*All perks (other than bonus shares) occur after the Offering is completed and for amount-based perks other than bonus shares, the Investor pays travel costs, accommodations provided.

*Perks are by threshold and will not include lower tiers.

*See additional terms applicable to bonus shares on the next pages 3-4.

IX Water Offering Memorandum (8 April 2025)

Terms (continued):

## Live Offering Company Perks and Investment Incentives* (continued)

## The 10% StartEngine Venture Club Bonus (stackable)

- IX Water will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Venture Club.
- This means eligible StartEngine Venture Club members will receive a 10% bonus for any shares they purchase in this Offering. For example, if you buy 100 shares of Series CF Non-Voting Preferred Stock at $2.50 per share (the $250 minimum investment in this Offering), you will receive 110 shares of Series CF Non-Voting Preferred Stock, meaning you will own 110 shares of Series CF Non-Voting Preferred Stock (which has an initial liquidation preference of $275) for $250. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
- This 10% StartEngine Venture Club Bonus is only valid during the investor's eligibility period. Investors eligible for this Bonus will also have priority if they are on a waitlist to invest and the Company surpasses its maximum funding goal. They will have the first opportunity to invest should room in this Offering become available if prior investments are canceled or fail.
- This 10% StartEngine Venture Club Bonus is the only "stackable" perk in this Offering, which means investors eligible to receive the 10% StartEngine Venture Club Bonus will receive the highest single bonus shares perk they are eligible for among the time-based ("early bird") and amount-based bonus share perks, not to exceed 10% bonus shares, plus the 10% StartEngine Venture Club Bonus, not to exceed for all such perks 20% bonus shares.

## Additional Terms, Bonus Shares

- If a subscriber in this Offering meets the eligibility requirements for time-based ("early bird") or amount-based bonus shares as set forth above, the relevant bonus shares will only be issued if, and concurrently with, the closing of the purchase and sale of the associated shares offered in this Offering for which the subscriber has subscribed in accordance with the applicable subscription and joinder agreement.
- All eligible time-based ("early bird") and amount-based bonus shares apply on a per investment commitment basis. The means that all eligible time-based ("early bird") and amount-based bonus shares will be determined for a particular (single) investment commitment transaction in this Offering. Investment commitment transactions (including investment commitment transactions that may be completed at the same "rolling closing" and/or at multiple "rolling closings" throughout the term of the Offering) may not be combined to meet any time-based ("early bird") or amount-based bonus perk requirement. The Company contemplates utilizing "rolling closings" for this Offering which could result in an investor receiving a lower number of bonus shares than a case where the Company has a single closing at the end of the Offering. For example, if the aggregate accepted investment commitment amounts of an investor at two separate investment commitment transactions (whether completed at the same "rolling closing" or two different "rolling closings") is $1,000 and $2,000, respectively, the investor is not eligible for the 5.0% Bonus Shares that would have been issued if the aggregate accepted investment subscription amount at a single closing at the end of the Offering was $3,000.

IX Water Offering Memorandum (8 April 2025)

Terms (continued):

## Live Offering Company Perks and Investment Incentives* (continued)

### Additional Terms, Bonus Shares (continued)

- Investors (other than investor eligible to receive the 10% StartEngine Venture Club Bonus) will receive the highest single bonus shares perk they are eligible for among the time-based ("early bird") and amount-based bonus share perks, not to exceed 10% bonus shares. Investors eligible to receive the 10% StartEngine Venture Club Bonus will receive the highest single bonus shares perk they are eligible for among the time-based ("early bird") and amount-based bonus share perks, not to exceed 10% bonus shares, plus the 10% StartEngine Venture Club Bonus, not to exceed for all such perks 20% bonus shares.
- Fractional shares will not be distributed and bonus shares will be determined by rounding down to the nearest whole share.

### Additional Terms, Amount-Based Perks other than Bonus Shares

- For amount-based perks other than bonus shares, the Company will aggregate all investments of a particular investor for this Offering at completion of the Offering to determine the level of amount-based perks (other than bonus shares).

### Eligible Investors will Receive only a Single Bonus

Eligible investors in this Offering will only receive a single bonus, which will be the highest bonus they are eligible for and, in the case of bonus shares, not to exceed 10% bonus shares or, in the case of an investor eligible to receive the 10% StartEngine Venture Club Bonus, 20% bonus shares.

### Limitations on Perks for Self-Directed IRAs

Crowdfunding investments made through a self-directed IRA cannot receive non-bonus share perks due to tax laws. The Internal Revenue Service (IRS) prohibits self-dealing transactions in which the investor receives an immediate, personal financial gain on investments owned by their retirement account. As a result, an investor must refuse those non-bonus share perks because they would be receiving a benefit from their IRA account.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)

# The Company and its Business

## Company Overview

IX Power Clean Water, Inc. (the "Company" or "IX Water") is a manufacturing, marketing, sales, support, and services company focused on innovative water treatment systems for unconventional sources of water. The Company sells water treatment systems that clean up the most contaminated waters: those from industry, mining, and oil &amp; gas recovery, landfills, chemical manufacturing, and refining. Unconventional sources of water can contain deadly chemicals including metals, heavy metals, hydrocarbons, scalants, and salts. Water treated by IX Water systems can be reused by industry, recycled for other uses, or discharged to the environment.

In addition to sale of water treatment systems, the Company's Board of Directors has authorized a new services division, "IX Water Reclamation" ("the division," "IX Water Reclamation," or "Reclamation"). This section of this Offering Memorandum (describing the Company and its business) explains the Company's plans for the capitalization, development, and operation of the new Reclamation business unit in addition to our existing business of manufacturing and selling IX Water treatment systems. The Company has not formed a subsidiary or other legal entity for operation of IX Water Reclamation. IX Water Reclamation is a division and business unit of the Company and so it is part of the Company.

IX Power LLC, a separate entity, is the founding shareholder ("Founder") of the Company. All the owners of IX Power LLC have been involved with the Company's business, as part of the management team or in another capacity, since the Company's incorporation in September of 2012 (with the exception of Dr. L. Robert (Bob) Libutti, who passed in February 2024).

Today, the Company is a registered Delaware "C" corporation. The Company is the surviving entity of a re-incorporation merger that occurred on September 26, 2014. The Company was originally incorporated as a New Mexico corporation on June 25, 2012. On September 26, 2014, IX Power Clean Water, Inc., a New Mexico corporation, was merged into and with IX Power Clean Water, Inc., a Delaware corporation, with the Delaware corporation continuing in existence as the surviving entity.

The Company is a spin-out from Los Alamos National Laboratory (LANL) in the U.S.A. and holds exclusive rights to technology developed at LANL, as well as to innovations developed solely by the Company. The IX Water management team has commercialized innovations from the U.S. Department of Energy for over 30 years and has spun out seven firms from U.S. DOE facilities.

In May 2020, the Company launched its first Regulation Crowdfunding (Regulation CF) crowdfunding campaign hosted by funding portal StartEngine Capital LLC, which initial crowdfunding campaign concluded earlier in 2022 and raised over $1.95 million (also sometimes referred to in this Offering Memorandum and/or or one or more of the Addendums hereto, as applicable, as the "initial crowdfunding campaign" or the "Initial Crowdfunding Offering"). The security offered and sold/issued in such initial crowdfunding campaign was shares of the Company's non-voting common security. The Company spent the five years prior to the launch of such initial crowdfunding campaign and over $2.5 million developing, testing, and validating its products with industry. For additional details and information regarding these prior offerings, see the section of this Offering Memorandum titled "Recent Offerings of Securities" (pp. 32-24 of this Offering Memorandum).

In October 2022, the Company authorized and designated a non-voting preferred security of the Company, Series CF Non-Voting Preferred Stock, for use in Regulation Crowdfunding (Reg CF) equity crowdfunding campaigns to raise up to $5 million of new capital for the foreseeable future

IX Water Offering Memorandum (8 April 2025)

(designated as a period of up to three years from the launch of the first such additional crowdfunding offering, which launch occurred on 17 November 2022 and so the expiration of such three-year period is 17 November 2025). This is sometimes referred to in this Offering Memorandum as the "existing equity crowdfunding strategy" of the Company and is further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). Based upon changes in market terms for equity crowdfunding campaigns since the October 2022 authorizations, including increases in equity compensation fees and allocations for bonus shares perks, Company management believes that the maximum amount to be raised under the current authorizations (i.e., without a requirement to obtain new voting shareholder approvals) is between $3.2 and $3.5 million, and not $5 million.

The first crowdfunding campaign utilizing the Series CF Non-Voting Preferred Stock launched on 17 November 2022 and concluded on 28 April 2024 (such crowdfunding campaign is sometimes referred to in this Offering Memorandum as the/this "Series CF Crowdfunding Offering #1" and was previously referred to in certain of the Company's Regulation Crowdfunding filings as the "additional crowdfunding campaign" or the "Additional Crowdfunding Offering"). Such Series CF Crowdfunding Offering #1 was hosted by a different funding portal, Wefunder Portal, LLC, with a maximum offering amount of $2 million. At conclusion of such offering, the Company had issued 188,904 shares of the Series CF Non-Voting Preferred Stock (including 17,170 "bonus shares," equivalent to 10% "bonus shares") in exchange for $429,335 aggregate cash consideration (approximately 21.5% of the $2 million maximum amount for such offering).

Although the $2 million maximum offering amount was not fully raised at conclusion of the Series CF Crowdfunding Offering #1, Company management continues to believe that executing this Offering as part of the existing equity crowdfunding strategy provides the Company with the best available opportunity to continue to raise additional capital in the near term, including for the planned start-up funding for its new services division, "IX Water Reclamation" (also referred to in this Offering Memorandum as the "Reclamation LOB"). In addition, our crowdfunding investors are some of our most passionate and engaged stakeholders. Equity crowdfunding continues to be integral to the Company's mission so we would like to offer our existing owners the opportunity to invest in this Offering, whether they did or did not invest in the Series CF Crowdfunding Offering #1 hosted by Wefunder Portal, LLC, in addition to growing and expanding our crowdfunding community.

This crowdfunding campaign (which is sometimes referred to in this Offering Memorandum as this Offering or the Series CF Crowdfunding Offering #2) is the second crowdfunding campaign pursuant to the Company's existing equity crowdfunding strategy, and is being hosted by StartEngine Primary LLC - an affiliate of StartEngine Capital LLC, the funding portal/intermediary for the Company's Initial Crowdfunding Offering. The maximum offering amount for this Series CF Crowdfunding Offering #2 is $2.75 million, which if fully raised, will result in aggregate gross cash proceeds for both the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2, on a combined basis, of $3,179,335.00.

Since the $2 million maximum amount of the Series CF Crowdfunding Offering #1 was not fully raised at conclusion of such offering: (1) the Company is delayed in commencement of the new IX Water Reclamation service business, which means such new line of business is not yet reflected in the Company's financial statements and that no special dividend has yet accrued or is payable on shares of Series CF Non-Voting Preferred Stock that were issued and outstanding as of 31 December 2024; and (2) the Company has recast and revised its projected operating plan, as further described in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum).

IX Water Offering Memorandum (8 April 2025)
Page 6

As a recent update, the Company's Board of Directors has authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with securing (i) approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and (ii) an additional $10 million credit facility which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days as well as provide an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws.

## How We Generate Revenue

With creation of the new Reclamation service line of business, the Company now generates revenue in two operating units (divisions) as seen in the chart below.

| IX Water Systems | IX Water Reclamation |
| --- | --- |
| Sales of IX Water Systems |  |
| Service & Support | Treatment of wastewater; revenue based on volume treated |
| Replacement Media |  |

Total costs for using IX Water systems are at least 50% less expensive than other known methods, including dumping the contaminated water or treating using other methods. Potential customer sales of IX Water systems range from $200,000 to $12 million depending on number of modules required to create a plant to treat specific daily volumes of water. Water treated with IX Water systems meets or exceeds the stringent standards for reuse, recycling, and discharge to the environment.

As discussed in the "Updated Projected Operating Plan" section below (pp. 8-9 of this Offering Memorandum), in connection with the authorization of the Reclamation division, the Company's management prepared an updated four-year projected operating plan, commencing 1 December 2022 (such 1 December 2022 is tied to the launch of the Series CF Crowdfunding Offering #1), which plan has been recast and revised on two occasions since 1 December 2022 to account for the results of the recently concluded the Series CF Crowdfunding Offering #1 and the date of launch of this Series CF Crowdfunding Offering #2, as further described in such section. The projected revenue per Reclamation customer is $456,250 to $684,375 per annum, per well pad, per block (a block is the daily amount of water treated).

As further described under "Global Marketing Program - Treatment Systems Business" below in this section: (1) the Company has developed a vigorous marketing program (direct contact with potential customers) and an initial sales pipeline that supports management's revenue projections (with certain timeline adjustments to conform to the updated projected operating plan); and (2) additional capital will allow the Company to expand its existing sales of IX Water treatment systems along with providing start-up capital for the IX Water Reclamation service business.

IX Water Offering Memorandum (8 April 2025)

IX Water Offering Memorandum (8 April 2025)
Page 8

## Competitors and Industry

We operate in a highly competitive and rapidly changing global marketplace and compete with a variety of organizations that offer products competitive with those we offer. We believe that the principal competitive factors in the industries in which we compete include: innovation and the evolution of water treatment technologies; elimination of chemical additives and long biologic degradation processes; and smaller infrastructure and land use. The driving force for the industry, besides treatment efficacy, is lowering costs.

We believe our primary competitors in the Reclamation business are local well and water service operators that have traditionally moved produced water from well-head to disposal well or evaporation pond. In our view, both methods lose the valuable water resource that could be treated and used for regional agricultural purposes. We believe IX Water Reclamation can offer these businesses the opportunity to partner with the Company to evolve their business into treatment services. However, these businesses may not agree with the Company that there is mutual value in these partnering opportunities.

We believe our primary competitors in the treatment systems business are municipal water treatment firms, such as GE, Veolia Environnement, Suez Environnement Group, and Siemens, that have taken ordinary freshwater treatment methods and adopted them for use with heavily contaminated industrial waters. In our view, these methods are either ineffective or the cost and time required for sufficient efficacy to meet standards make them unaffordable. IX Water systems have proven to be effective and at least 50% less expensive than known alternatives.

## Corporate Development

The Company secured the intellectual property rights to its technology in 2013 and, through the support of its founder IX Power LLC, spent two years surveying the market to fully understand what kind of product needed to be built to be 1) durable, 2) easy to use, 3) effective, and 4) beat customer cost expectations.

The Company and its founder IX Power LLC took the time and capital necessary to design the product required by the oil &amp; gas, landfill, and mining industries. This required several iterations of design/test/redesign/test cycles, over the course of about three years.

Product development has "unknown unknowns," and the Company's product development required an additional 24 months longer than the Company and its founder IX Power LLC initially planned. The result is a robust suite of scalable machines that meet the need and desires of several industrial sectors.

Our product line has been commercially tested and validated through treatment samples analyzed by US EPA licensed laboratories. IX Water machines are now being manufactured for our initial customers using our fully developed supply chain at our existing facilities in Golden, Colorado along with assistance from contracted sub-assembly vendors. Additional manufacturing capacity can be added without additional capital, as unit sales grow.

## Updated Projected Operating Plan

In connection with the authorization of the new Reclamation line of business, the Company prepared an updated four-year projected operating plan, commencing 1 December, 2022 and continuing through December 2026. This updated projected operating plan addressed both the new Reclamation line of business and the Company's existing treatment systems business and assumed the maximum offering amount of $2,750,000 in Series CF Crowdfunding Offering #1 would be raised. Such Series CF Crowdfunding Offering #1 concluded 29 April 2024, and the $2 million maximum amount was not fully raised at conclusion of the offering. Such Series CF Crowdfunding Offering #1 raised approximately 21.5% of such $2 million maximum amount. Based on these

results, as part of the Company's Annual Report filing submitted 29 April 2024, the Company revised the four-year projected operating plan, commencing 1 December, 2022, for the following: (1) the term of the plan was changed from a four-year projected operating plan to a five-year projected operating plan, continuing through December 2027; (2) the first year of the four-projected operating plan was adjusted to equate to the first two years of the five-year projected operating plan; and (3) the $2 million maximum amount of a next equity crowdfunding campaign is retained, but such $2 million maximum amount is updated to include the next one or more offerings implemented as part of the Company's existing equity crowdfunding strategy (to occur by 17 November 2025 per the current authorizations), as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum), which offerings include, but are not necessarily limited to, the recently concluded Series CF Crowdfunding Offering #1 and this Series CF Crowdfunding Offering #2.

The revisions to the Company's projected operating plan that were implemented as part of the Company's Annual Report filing submitted 29 April 2024 (and which are described above) assumed that the Series CF Crowdfunding Offering #2 would launch shortly after conclusion of the Series CF Crowdfunding Offering #1 and, in any event, during the Company's second quarter of 2024 (which is the quarter ending June 30, 2024). With the actual launch date of the Series CF Crowdfunding Offering #2 occurring at the beginning of the Company's second quarter of 2025 (which is the quarter beginning April 1, 2025 and ending June 30, 2025), the Company has further revised the projected operating plan, commencing 1 December, 2022, for the following: (1) the term of the plan is further extended from the most recent five-year projected operating plan to a six-year projected operating plan, continuing through December 2028; (2) the first year of the four-projected operating plan, which was previously adjusted to equate to the first two years of the recent, updated five-year projected operating plan, is now adjusted to equate to the first three years of the six-year projected operating plan; and (3) the $2 million maximum amount of a next equity crowdfunding campaign is retained, but such $2 million maximum amount is updated to include the next one or more offerings implemented as part of the Company's existing equity crowdfunding strategy (to occur by 17 November 2025 per the current authorizations), as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum), which offerings include, but are not necessarily limited to, the recently concluded Series CF Crowdfunding Offering #1 and this Series CF Crowdfunding Offering #2.

As noted above, if the $2.75 million maximum offering amount for this Series CF Crowdfunding Offering #2 is fully raised, the aggregate gross cash proceeds for both the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2, on a combined basis, will be $3,179,335.00, which aligns with the targeted next crowdfunding campaign(s) in the aggregate minimum amount of $2 million.

For clarity, projections are only projections. See the risk factors sections of this Offering Memorandum and the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A.

## Global Marketing Program - Treatment Systems Business

The Company's initial crowdfunding campaign (for additional details and information regarding the initial crowdfunding campaign, see the section of this Offering Memorandum titled "Recent Offerings of Securities" (pp. 32-24 of this Offering Memorandum), supported the Company's efforts to develop a vigorous marketing program (direct contact with potential customers) for its treatment systems business. The Company has developed an initial possible $50 million sales pipeline for its treatment systems business, with approximately $5 million of that in sales potential for the first three years of the Company's updated six-year projected operating plan (revised from the prior iterations of such projected operating plan, as described in the previous section) that

IX Water Offering Memorandum (8 April 2025)

supports management's revenue projections (for clarity, projections are only projections; see the risk factors sections of this Offering Memorandum and the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A). A sales pipeline is a way of tracking the progress of deals that your sales team is currently working on and expect to close within a reasonable amount of time. In the case of the Company, we view a sales pipeline as a three-year look ahead. The Company currently intends to rely on this Offering and its recently expanded overall capital raising strategy for the additional capital to allow the Company to expand its existing sales of IX Water treatment systems along with providing start-up capital for the IX Water Reclamation service business. For additional details regarding the Company's existing equity crowdfunding strategy, see the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). For additional details regarding the Company's expanded overall capital raising strategy, see the section of this Offering Memorandum titled "Updated Overall Capital Raising Strategy" (p. 37 of this Offering Memorandum).

## About IX Water Reclamation

## Overview of New Reclamation Division

In addition to sale of water treatment systems, the Company's Board of Directors has authorized a new services division, "IX Water Reclamation" ("the division," or "IX Water Reclamation, or "Reclamation"). The Company has not formed a subsidiary or other legal entity for operation of IX Water Reclamation. IX Water Reclamation is a division/business unit of the Company and so it is part of the Company.

IX Water Reclamation has been authorized to meet the following objectives:

- Operate IX Water wastewater treatment systems as a service for industry and charge for treatment of unconventional sources of water on a volume basis.
- Provide a showcase for IX Water wastewater treatment systems.
- Provide immediate and on-going revenue to the Company.
- Enable a new source of water for agriculture.
- Provide a model for how unconventional sources of water can be treated and deployed to water stressed regions around the world.

The Company is in the process of developing the IX Water Reclamation line of business. Start-up capital for the IX Water Reclamation service business remains a primary intended use of proceeds for this Series CF Crowdfunding Offering #2. See the "Use of Proceeds" section of this Offering Memorandum (pp. 61-62 of this Offering Memorandum).

The IX Water Reclamation line of business, as described above, is sometimes referred to in this Offering Memorandum (including in relation to the special dividend entitlement of the Company's Series CF Non-Voting Preferred Stock, which is the security authorized for the Company's existing equity crowdfunding strategy and offered in this crowdfunding campaign) as the "Reclamation LOB." As of the date of this Offering Memorandum, the Reclamation LOB is referred to by the Company as "IX Water Reclamation"; however, for clarity, the Reclamation LOB shall mean the Reclamation LOB, as defined herein, whether referred to by the Company as "IX Water Reclamation" or a successor or alternative name.

IX Water Offering Memorandum (8 April 2025)

# Initial Customer Service Area for IX Water Reclamation

The initial customer service area for the Reclamation division will be in Bakersfield, California to serve the Southern Central (San Joaquin) Valley, including Kern County.

Kern County is home to $8 billion of annual agricultural production and 119 million bbl (42 gallon barrels) of oil and 129 billion CF (cubic feet) of gas annually1 from some 47,750 wells. The oil wells in the region are in many cases integrated within farm acreage or in a nearby field, providing a natural place to discharge treated oil &amp; gas produced water.

Despite the dramatic increase in rain and snow during the 2022/2023 Winter, this area continues to suffer through drought. Most all of the extra precipitation ran across dry gully and riverbeds into the Pacific Ocean.

![img-0.jpeg](img-0.jpeg)
Kern County, CA - Wells and Farm Land

# Reclamation Rigs &amp; Water Gang Description

A "Rig" is a term used by the Company to refer to each IX Water system deployed by the Company for the new Reclamation service business. A "Water Gang" is the term used by the Company to refer to the driver and an operator/engineer for each IX Water Rig. The driver will most likely be a contract tractor-trailer driver, and the operator/engineer will most likely be either IX Water personnel or contracted well service personnel. The number of Rigs and composition of the Water Gang for a particular Reclamation project will depend on customer need and physical location. While IX Water Rigs are highly automated and could operate 24/7/365, deployment and relocation of a Rig is dependent on the Water Gang and is hard, vigorous work. The environment of the customer's physical location also affects a customer's Reclamation service plan. For example, the environment in the San Joaquin Valley is harsh with brutally hot summers and chilly winters. As a result, in the initial phase of the new service business, the Company's management expects to operate the IX Water Rigs only for particular times during days of operation and for non-continuous operating periods, so that there will be operating cycles with "on" and "off" days, as determined for each customer depending on customer need and physical location.

1 KEDF-Economic-Contribution-of-the-Oil-and-Gas-Industry-in-Kern-County_-2021.pdf, accessed 19 July 2022

IX Water Offering Memorandum (8 April 2025)

The Company's current business plan for the Reclamation division is to compensate Water Gangs with a fixed amount along with a small royalty for each unit of wastewater treated. The Company's management may adjust this compensation structure as its Reclamation business activities commence and progress.

## Target Market for Reclamation Division

IX Water Reclamation will initially focus on small to medium sized oil &amp; gas operators that either do not have, or do not want to deploy, the capital to purchase their own IX Water system, or those that would prefer to just outsource the disposition of their produced water.

## Additional Information - Competitors and Industry for Reclamation Division

The Company's initial customer service area for the Reclamation division - Southern California - is a highly competitive marketplace and the Company will compete with a variety of organizations that offer products and services offerings competitive with those we offer.

We believe that the principal competitive factors in the industries in which we compete with respect to the Reclamation division include: innovation and the evolution of water treatment technologies; charging a "by the barrel" fee instead of forcing customers to buy and operate capital equipment; elimination of chemical additives and long biologic degradation processes; and smaller infrastructure and land use. The driving force for the industry, besides treatment efficacy, is lowering costs.

As noted above in the "Competitors and Industry" section, we believe our primary competitors in the Reclamation business are local well and water service operators that have traditionally moved produced water from well-head to disposal well or evaporation pond. In our view, both methods lose the valuable water resource that could be treated and used for regional agricultural purposes. We believe IX Water Reclamation can offer these businesses the opportunity to partner with the Company to evolve their business into treatment services. However, these businesses may not agree with the Company that there is mutual value in these partnering opportunities.

## Personnel

At the time of launch of this crowdfunding campaign, the Company has no full-time employees, but rather has at any one time 12 to 15 people working as contractors or stockholders contributing time and talents to the Company. The Company's updated six-year projected operating plan, commencing 1 December 2022 (such 1 December 2022 is tied to the launch of the Series CF Crowdfunding Offering #1), that is referenced above in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum) (revised from the prior iterations of such projected operating plan, as further described in such section) includes the following assumptions for increases in full-time equivalent (FTE) personnel, which generally scale with projected increases of revenue year to year: Years 1-3: 12 FTEs; Year 4: 13 FTEs; Year 5: 29 FTEs; and Year 6: 31 FTEs. For clarity, projections are only projections; see the risk factors sections of this Offering Memorandum and the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A

Manufacturing personnel and Reclamation Water Gang personnel are not included in these FTE personnel assumptions since the cost of such personnel is built into the Company's cost of goods sold (COGS) model for all lines of business. As to the Company's treatment systems line of business, the method of manufacturing provides Company management flexibility to scale their just-in-time manufacturing through the hiring of contracted manufacturing personnel or outsourcing, as needed.

IX Water Offering Memorandum (8 April 2025)

# Targeted Future Sale of the Company / Speculative Nature of Exit Projections

The Company has a single overriding goal: to provide our technology and solutions as far and wide as possible. Management recognizes that it is difficult to achieve such a goal organically so the projected operating plan is prepared to target an exit/liquidity event through a sale of the Company. The Company previously targeted an exit/liquidity event to occur three to four years following the launch of the Company's initial crowdfunding campaign (which launch occurred in May 2020). In connection with the authorization of the IX Water Reclamation line of business and the updated projected operating plan referenced above in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum) (revised from the prior iterations of such projected operating plan, as further described in such section), the Company is now targeting an exit/liquidity event to occur four to six years (adjusted from the previously published three to four year and four to five year time frames) following the launch of the Series CF Crowdfunding Offering #1, which launch occurred on 17 November, 2022.

The Company's targeted timeline for an exit or liquidity event is highly speculative and subject to numerous factors outside of the Company's control. While the Company may consider strategic opportunities such as a sale or merger, there are no current negotiations, agreements, or plans in place for any such event. Investors should not rely on any projected timeline or anticipated liquidity event as a basis for investment. The Company is in the early stages of revenue generation, having reported approximately $100,000 in revenue in 2023, and has not yet demonstrated consistent profitability or growth. The timing and nature of any exit or liquidity event will depend on numerous market conditions, economic factors, and regulatory considerations, which may change over time. Even if a liquidity event occurs, there is no assurance that the Company's valuation at that time will result in a positive return for investors, and investors may experience a partial or total loss of their investment. Any statements regarding future liquidity events are forward-looking and inherently uncertain, and actual results may differ materially from those expressed or implied in such statements. Investors are encouraged to review the Risk Factors section of this Offering Memorandum and the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A for additional information.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 13

The Team: Officers and Directors

Name: John R. (Grizz) Deal
John R. (Grizz) Deal's current primary role is with the Issuer.

Positions and offices currently held with the issuer:
- Position: Executive Chairman &amp; Chief Executive Officer, and serves on the Company's Board of Directors (Director)
Dates of Service: June 25, 2012 - Present
Responsibilities: Mr. Deal has served as an executive officer and director of the Company since the Company's incorporation on June 25, 2012. Mr. Deal is currently serving on the Company's board of directors in one of the two director seats designated by the Company's founder IX Power LLC.

Other business experience in the past three years:
- Employer: New Mexico Desalination Association (501-C6 non-profit corporation)
Title: Vice President
Dates of Service: February 01, 2022 - August 2024
Responsibilities: Volunteer officer position. This Association promotes and assists the desalination industry in New Mexico and the Southwest by developing professional and stakeholder knowledge of current and emerging desalination approaches, technologies, and applications.

Name: Randall (Randy) Wilson
Randall (Randy) Wilson's current primary role is with the Issuer.

Positions and offices currently held with the issuer:
- Position: Chief Financial Officer, and serves on the Company's Board of Directors (Director)
Dates of Service: June 25, 2012 - Present
Responsibilities: Mr. Wilson has served as an executive officer and director of the Company since the Company's incorporation on June 25, 2012. Mr. Wilson is currently serving on the Company's board of directors in one of the two director seats designated by the Company's founder IX Power LLC.

Other business experience in the past three years:
- Employer: New Mexico Angels
Title: Treasurer
Dates of Service: April 01, 1999 - Present
Responsibilities: Management and oversight of the financial affairs of the organization.
- Employer: Sandia Science &amp; Technology Park Development Corporation
Title: Chief Financial Officer
Dates of Service: July 01, 1998 - Present
Responsibilities: Management and oversight of the financial affairs of the organization.

IX Water Offering Memorandum (8 April 2025)
Page 14

IX Water Offering Memorandum (8 April 2025)
Page 15

# The Team: Officers and Directors (continued)

Name: Robert S. Bednarz, Ph.D.

Dr. Bednarz's current primary role is as a retired professor of geography and independent board director. Dr. Bednarz's currently services four hours per week in his role with the Issuer.

Positions and offices currently held with the issuer:

- Position: Director
- Dates of Service: October 26, 2022 - Present
- Responsibilities: Dr. Bednarz was appointed to the Company's Board of Directors, effective October 26, 2022, and is currently serving in the board seat designated and elected by the holders of a majority of the outstanding shares of Class A Common Stock. Dr. Bednarz replaced Dr. Libutti as such director seat designee, effective October 26, 2022.

Name: John Michael (Michael) Bell

John Michael (Michael) Bell's current primary role is with Bell Commercial Real Estate Advisors, LLC. John Michael (Michael) Bell currently services four hours per week in their role with the Issuer.

Positions and offices currently held with the issuer:

- Position: Director
- Dates of Service: May 17, 2014 - Present
- Responsibilities: Michael Bell was appointed to the Company's Board of Directors, effective May 17, 2014, and is currently serving in the "fifth director" board seat.

Other business experience in the past three years:

- Employer: Bell Commercial Real Estate Advisors, LLC
- Title: Broker &amp; Principal, Commercial Real Estate
- Dates of Service: January 01, 2009 - Present
- Responsibilities: Mr. Bell creates or participates in project teams to build or buy commercial properties. He delivers personalized scope of services to help clients and partners create and maximize investment yield and identifies opportunities for more efficient financial and operating performance of multi-family and commercial assets.

- Employer: 10X Tech Ventures, LLC
- Title: Principal
- Dates of Service: January 01, 2012 - Present
- Responsibilities: Angel, Seed, Series A&amp;B investing in technology companies that focus on Eco-Sustainable and Mil-Spec enterprises.

[Remainder of this page intentionally left blank.]

The Team: Officers and Directors (continued)

Name: Deborah A. (Deal) Blackwell

Deborah A. (Deal) Blackwell's current primary role is with the Issuer.

Positions and offices currently held with the issuer:

- Position: Chief Marketing Officer
Dates of Service: June 25, 2012 - Present
Responsibilities: Ms. Blackwell has served as the principal officer in charge of the Company's marketing since the Company's incorporation on June 25, 2012.

Other business experience in the past three years:

- Employer: IX Power Foundation, Inc.
Title: Chief Executive Officer
Dates of Service: December 01, 2012 - Present
Responsibilities: Ms. Blackwell serves as the CEO of the IX Power Foundation and is responsible for all day-to-day operations. IX Power Foundation, Inc. is a 501(c)(3) non-profit entity (also referred to by the Company as a non-governmental organization, or NGO) that was founded by the Company's founder, IX Power LLC, to advance innovative technologies, and the issues surrounding power and clean water for developed, developing and undeveloped regions of the world. Currently, special emphasis is on cleaning produced water from the oil and gas industry, and on cleaning drinking water.

- Employer: Joni Inman Consulting, LLC
Title: Ms. Deal is an associate and consultant with Joni Inman Consulting, LLC.
Dates of Service: January 01, 2019 - August 2023
Responsibilities: Business consulting services.

Name: Robert (Bob) FitzGerald

Robert (Bob) FitzGerald's current primary role is as retired. Upon completion of his appointment to the Company's Board of Directors (expected to occur by end of April 2025), Robert (Bob) FitzGerald will service four hours per week in their role with the Issuer.

Positions and offices currently held with the issuer:

- Position: Director (pending as of the date of launch of this Offering; see below)
Dates of Service: Pending as of the date of launch of this Offering (expected to occur by end of April 2025)
Responsibilities: *Mr. FitzGerald's appointment to the Company's Board of Directors is pending as of the date of launch of this Offering, expected to occur by end of April 2025. Upon completion of his appointment, Mr. FitzGerald will occupy the board seat designated and elected by the holders of the Company's Series A Preferred Stock, succeeding Paul Gatzemeier with respect to such director seat. The Company is saddened to announce the death of former director Paul Gatzemeier who passed in March 2024. As of the date of launch of this Offering, the Company is soliciting the required approvals (per the Company's existing certificate of incorporation and stockholder agreement) to designate and appoint Mr. FitzGerald as the successor Series A Director; the Company expects that Mr. FitzGerald's appointment will occur by end of April 2025.

IX Water Offering Memorandum (8 April 2025)
Page 16

IX Water Offering Memorandum (8 April 2025)
Page 17

# The Team: Officers and Directors (continued)

Name: Robert (Bob) FitzGerald (continued)

Other business experience in the past three years:

Mr. FitzGerald is retired. He holds BS in Business from Rocky Mountain College (RMC) and a Masters in Business Management from the University of Denver. Mr. FitzGerald sang professionally for 50 years all over the US, recorded two albums, performed for several national TV shows. Mr. FitzGerald also worked as a political campaign manager and ran two successful campaigns for US Senator Max Baucus. He was also a major gifts fundraiser for RMC, the Helena Symphony and other assorted causes.

# Note, Former Director and Officer Dr. Libutti:

The Company is saddened to announce the death of former director and officer Dr. L. Robert (Bob) Libutti, who passed in February 2024.

Name: Dr. Otis (Pete) Peterson

Dr. Otis (Pete) Peterson's current primary role is with the Issuer.

Positions and offices currently held with the issuer:

- Position: Chief Technical Officer
- Dates of Service: June 25, 2012 - Present
- Responsibilities: As Chief Technical Officer of the Company, Dr. Peterson supervises the review of all technologies and the coordination of research efforts in the public and private sectors. Dr. Peterson has served as the Company's chief technical officer since the Company's incorporation on June 25, 2012.

# Note, Non-Voting Board Observer Robert C. Rowe:

Robert C. Rowe is being appointed as a non-voting board observer, effective on or about the effective date of Robert (Bob) FitzGerald's appointment as a director of the Company (expected to occur by end of April 2025). Subject to the Company's right to exclude or limit Mr. Rowe's access if the Company believes, upon advice of counsel, that such exclusion is reasonably necessary to preserve the attorney-client privilege or other applicable legal privilege or to protect highly confidential proprietary information such as trade secrets, Mr. Rowe is entitled to attend meetings of the Company's board of directors in a non-voting observer capacity, and to receive copies of all notices, minutes, consents, and other material or information that it provides to members of the Board in their capacities as directors in connection with such meetings. Mr. Rowe's appointment as a non-voting board observer will continue until the first to occur of: (1) immediately prior to the consummation of the sale of shares of Common Stock in the Company's first underwritten public offering of its Common Stock under the Securities Act of 1933, as amended; (2) when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the Securities Exchange Act of 1934 (or any similar successor federal statute); (3) the consummation of a Deemed Liquidation Event (as defined in the Company's certificate of incorporation) or other Sale of the Company (as defined in the Stockholder Agreement); (4) termination of the Stockholder Agreement in accordance with its terms; or (5) the mutual agreement of Mr. Rowe and the Company. Position declined due to conflicting commitments.

The Team: Officers and Directors (continued)

Note, Non-Voting Board Observer Robert C. Rowe (continued):

Mr. Robert C. Rowe is the former President, Chief Executive Officer, Director of NorthWestern Corp. Prior to joining the NorthWestern, Mr. Rowe was co-founder and senior partner at Balhoff, Rowe &amp; Williams, LLC, a specialized national professional services firm providing financial and regulatory advice to clients in the telecommunications and utility industries (January 2005-August 2008). Prior to that, Mr. Rowe was Chairman (2003-2004) and Commissioner (1993-2002) of the Montana Public Service Commission. Chairman of Western Energy Institute (2012-2013); Co-Chair of the Institute of Electric Innovation, an institute of the Edison Electric Foundation focused on advancing the adoption of innovative and efficient technologies among electric utilities and their technology partners that will transform the power grid. Position declined due to conflicting commitments.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 18

# Risk Factors

The SEC requires the Company to identify risks that are specific to its business and its financial condition. The Company is still subject to all the same risks that all companies in its business, and all companies in the economy, are exposed to. These include risks relating to economic downturns, political and economic events and technological developments (such as hacking and the ability to prevent hacking).

Additionally, early-stage companies are inherently more risky than more developed companies. You should consider general risks as well as specific risks when deciding whether to invest.

These are the risks that relate to the Company:

## Uncertain Risk

An investment in the Company (also referred to as "IX Water," "Nine Power," "we", "us", "our", or "Company") involves a high degree of risk and should only be considered by those who can afford the loss of their entire investment. Furthermore, the purchase of any of the Series CF Non-Voting Preferred Stock (convertible into shares of the Company's Class B Non-Voting Common Stock as described herein) should only be undertaken by persons whose financial resources are sufficient to enable them to indefinitely retain an illiquid investment. Each investor in the Company should consider, on its own or with such investor's independent personal advisors, all of the information provided to such potential investor regarding the Company as well as the following risk factors (as supplemented by Addendum 1 to this Exhibit A), in addition to the other information listed in the Form C Offering Statement of which this Offering Memorandum forms a part. The following risk factors, including as supplemented by Addendum 1 to this Exhibit A, are not intended, and shall not be deemed to be, a complete description of the commercial and other risks inherent in the investment in the Company. Additional risk factors not presently known to the Company or that the Company currently deems immaterial may also impair the Company. The Company's business, financial condition, results of operations or prospects could be materially and adversely affected by any of these risks. In such case, an investor could lose all or part of his, her or its investment. The order in which the risks are presented is not intended to represent the magnitude of the risks described.

## Our business projections are only projections

There can be no assurance that the Company will meet our projections. There can be no assurance that the Company will be able to find sufficient demand for our product, that people think it's a better option than a competing product, or that we will be able to provide the service at a level that allows the Company to make a profit and still attract business.

## Any valuation at this stage is difficult to assess

The valuation for the Offering was established by the Company. We did not seek or obtain an opinion of a financial advisor or third-party valuation firm in establishing valuation for the offering. Unlike listed companies that are valued publicly through market-driven stock prices, the valuation of private companies, especially startups, is difficult to assess and you may risk overpaying for your investment. The purchase price of the shares of the Series CF Non-Voting Preferred Stock (convertible into shares of the Company's Class B Non-Voting Common Stock as described herein) offered in this crowdfunding campaign is not related to earnings, book value, or net worth of the Company and should not be considered to be an indication of the actual value of the Company, the Series CF Non-Voting Preferred Stock, Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein, any other security of the Company. There is not now nor is there expected to be a public market for any securities of the Company, including the Series CF Non-Voting Preferred Stock offered in this crowdfunding campaign or the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein; and the Company makes no representations or warranties, actual or implied that any of the Series CF Non-Voting Preferred Stock purchased in

IX Water Offering Memorandum (8 April 2025)

this crowdfunding campaign (or any of the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein) can be resold at the $2.50 offering price per share or any other price. Before making an investment decision, you should carefully consider this valuation and the factors used to reach such valuation. Such valuation may not be accurate, and you are encouraged to determine your own independent value of the Company prior to investing.

## The transferability of the Securities you are buying is limited

Any Series CF Non-Voting Preferred Stock purchased in this crowdfunding campaign (as well as the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein) purchased through this crowdfunding campaign is subject to substantial legal and contractual restrictions on transfer, including restrictions on resale. The legal restrictions on transfer include (1) SEC limitations on transfer (one-year resale restriction, subject to certain limited exceptions, per Regulation Crowdfunding) and (2) any applicable limitations on transfer imposed under the securities laws of the states or other jurisdictions in which such Series CF Non-Voting Preferred Stock may be offered or sold. In addition to restrictions on transfer and resale under applicable securities laws: (a) the Series CF Non-Voting Preferred Stock (and, if applicable, any and all shares of Class B Non-Voting Common Stock that may be issued upon any conversion of such Series CF Non-Voting Preferred Stock) will be held by the purchaser thereof subject to all of the provisions of the certificate of incorporation and bylaws of the Company as in effect from time to time; and (b) as a condition to the issuance of any Series CF Non-Voting Preferred Stock in this crowdfunding campaign, the purchaser thereof will be required to become a party to and be bound by the Company's stockholder agreement. See Addendum 2 to this Exhibit A, specifically the sections of such Addendum 2 titled "Transfer Restrictions" and "Stockholder Agreement." A copy of the Stockholder Agreement as in effect on the date of this Offering Memorandum is also attached as Exhibit G to the Form C Offering Statement of which this Offering Memorandum forms a part. Limitations on the transfer of both the Series CF Non-Voting Preferred Stock and the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein, may adversely affect your ability to find another party willing to purchase them and the price that you might be able to obtain for such stock in a private sale.

## Your investment could be illiquid for a long time

An investment in the Company is a long-term commitment. Purchasers of the Series CF Non-Voting Preferred Stock offered in this crowdfunding campaign must be ready to hold such securities for an indefinite period of time and must be able to bear a risk of total loss of their entire investment. None of the capital stock or other securities of the Company (including the Series CF Non-Voting Preferred Stock and the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein) are publicly-traded and all of such capital stock and other securities of the Company (including the Series CF Non-Voting Preferred Stock and the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein) are subject to substantial legal and contractual restrictions on transfer, including restrictions on resale. There is presently no public market for the securities of the Company and no assurance that any market will develop for the securities upon completion of this Offering or otherwise at any time. There also can be no assurance as to the depth or liquidity of any such market, if any, or the prices at which holders may be able to sell the securities.

Consequently, an investment in the securities may be totally illiquid and investors may not be able to liquidate their investment readily or at all when they need or desire to sell. The Company may be acquired by another company; however, that may never happen or it may happen at a price that results in you losing money in this investment. Each purchaser in this Offering will be required to represent that such purchaser is purchasing the Series CF Non-Voting Preferred Stock for such purchaser's own account, for investment purposes and not with a view to resale or distribution thereof.

IX Water Offering Memorandum (8 April 2025)

If the Company cannot raise sufficient funds it will not succeed

The Company is offering shares of its Series CF Non-Voting Preferred Stock in the amount of up to $2,750,000.00 in this Offering, and may close on any investments that are made.

Even if the maximum amount is raised, the Company is likely to need additional funds in the future in order to grow, and if it cannot raise those funds for whatever reason, including reasons relating to the Company itself or the broader economy, it may not survive. If the Company manages to raise only the minimum amount of funds, sought, it will have to find other sources of funding (debt or equity) for some of the plans outlined in the "Use of Proceeds" section of this Offering Memorandum (pp. 61-62 of this Offering Memorandum). Our ability to obtain needed funding may be impaired by such factors as the capital markets and our history of losses, which could impact the availability or cost of future funding. Our inability to raise additional capital on favorable terms could have a material adverse effect on our business, financial condition and results of operations. If we are unsuccessful in achieving profitability and we cannot obtain additional funds on commercially reasonable terms or at all, we may be required to curtail significantly or cease our operations, which could result in the loss of all of your investment in our securities.

We may not have enough capital as needed and may be required to raise more capital. We anticipate needing access to credit in order to support our working capital requirements as we grow. Although interest rates are low, it is still a difficult environment for obtaining credit on favorable terms. If we cannot obtain credit when we need it, we could be forced to raise additional equity capital, modify our growth plans, or take some other action. Issuing more equity may require bringing on additional investors. Securing these additional investors could require pricing our equity below its current price. If so, your investment could lose value as a result of this additional dilution. In addition, even if the equity is not priced lower, your ownership percentage would be decreased with the addition of more investors. If we are unable to find additional investors willing to provide capital, then it is possible that we will choose to cease our sales activity. In that case, the only asset remaining to generate a return on your investment could be our intellectual property. Even if we are not forced to cease our sales activity, the unavailability of credit could result in the Company performing below expectations, which could adversely impact the value of your investment.

Terms of subsequent financings may adversely impact your investment

We will likely need to engage in common equity, debt, or preferred stock financings in the future, which may reduce the value of your investment in the Series CF Non-Voting Preferred Stock (of which only a portion of the total authorized shares of such Series CF Non-Voting Preferred Stock is being offered, sold and issued in this Offering). Interest on debt securities could increase costs and negatively impact operating results. While any future offerings of the Company's authorized shares of Series CF Non-Voting Preferred Stock not included in this Offering will have the same offering price and other material terms applicable to the currently authorized Series CF Non-Voting Preferred Stock as required by applicable law, new Preferred Stock other than the Series CF Non-Voting Preferred Stock could be authorized and issued in series from time to time with such designation, rights, preferences, and limitations as needed to raise capital. The terms of any such new Preferred Stock other than the Series CF Non-Voting Preferred Stock could be more advantageous to those investors than to the holders of the Series CF Non-Voting Preferred Stock. In addition, if we need to raise more equity capital from the sale of Common Stock or Preferred Stock, institutional or other investors may negotiate terms that are likely to be more favorable than the terms of your investment, and possibly a lower purchase price per share. Further, we may incur substantial costs in pursuing future capital and/or financing, including investment banking fees, filing fees, legal fees, accounting fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection with certain securities we may issue, such as convertible notes and warrants, which could adversely impact our financial condition.

IX Water Offering Memorandum (8 April 2025)

IX Water Offering Memorandum (8 April 2025)
Page 22

# Management Discretion as to Use of Proceeds

Our success will be substantially dependent upon the discretion and judgment of our management team with respect to the application and allocation of the proceeds of this Offering. The use of proceeds described below is an estimate based on our current business plan. We, however, may find it necessary or advisable to re-allocate portions of the net proceeds reserved for one category to another, and we will have broad discretion in doing so. Further, as is the case with any business, it should be expected that certain expenses unforeseeable to management at this juncture will arise in the future. There can be no assurance that management's use of proceeds generated through this Offering will prove optimal or translate into revenue or profitability for the Company. Further, the Company may choose to use the proceeds in a manner that you do not agree with and you will have no recourse. A use of proceeds that does not further the Company's business and goals could harm the Company and its operations and ultimately cause an Investor to lose all or a portion of his or her investment.

# Projections: Forward Looking Information

See the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A.

# Minority Holder; Securities with No Voting Rights

Except as specifically provided in the Company's certificate of incorporation or as otherwise required by the Delaware General Corporation Law or other applicable law which cannot be superseded by the provisions of such certificate of incorporation: (a) both the Series CF Non-Voting Preferred Stock that is an investor is purchasing in this Offering, and the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein, have no voting rights attached to them; and (b) the holders of the Company's Class A Common Stock and Series A Preferred Stock shall possess exclusively all voting power. See the description of voting rights contained in Addendum 2 to this Exhibit A. This means that you will have no rights to vote in elections of the Company's directors and no rights in dictating on how the Company will be run. You are trusting in management discretion in making good business decisions that will grow your investments. As to matters presented to voting stockholders, the interests of such voting stockholders may differ from, or conflict with, the interests of non-voting stockholders of the Company, including the interests of purchasers of the Series CF Non-Voting Preferred Stock in this Offering. Furthermore, in the event of a liquidation of our company, (1) you will only be paid out if there is any cash remaining after all of the creditors of our Company have been paid out and any future senior debt or equity securities are satisfied and (2) as among the Company's existing Preferred Stock, which is the Series A Preferred Stock, the Series B Non-Voting Preferred Stock and the Series CF Non-Voting Preferred Stock (which Series CF Non-Voting Preferred Stock is the security offered in this Offering), except for a priority repayment right related to certain unpaid "Accrued Reclamation Dividends" as described in Addendum 3 to this Exhibit A, the liquidation preference of the Series CF Non-Voting Preferred Stock is paid out only after all liquidation preferences of the Company's Series A Preferred Stock and Series B Non-Voting Preferred Stock are satisfied in full.

You are trusting that management will make the best decision for the Company. You are trusting in management discretion. You are buying securities as a minority holder, and therefore must trust the management of the Company to make good business decisions that grow your investment.

# Insufficient Funds

The Company might not sell enough securities in this Offering to meet its operating needs and fulfill its plans, in which case it will cease operating and you will get nothing. Even if we sell all the Series CF Non-Voting Preferred Stock we are offering now, the Company will (possibly) need to raise more funds in the future, and if it can't get them, we will fail. Even if we do make a successful offering in the future, the terms of that offering might result in your investment in the Company being worth less, because later investors might get better terms.

This offering involves "rolling closings," which may mean that earlier investors may not have the benefit of information that later investors have.

Once we meet our target amount for this Offering, we may request that StartEngine instruct the escrow agent to disburse offering funds to us. At that point, investors whose subscription agreements have been accepted will become our investors. All early-stage companies are subject to a number of risks and uncertainties, and it is not uncommon for material changes to be made to the offering terms, or to companies' businesses, plans or prospects, sometimes on short notice. When such changes happen during the course of an offering, we must file an amendment to our Form C with the SEC, and investors whose subscriptions have not yet been accepted will have the right to withdraw their subscriptions and get their money back. Investors whose subscriptions have already been accepted, however, will already be our investors and will have no such right.

We face significant market competition

We will compete with larger, established companies who currently have products on, and services offerings in, the market and/or various respective product development programs and services offerings. They may have much better financial means and marketing/sales and human resources than us. They may succeed in developing and marketing competing equivalent products and services offerings earlier than us, or superior products and services offerings than those developed by us. There can be no assurance that competitors will render our technology or products obsolete or that the products and services offerings developed by us will be preferred to any existing or newly developed technologies and/or services. It should further be assumed that competition will intensify.

Industry and Market Data Disclosure

The opinions, estimates and projections and other forward-looking statements contained in this Offering Memorandum and the other portions of the Form C Offering Statement of which this Offering Memorandum forms a part, as well as industry and market data and certain other information used herein and therein are derived from a variety of sources, including independent industry publications, government publications, academic publications or other published independent sources, which the Company did not participate in preparing. Although the Company has not independently verified the accuracy or completeness of the third-party information included in this Offering Memorandum and the other portions of the Form C Offering Statement of which this Offering Memorandum forms a part, based on management's knowledge and experience, the Company believes that these third-party sources are credible and reliable. However, the Company makes no representations or guarantees as to its accuracy or completeness. Investors are cautioned not to place undue reliance on such market and industry data, estimates, projections and opinions, which may be based on numerous assumptions and subject to change based on various factors, including but not limited to, those discussed in the risk factors sections of this Offering Memorandum and matters described in this Offering Memorandum and the other portions of the Form C Offering Statement of which this Offering Memorandum forms a part, generally, which prospective investors should carefully review.

Non-accredited investors may not be eligible to participate in a future merger or acquisition of the Company and may lose a portion of their investment

Investors should be aware that under Rule 145 under the Securities Act of 1933 if they invest in a company through Regulation Crowdfunding and that company becomes involved in a merger or acquisition, there may be significant regulatory implications. Under Rule 145, when a company plans to acquire another and offers its shares as part of the deal, the transaction may be deemed an offer of securities to the target company's investors, because investors who can vote (or for whom a proxy is voting on their behalf) are making an investment decision regarding the securities they would receive. All investors, even those with non-voting shares, may have rights with respect to the merger depending on relevant state laws. This means the acquirer's "offer" to the target's investors would require registration or an exemption from registration (such as Reg. D or Reg. CF), the

IX Water Offering Memorandum (8 April 2025)

burden of which can be substantial. As a result, non-accredited investors may have their shares repurchased rather than receiving shares in the acquiring company or participating in the acquisition. This may result in investors' shares being repurchased at a value determined by a third party, which may be at a lesser value than the original purchase price. Investors should consider the possibility of a cash buyout in such circumstances, which may not be commensurate with the long-term investment they anticipate.

**Additional Risk Factors Related to the Company's Securities and this Offering**
See Part II of Addendum 1 to this Exhibit A.

**Additional Risk Factors Related to the Company's Business and Industry**
See Part III of Addendum 1 to this Exhibit A.

**Tax Risks**
See Part IV of Addendum 1 to this Exhibit A.

**Conflicts of Interest**
See Part V of Addendum 1 to this Exhibit A.

**Statement as to Indemnification**
See Part VI of Addendum 1 to this Exhibit A.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 24

IX Water Offering Memorandum (8 April 2025)
Page 25

# Ownership of Voting Securities and Capital Structure; Rights of the Securities

## Ownership of Voting Securities

The following table sets forth information regarding beneficial ownership of the Company's holders of 20% or more of any class of **voting securities** as of the date of this Offering Memorandum.

As of the date of this Offering Memorandum, the classes of voting securities of the Company are the Class A Common Stock and the Series A Preferred Stock.

| Stockholder Name | Number of Securities Owned | Type of Security Owned | Percentage of Voting Securities |
| --- | --- | --- | --- |
| IX Power LLC (as of the date of this Offering Memorandum, owned 20% each by John R. (Grizz) Deal, Randall (Randy) Wilson, Deborah A. (Deal) Blackwell, Dr. Otis (Pete) Peterson, and Dr. L. Robert (Bob) Libutti (deceased; Mary Tendall, surviving spouse and personal representative)(1)) | 6,813,438 | Class A Common Stock | 65.59% |

(1) The Company is saddened to announce the death of former director and officer Dr. L. Robert (Bob) Libutti, who passed in February 2024. The agreements among the original owners of IX Power LLC include certain buy-sell agreements applicable to the 20% ownership interest of IX Power LLC originally issued to Dr. L. Robert (Bob) Libutti, now deceased. It is possible that all or a portion of such 20% ownership interest of IX Power LLC will be acquired by IX Power LLC (or by one or more of John R. (Grizz) Deal, Randall (Randy) Wilson, Deborah A. (Deal) Blackwell and/or Dr. Otis (Pete) Peterson, as designees of IX Power LLC), pursuant to such buy-sell agreements. To the extent that all or a portion of such 20% ownership interest of IX Power LLC is not so acquired, it is the intent of the IX Power LLC owners that such retained ownership interest in IX Power LLC convert to a non-voting, economic interest.

## The Company's Securities

The Company has authorized Series CF Non-Voting Preferred Stock, Series A Preferred Stock, Series B Non-Voting Preferred Stock, and Class A Common Stock, and Class B Non-Voting Common Stock. Only the Series A Preferred Stock and Class A Common Stock are voting stock. The class of stock that was offered in the Company's initial and now concluded Regulation Crowdfunding (Regulation CF) crowdfunding campaign is the Company's Class B Non-Voting Common Stock. Additional details and information regarding such initial crowdfunding campaign are provided in the section of this Offering Memorandum titled "Recent Offerings of Securities" (pp. 32-24 of this Offering Memorandum).

The class of stock that (i) was offered in the recently concluded Series CF Crowdfunding Offering #1, (ii) is authorized for the offer, sale and/or issuance, as the case may be, in this crowdfunding campaign (also referred to herein as the Series CF Crowdfunding Offering #2), and (3) is authorized for the offer, sale and/or issuance, as the case may be, for any additional crowdfunding campaign(s) after the conclusion of this crowdfunding campaign, pursuant to the Company's existing equity crowdfunding strategy (as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings", pp. 35-36 of this Offering Memorandum), is the Company's Series CF Non-Voting Preferred Stock.

As of the date of this Offering Memorandum:

## Series CF Non-Voting Preferred Stock

The amount of security authorized is 2,200,000 with a total of 188,904 of such shares (including 17,170 "bonus shares," equivalent to 10% "bonus shares") outstanding as of date of this Offering Memorandum, all of which outstanding shares were issued pursuant to the Series CF Crowdfunding Offering #1 in exchange for $429,335 aggregate cash consideration.

## Voting Rights

There are no voting rights associated with Series CF Non-Voting Preferred Stock.

## Special Revenue Share Dividend, Reclamation Line of Business - Shares of Series CF Non-Voting Preferred Stock

This special dividend applies only to issued shares of the Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2 or any future crowdfunding campaigns). The rights and terms of this special dividend are described in Addendum 3 to this Exhibit A.

As further described in Addendum 3 to this Exhibit A, this special dividend is sourced and payable solely from cash revenues of the Company's new services division/line of business, "IX Water Reclamation" (also referred to as the "Reclamation LOB") that are collected by the Company (referred to as "Reclamation Revenues"). Dividend calculations generally occur on an annual basis, for, and as of the last day of, the Company's fiscal year then ended. The first dividend calculation period included both the fiscal year ending December 31, 2022 and the fiscal year ending December 31, 2023, on a combined basis. As of each of December 31, 2023 and December 31, 2024, the Company had not yet generated Reclamations Revenues; accordingly, no special dividend accrued or is payable on any of the shares of Series CF Non-Voting Preferred Stock that were issued and outstanding as of December 31, 2023 or as of December 31, 2024. This special dividend will next be calculated by the Company for, and as of the last day of, the Company's fiscal year ending December 31, 2025, as further described in Addendum 3 to this Exhibit A.

## 1x Non-Participating Liquidation Preference

Each of the existing series of Preferred Stock of the Company - which are the Series A Preferred Stock, Series B Non-Voting Preferred and Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2 or any future crowdfunding campaigns) - have a 1x non-participating liquidation preference. With the exception of priority payment at the time of a liquidation event of certain unpaid amounts relating to the special dividend as described above for issued shares of the Series CF Non-Voting Preferred Stock, the liquidation preference of the Series CF Non-Voting Preferred Stock is junior to the liquidation preferences of each of the Series A Preferred Stock and the Series B Non-Voting Preferred Stock. See Addendum 2 to this Exhibit A.

## Conversion Security

Class B Non-Voting Common Stock (a non-voting security).

## Other Material Rights

See Addendum 2 to this Exhibit A.

IX Water Offering Memorandum (8 April 2025)
Page 26

IX Water Offering Memorandum (8 April 2025)
Page 27

# Series B Non-Voting Preferred Stock

The amount of security authorized is 626,014 (reduced from 2,160,000 originally authorized shares) with a total of 626,014 outstanding.

The total amount outstanding includes: (1) 40,000 shares issued in May 2018 at the initial and only closing of a Rule 506(c) offering; (2) 488,067 shares issued in April 2020 pursuant to a limited Rule 506(b) offering; and (3) 97,947 issued in May 2022 pursuant to a limited Rule 506(b) offering. For additional information regarding such offerings, see the section of this Offering Memorandum titled "Recent Offerings of Securities" (pp. 32-24 of this Offering Memorandum) and Addendum 2 to this Exhibit A.

## Voting Rights

There are no voting rights associated with Series B Non-Voting Preferred Stock, except for limited circumstances where the Series B Non-Voting Preferred Stock and the Series A Preferred Stock vote together on certain matters, as described in Addendum 2 to this Exhibit A.

## 1x Non-Participating Liquidation Preference

Each of the existing series of Preferred Stock of the Company - which are the Series A Preferred Stock, Series B Non-Voting Preferred and Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2 or any future crowdfunding campaigns) - have a 1x non-participating liquidation preference. With the exception of priority payment at the time of a liquidation event of certain unpaid amounts relating to the special dividend as described above for issued shares of the Series CF Non-Voting Preferred Stock, the liquidation preference of the Series B Non-Voting Preferred Stock is senior to the liquidation preferences of each of the Series A Preferred Stock and the Series CF Non-Voting Preferred Stock. See Addendum 2 to this Exhibit A.

## Conversion Security

Class B Non-Voting Common Stock (a non-voting security).

## Other Material Rights

See Addendum 2 to this Exhibit A.

## Series A Preferred Stock

The amount of security authorized is 2,021,850 with a total of 2,021,850 outstanding.

## Voting Rights

See the section of Addendum 2 to this Exhibit A titled "Description of Capital Stock."

## 1x Non-Participating Liquidation Preference

Each of the existing series of Preferred Stock of the Company - which are the Series A Preferred Stock, Series B Non-Voting Preferred and Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2 or any future crowdfunding campaigns) - have a 1x non-participating liquidation preference. With the exception of priority payment at the time of a liquidation event of certain unpaid amounts relating to the special dividend as described above for issued shares of the Series CF Non-Voting Preferred Stock, the liquidation preference of the Series A Non-Voting Preferred Stock is junior to the liquidation preferences of each of the Series B Non-Voting Preferred Stock and senior to the liquidation preference of the Series CF Non-Voting Preferred Stock. See Addendum 2 to this Exhibit A.

IX Water Offering Memorandum (8 April 2025)
Page 28

## Series A Preferred Stock (continued)

### Conversion Security
Class A Common Stock (a voting security).

### Other Material Rights
See Addendum 2 to this Exhibit A.

### Class A Common Stock
The amount of security authorized is 11,000,000 with a total of 8,366,699 outstanding.

### Voting Rights
See the section of Addendum 2 to this Exhibit A titled "Description of Capital Stock."

### Material Rights
See Addendum 2 to this Exhibit A.

### Class B Non-Voting Common Stock
The amount of security authorized is 6,666,014 with a total of 1,704,267 shares issued and outstanding and 605,000 additional shares reserved for issuance as described below and treated as outstanding for purposes of the disclosures herein (2,309,267 aggregate outstanding shares).

The total amount outstanding includes: (1) 1,672,899 shares issued for $1,960,512.50 cash consideration (of which 104,489, or approximately 6.25%, of such 1,672,899 shares are "bonus shares") pursuant to the Company's initial crowdfunding campaign hosted by funding portal StartEngine Capital LLC and which concluded earlier in 2022; (2) 31,368 shares (which is the number of shares equal to two percent (2%) of the $1,960,512.50 total amount of investments raised in the Company's initial crowdfunding campaign) issued to StartEngine Capital LLC, the intermediary/funding portal for the initial crowdfunding campaign, as compensation for services provided to, or for the benefit of, the Company in connection with such initial crowdfunding campaign, (3) 480,000 shares issuable pursuant to outstanding warrants (subject to reduction to the extent of unexercised warrants; the warrant expiration date for all of such warrants is April 1, 2025); and (4) 125,000 shares issuable pursuant to for stock options or other equity compensation awards issuable to employees or directors of, or consultants or advisors to, the Company, reserved but unissued.

### Voting Rights
There are no voting rights associated with Class B Non-Voting Common Stock.

### Material Rights
See also Addendum 2 to this Exhibit A.

## What it means to be a minority holder
With the exception of the Company's founder, IX Power LLC, all of the Company's existing stockholders are minority holders, and all prospective investors in any Series CF Crowdfunding Offering (as defined below in the "Dilution" section), including all investors in this crowdfunding campaign, who become stockholders of the Company after the date of this Offering Memorandum will be minority holders. Minority holders of stock of the Company have limited, or no, rights in regards to the corporate actions of the Company, including additional issuances of securities, company repurchases of securities, a sale of the company or its significant assets, or company transactions with related parties. Further, investors in the Company's crowdfunding campaign and other investors that own the Company's non-voting stock have rights less than those of other investors holding voting stock, and have limited, or no, influence on the corporate actions of the company. See the "Risk Factors" section of this Offering Memorandum, including as supplemented by Addendum 1 to this Exhibit A, as well as the more detailed description of the Company's capital stock contained in Addendum 2 to this Exhibit A.

# Dilution

For purposes of this "Dilution" section, the terms "Series CF Crowdfunding Offering(s)," "Series CF Crowdfunding Offering #1" and "Series CF Crowdfunding Offering #2" (which "Series CF Crowdfunding Offering #2" is this crowdfunding campaign), have the meanings given to such terms in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum).

## Generally

Investors should understand the potential for dilution. The investor's stake in a company could be diluted due to the company issuing additional shares or other securities (such as options or convertible securities). In other words, when the company issues more shares or other securities, the percentage of the company that you own will go down, even though the value of the company may go up. You will own a smaller piece of a larger company. This increase in number of shares outstanding could result from a stock offering (such as an initial public offering, another crowdfunding round (including with respect to the Series CF Non-Voting Preferred Stock, as further described below), a venture capital round, angel investment), employees exercising stock options, or by conversion of certain instruments (e.g. convertible bonds, preferred shares or warrants) into stock.

If the Company decides to issue more shares or other securities (such as options or convertible securities), an investor could experience value dilution, with each share being worth less than before, and control dilution, with the total percentage an investor owns being less than before. There may also be earnings dilution, with a reduction in the amount earned per share (though this typically occurs only if the company offers dividends, and most early stage companies are unlikely to offer dividends, preferring to invest any earnings into the company).

In addition, investors should understand that the value and control dilution described above will be magnified and more substantial if price-based anti-dilution protections applicable to certain of the Company's securities are triggered. The most common trigger of price-based anti-dilution protections is when the company sells more shares in a "down round," meaning at a lower valuation than in earlier offerings. In such case, the conversion price for the shares entitled to price-based anti-dilution protection is adjusted so that such shares are treated as if they were originally issued at a lower valuation. These adjustments result in disproportionate, and more substantial, dilution to all other shares that do not have the price-based anti-dilution protection.

Currently, each of the existing series of Preferred Stock of the Company - which are the Series A Preferred Stock, Series B Non-Voting Preferred and Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2 or any future crowdfunding campaigns) - have price-based anti-dilution protection (see Addendum 2 to this Exhibit A); however, these price-based anti-dilution protections terminate upon any conversion (voluntary/optional or automatic) of such Preferred Stock into the Company common stock (Class A Common Stock or Class B Non-Voting Common Stock). In addition, the Company may issue debt or equity securities in the future with price-based anti-dilution protection (see the "Risk Factors" section of this Offering Memorandum, including as supplemented by Addendum 1 to this Exhibit A). Since none of the Company's currently authorized common stock has price-based anti-dilution protections, all holders of such common stock will be affected if price-based anti-dilution adjustments applicable to other Company securities are triggered. The Company's management will seek to structure any future offerings of new debt or equity securities to avoid triggering the price-based anti-dilution protections; however, there are many factors, including factors outside the Company's control, that affect terms of future financings (see the "Risk Factors" section of this Offering Memorandum, including as supplemented by Addendum 1 to this Exhibit A) and there is no assurance that further dilution, including dilution resulting from price-based anti-dilution protections being triggered, will not occur in the future.

IX Water Offering Memorandum (8 April 2025)

# Dilution (continued)

## Series CF Non-Voting Preferred Stock:

The Series CF Non-Voting Preferred Stock has been approved by the Company's Board of Directors and its requisite stockholders for use in equity crowdfunding campaigns between its authorization in October 2022 and 17 November 2025 (three years from the launch of the Series CF Crowdfunding Offering #1), to raise an aggregate amount of up to $5 million for all Series CF Crowdfunding Offerings, including the recently concluded Series CF Crowdfunding Offering #1 and this Series CF Crowdfunding Offering #2. This is referred to elsewhere in the Form C Offering Statement of which this Offering Memorandum forms a part (including this Offering Memorandum) as the "existing equity crowdfunding strategy" of the Company.

The $5 million maximum amount allocated to the Company's existing equity crowdfunding strategy equates to 2,000,000 shares of the Series CF Non-Voting Preferred Stock ($5 million divided by the $2.50/share issue price). The total number of authorized shares of Series CF Non-Voting Preferred Stock is 2,200,000. The 200,000 shares difference (equivalent in value and liquidation preference to approximately $500,000 at the $2.50 per share price) is an allocation for funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, which are a customary feature of equity crowdfunding campaigns, in each case as is approved by Company management (subject to any limitations or conditions imposed by the Company's Board of Directors, if applicable). Based upon changes in market terms for equity crowdfunding campaigns since the October 2022 authorizations, including increases in equity compensation fees and allocations for bonus shares perks, Company management believes that the maximum amount to be raised under the current authorizations (i.e., without a requirement to obtain new voting shareholder approvals) is between $3.2 and $3.5 million, and not $5 million.

For dilution purposes, it is assumed that up to all 2,200,000 shares of the Series CF Non-Voting Preferred Stock may be issued, which represents an aggregate liquidation preference for the Series CF Non-Voting Preferred of $5.5 million. The issuance of additional shares of Series CF Non-Voting Preferred as part of the Company's existing equity crowdfunding strategy is an issuance of additional shares by the Company that will result in dilution, as described in the foregoing paragraphs of this "Dilution" section.

As stated elsewhere in this Form C, the Company's Board of Directors has authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with securing approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and an additional $10 million credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days and also serve as an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws. The terms on which such additional capital may be secured, if secured, are unknown as of the date of this Offering Memorandum. However, any transactions involving the issuance of equity will result in dilution, as described in the foregoing paragraphs of this "Dilution" section.

IX Water Offering Memorandum (8 April 2025)
Page 30

# Transferability of securities

For a year, the securities purchased in a Regulation CF crowdfunding campaign can only be resold:

- In an IPO;
- To the Company;
- To an accredited investor; and
- To a member of the family of the purchaser or the equivalent, to a trust controlled by the purchaser, to a trust created for the benefit of a member of the family of the purchaser or the equivalent, or in connection with the death or divorce of the purchaser or other similar circumstance.

The above describes the SEC limitations on transfer of the securities pursuant to Regulation Crowdfunding. All of the securities of the Company are subject to substantial legal and contractual restrictions on transfer, including restrictions on resale. These restrictions include (1) applicable limitations imposed under Federal securities laws (including in the case of securities previously or hereafter issued in the Company's active crowdfunding campaign, Regulation Crowdfunding as described above), (2) any applicable limitations on transfer imposed under the securities laws of the states or other jurisdictions in which the securities of the Company (including, but not limited, to the Class B Non-Voting Common Stock and/or the Series CF Non-Voting Preferred Stock) may be offered or sold and (3) contractual restrictions on transfer. For additional information on the transfer restrictions applicable to the shares of Series CF Non-Voting Preferred Stock being offered in this crowdfunding campaign, and the shares of Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described hereins, see the risk factors contained in this Offering Memorandum (including as supplemented by Addendum 1 to this Exhibit A) and Addendum 2 to this Exhibit A, specifically the sections of such Addendum 2 titled "Transfer Restrictions" and "Stockholder Agreement." A copy of the Stockholder Agreement as in effect on the date of this Offering Memorandum is also attached as Exhibit G to the Form C Offering Statement of which this Offering Memorandum forms a part.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 31

# Recent Offerings of Securities

The Company recently concluded the Series CF Crowdfunding Offering #1, which is the Regulation CF crowdfunding campaign hosted by Wefunder Portal, LLC that launched on 17 November 2022 and concluded on 29 April 2024. Such Series CF Crowdfunding Offering #1 is further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum).

In addition to such Series CF Crowdfunding Offering #1, we have made the following issuances of securities within the last five years (and also including issuances of securities within the five years preceding the May 2020 launch of the Company's initial crowdfunding campaign hosted by funding portal/intermediary StartEngine Capital LLC):

- Name: Series A Preferred Stock
- Type of security sold: Equity
- Final amount sold: $1,515,395.00
- Number of Securities Sold: 2,021,850
- Use of proceeds: Product development, commercial testing, and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.
- Date: February 14, 2018
- Offering exemption relied upon: 506(b)

- Name: Class A Common Stock
- Type of security sold: Equity (issued upon the exercise of outstanding warrants)
- Final amount sold: $15,795.00
- Number of Securities Sold: 48,660
- Use of proceeds: Product development, commercial testing, and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.
- Date: October 04, 2019
- Offering exemption relied upon: 506(b)

- Name: Series B Non-Voting Preferred Stock
- Type of security sold: Equity
- Final amount sold: $50,000.00
- Number of Securities Sold: 40,000
- Use of proceeds: Go-to-market strategy and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.
- Date: May 25, 2018
- Offering exemption relied upon: 506(c)

IX Water Offering Memorandum (8 April 2025)

# Recent Offerings of Securities (continued)

- **Name:** Series B Non-Voting Preferred Stock &amp; Warrants to acquire Class B Non-Voting Common Stock
- **Type of security sold:** Equity
- **Final amount sold:** $610,083.75
- **Number of Securities Sold:** 488,067 shares of Series B Non-Voting Preferred Stock
- **Warrants Issued:** Class B Non-Voting Common Stock Warrants, up to 480,000 warrant shares. The exercise price of such warrants is $1.25 per share. The warrant expiration date is April 1, 2025, subject to early termination upon an initial public offering of the Company's capital stock and certain corporate transaction events as described in the warrants.
- **Use of proceeds:** Go-to-market strategy and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company. NOTE: Such amount raised excludes the up to $600,000 of contingent proceeds receivable, if and when the warrants issued as part of the offering are exercised.
- **Date:** April 10, 2020
- **Offering exemption relied upon:** 506(b)
- **NOTE-additional information, related party debt conversion:** This Rule 506(b) offering was a limited offering for the purposes of restructuring and satisfying certain related party liabilities through conversion to equity in lieu of cash payment.

- **Name:** Class B Non-Voting Common Stock
- **Type of security sold:** Equity
- **Final amount sold:** $1,960,512.50 (this amount is the cash proceeds of the offering; this amount excludes the value of the intermediary equity compensation shares reserved but unissued, as described below)
- **Number of Securities Sold In Exchange For Cash Consideration:** 1,672,899, issued in exchange for the $1,960,512.50 cash consideration identified above (of which 104,489, or approximately 6.25%, of such 1,672,899 shares are "bonus shares")
- **Intermediary Equity Compensation:** 31,368 shares (which is the number of shares equal to two percent (2%) of the $1,960,512.50 total amount of investments raised in the crowdfunding campaign). These shares have been issued to StartEngine Capital LLC, the intermediary/funding portal for this initial crowdfunding campaign, as compensation for services provided to, or for the benefit of, the Company in connection with the crowdfunding campaign.
- **Use of proceeds:** These crowdfunding campaign funds, net of fees paid to the funding portal and escrow agent for the crowdfunding campaign and other offering expenses, were used to expand the current sales and marketing activities of the Company in the USA, China, and the North Sea, to build a one-fifth scale complete IX Water demonstration system, to build out an analytical chemistry and test lab, to rent additional facilities, and to extend the company cash out date then in effect. This offering concluded earlier in 2022,

IX Water Offering Memorandum (8 April 2025)
Page 33

and the final application and allocation of proceeds of the crowdfunding campaign is subject to the discretion and judgment of the Company's management team.

Date: May 2020 - March/April 2022 (the offering deadline occurred in January 2022 with funds reconciliations pending and the final closing occurred in April 2022 once the funds reconciliations were completed)

Offering exemption relied upon: Regulation Crowdfunding

NOTE, initial crowdfunding campaign/"Initial Crowdfunding Offering": The above offering is the initial crowdfunding campaign conducted by the Company, also sometimes referred to in this Offering Memorandum and/or or one or more of the Addendums hereto, as applicable, as the "initial crowdfunding campaign" or the "Initial Crowdfunding Offering."

- Name: Series B Non-Voting Preferred Stock
- Type of security sold: Equity
- Final amount sold: $122,433.75 (debt conversion; $87,475 of principal and $34,958.75 of interest)
- Number of Securities Sold: 97,947
- Use of proceeds: Go-to-market strategy and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.
- Date: May 31, 2022
- Offering exemption relied upon: 506(b)

NOTE-additional information, related party debt conversion: All Series B Non-Voting Preferred Stock shares issued in this offering were issued in exchange for conversion of indebtedness (including interest) owed by the Company to certain existing stockholders/investors, including existing stockholders/investors currently holding positions as directors and/or officers of the Company. The indebtedness that was converted included indebtedness owing by the Company (1) under the existing bridge loan facility authorized by the Company prior to the launch in May 2020 of the Company's Regulation Crowdfunding campaign, and still outstanding, and (2) in connection with loans or advances previously made by existing stockholders/investors (including existing stockholders/investors currently holding positions as directors and/or officers of the Company) to, or on behalf of, the Company for payment of Company expenses. Indebtedness converted in this offering was, by its stated terms, non-convertible. Accordingly, the conversion of indebtedness in this offering occurred by voluntary conversion of indebtedness with mutual agreement of the Company and each applicable holder of the indebtedness that is converted.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)

# Preferred Stock Crowdfunding Offerings

For purposes of this "Preferred Stock Crowdfunding Offerings" section and other applicable sections of this Offering Memorandum:

a) "Series CF Crowdfunding Offering(s)" means any one or more Regulation Crowdfunding offerings (an offering in reliance on Section 4(a)(6) of the Securities Act of 1933, as amended, and pursuant to Regulation Crowdfunding (§ 227.100 et seq.)) pursuant to which the security offered, sold and/or issued, as applicable, is the Company's Series CF Non-Voting Preferred Stock. As of the date of this Offering Memorandum, the Series CF Crowdfunding Offering(s) includes the following offering(s): the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2 (which Series CF Crowdfunding Offering #2 is this crowdfunding campaign).

b) "Series CF Crowdfunding Offering #1" means the Regulation Crowdfunding offering hosted by Wefunder Portal that launched on 17 November 2022 and is concluding 29 April 2024 (the date of this Offering Memorandum), as is further described in this section. This Series CF Crowdfunding Offering #1 has previously been referred to as the "additional crowdfunding campaign" or "the Additional Crowdfunding Offering."

c) "Series CF Crowdfunding Offering #2" means the Regulation Crowdfunding offering hosted by StartEngine Primary LLC that is launching on or about the date of the Form C Offering Statement of this Offering Memorandum forms a part. This Series CF Crowdfunding Offering #2 is sometimes referred to in this Offering Memorandum as "this crowdfunding campaign," "the Offering" or "this Offering."

# Overview of Existing Equity Crowdfunding Strategy

The Company's Series CF Non-Voting Preferred Stock has been approved by the Company's Board of Directors and its requisite stockholders for use in one or more Series CF Crowdfunding Offerings between its authorization in October 2022 and 17 November 2025 (three years from the launch of the Series CF Crowdfunding Offering #1), to raise an aggregate amount of up to $5 million for all applicable Series CF Crowdfunding Offerings. This is referred to elsewhere in this Offering Memorandum and the "existing equity crowdfunding strategy" of the Company.

The October 2022 authorizations limit the total shares of Series CF Non-Voting Preferred Stock allocated to funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, for all applicable offerings, to 200,000 shares of Series CF Non-Voting Preferred Stock (which is equivalent to $500,000 in value and liquidation preference at the $2.50 per share issue price of the Series CF Non-Voting Preferred Stock). Based upon changes in market terms for equity crowdfunding campaigns since the October 2022 authorizations, including increases in equity compensation fees and allocations for bonus shares perks, Company management believes that the maximum amount to be raised under the current authorizations (i.e., without a requirement to obtain new voting shareholder approvals) is between $3.2 and $3.5 million, and not $5 million.

(continues on next page)

IX Water Offering Memorandum (8 April 2025)

# Preferred Stock Crowdfunding Offerings (continued)

## Series CF Crowdfunding Offering #1

This first crowdfunding campaign utilizing the Series CF Non-Voting Preferred Stock launched on 17 November, 2022 and concluded on 29 April, 2024. Such Series CF Crowdfunding Offering #1 was hosted by a different funding portal, Wefunder Portal, LLC. 188,904 shares of the Series CF Non-Voting Preferred Stock (including 17,170 "bonus shares," equivalent to 10% "bonus shares") were issued pursuant to the Series CF Crowdfunding Offering #1 in exchange for $429,335 aggregate cash consideration. The shares actually issued pursuant to the Series CF Crowdfunding Offering #1 equate to approximately 21.5% of the $2 million maximum share reservation for such offering. All of such shares of Series CF Non-Voting Preferred reserved for the Series CF Crowdfunding Offering #1 and not actually issued are no longer reserved for such offering and are currently available for offer, issuance and/or sale of the Company, including pursuant to this Series CF Crowdfunding Offering #2.

Subject to final determinations of the Company's officers with respect to application of uses of proceeds, the previously published intended uses of proceeds for the Series CF Crowdfunding Offering #1, after deducting offering fees and other offering expenses, included (i) providing start-up capital for the IX Water Reclamation service business, (ii) expanding the Company's current sales and marketing activities with respect to its treatment systems, and (iii) paying for ongoing fees and expenses associated with the Company using equity crowdfunding to raise capital, including compliance with ongoing Regulation CF reporting requirements and maintaining a third party stock transfer agent. Since the $2 million maximum amount of the Series CF Crowdfunding Offering #1 was not fully raised at conclusion of such offering, the targeted start-up capital for such new service business has not yet been raised and the proceeds have been allocated primarily to maintaining versus expanding the Company's operations. Start-up capital for the IX Water Reclamation service business remains a primary intended use of proceeds for this Series CF Crowdfunding Offering #2, referenced below.

## Series CF Crowdfunding Offering #2

The crowdfunding campaign/offering described in the Form C Offering Statement of which this Offering Memorandum forms a part, including this Offering Memorandum, is the Series CF Crowdfunding Offering #2 and the second crowdfunding campaign of the Company's existing equity crowdfunding strategy.

This Series CF Crowdfunding Offering #2 is being hosted by StartEngine Primary LLC, an affiliate of StartEngine Capital LLC, the funding portal/intermediary for the Company's Initial Crowdfunding Offering.

The maximum offering amount for this Series CF Crowdfunding Offering #2 is $2.75 million, which if fully raised, will result in aggregate gross cash proceeds for both the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2, on a combined basis, of $3,179,335.00.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)

# Updated Overall Capital Raising Strategy

As stated elsewhere in this Form C, the Company's Board of Directors has authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with securing (i) approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and (ii) an additional $10 million credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days as well as provide an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws. The terms on which such additional capital may be secured, if secured, are unknown as of the date of this Offering Memorandum.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 37

# Financial Condition and Results of Operations

## Financial Condition

You should read the following discussion and analysis of our financial condition and results of our operations together with our financial statements and related notes included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors, including those discussed in the section entitled "Risk Factors" and elsewhere in this Offering Memorandum.

## Results of Operations

### Circumstances which led to the performance of financial statements:

Our financial statements reflect those of a startup; where capital is put toward creating and proving its product line and business model(s).

As to the Company's existing treatment systems business:

- While the Company did have some early service-based revenue during its commercial testing, it is just achieving product sales and has yet to achieve substantial product sales. The Company shipped its first full commercial unit in a sale to a Chinese customer near Dalian, in Northeast China. This unit, which is transportable, is being used in a service offering ("treatment by the cubic metre") for the oil &amp; gas, coking, and landfill leachate markets. The expectation is that the customer will help drive sales in this part of China for which they will be renumerated with a small finder's fee based on the price of each system sold as a result of their efforts.
- The Company also has purchase orders from new customers, and verbal agreements for additional IX Water units in chemical manufacturing, mining, and landfill leachate.
- IX Water cost of goods sold for such existing treatment systems business are approximately 52% of revenue, leaving sufficient funds for the Company to pay its minimal current overhead cost associated with such line of business, without market expansion.

As to the Company's IX Water Reclamation service business, this is a new line of business that is not reflected in the Company's existing financial statements for the fiscal years ending December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020, and will not be reflected in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

### Historical results and cash flows:

Historical results are not representative of what the Company's investors/stockholders should expect in the future.

Management, having raised capital for eight other ventures based on USA government lab technology, took that experience and, prior to May 2020 launch of the Company's initial crowdfunding campaign, raised only enough funds from its existing investors/stockholders to complete and commercially test the IX Water product line-with no substantial revenue expected. Product development has "unknown unknowns," and IX Water product development required an additional 36 months (increased from the previously published projected time frame of 30 months) longer than initially planned.

IX Water Offering Memorandum (8 April 2025)

Rather than disappointing its investors/stockholders with uncertain revenue forecasts, the Company always planned to raise a separate amount of capital for global marketing and sales: the initial crowdfunding campaign, launched in May 2020. This "whole product marketing" approach allowed the IX-Force to fully develop the Company's commercial offering, test the products in the field, refine the product line, and finally go to market in 2019 using the Company's existing, modest resources.

The global pandemic limited opportunity for sales from 2020 through 2022. These limitations continued in 2023 and through the current time based upon the economic downturn and global inflation in recent periods. IX Water requires a "consultative" sales approach, including site visits, direct consultations, and in-person meetings with regulators and stakeholders.

Commencing in April 2022, the wide availability of COVID-19 inoculation allowed staff and potential customers to start direct interactions once again, but the Company is now impacted by the economic downturn and global inflation in recent periods. Management expects the sales forecast to essentially be delayed by up to 54-60 months (adjusted from the previously published up to 48 months delay), reflected in the Company's updated six-year projected operating plan referenced above in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum) (revised from the prior iterations of such projected operating plan, as further described in such section).

As described elsewhere in this Offering Memorandum (including the section of this Offering Memorandum titled "The Company and its Business: About IX Water Reclamation"), the Company's Board of Directors has authorized a new services division/line of business, "IX Water Reclamation." IX Water Reclamation will initially focus on small to medium sized oil &amp; gas operators that either do not have, or do not want to deploy, the capital to purchase their own IX Water system, or those that would prefer to just outsource the disposition of their produced water. As a new line of business IX Water Reclamation is not, or will not be, reflected in the Company's existing financial statements for the fiscal years ending December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020, the Company's pending financial statements for the most recent fiscal year ending December 31, 2024 (which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part), or the Company's historical results and cash flows. Since the $2 million maximum amount of the Series CF Crowdfunding Offering #1 was not fully raised at conclusion of such offering: (1) the Company is delayed in commencement of the new Reclamation line of business, which means (x) such new line of business is not reflected in the Company's financial statements, and (y) no special dividend has yet accrued or is payable on shares of Series CF Non-Voting Preferred Stock that were issued and outstanding as of December 31, 2023 or as of December 31, 2024; and (2) the Company has further recast and revised its projected operating plan, as further described in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum). The Company's plans to develop and grow the new IX Water Reclamation service business are delayed but not abandoned. The updated six-year projected operating plan, commencing 1 December 2022 (such 1 December 2022 is tied to the launch of the Series CF Crowdfunding Offering #1) for a description of the revisions to such plan since the 1 December 2022 commencement date), still includes both the existing treatment systems business and the new IX Water Reclamation service business. Based on actual results of the Series CF Crowdfunding Offering #1, the Company's ability to develop and accelerate the Reclamation

IX Water Offering Memorandum (8 April 2025)
Page 39

division operations is dependent on the Company's efforts to continue to execute the Company's existing equity crowdfunding strategy (as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum), including pursuant to this Series CF Crowdfunding Offering #2. Start-up capital for such new service business remains a primary intended use of proceeds for this Series CF Crowdfunding Offering #2.

## Liquidity and Capital Resources

## What capital resources are currently available to the Company? (Cash on hand, existing lines of credit, shareholder loans, etc...)

As of 19 February 2025, the Company has cash on hand of approximately $27,137. All net cash proceeds of the Company's initial crowdfunding campaign have been released by StartEngine Capital LLC, the intermediary/funding portal for such initial crowdfunding campaign, to the Company, including amounts previously held in escrow holdback accounts for such initial crowdfunding campaign. In addition, all net cash proceeds of the Series CF Crowdfunding Offering #1 have been released by Wefunder Portal LLC, the intermediary/funding portal for such offering.

As of the date of this Offering Memorandum, the current Company "burn" or cash run-rate varies from $20,000 to $35,000 per month, and excluding non-recurring start-up costs for the new Reclamation division. Such increase in the Company's cash-run rate is consistent with the Company's projected operating plan that was in place during the initial crowdfunding campaign and primarily is the result of (i) the Company commencing services compensation payments to the Company's management team after such launch, (ii) an increase in personnel, and (iii) the Company securing new manufacturing space. The Company notes the services compensation payments to the Company's management team, who are owners in the Company's founder IX Power LLC, are for services rendered after launch of the crowdfunding campaign in May 2020. The Company is not under any agreement to pay the IX Power LLC founders back-pay for periods prior to such launch; this is their "sweat equity."

As is customary in the industry, IX Water customers purchasing IX Water treatment systems usually pay a fifty percent (50%) deposit when ordering a unit. These funds, along with vendor payment terms, provide sufficient funds to pay the cost of building each IX Water unit. As sales grow and assuming the Company's new IX Water Reclamation business generates revenue from the Company's additional Reclamation service offerings, Management expects to generate sufficient cash flow to also cover the Company's overhead.

The Company may, from time to time, leverage its accounts receivable (AR) to insure cash flow. The Company has existing relationships with various non-bank entities under which AR may be purchased for a discount based on the nature of the accounts receivable and Company creditworthiness. A lien against Company assets may also be filed to further ensure collection of AR. The Company has no outstanding balances under receivables factoring arrangements as of the date of this Offering Memorandum.

The Company may, from time to time, use irrevocable bank letters of credit (LOC) to fund specific customer builds of IX Water products. The Company has an existing relationship with HSBC (which replaces the Company's prior relationship with Silicon Valley Bank) under which HSBC would purchase the LOC for a discount based on the nature of the sale and customer creditworthiness. The bank also may file a lien against Company assets to further ensure payment should the customer cancel the order or the LOC is otherwise invalidated.

IX Water Offering Memorandum (8 April 2025)
Page 40

As described elsewhere in this Offering Memorandum, the Company is currently executing its existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum), of which the Series CF Crowdfunding Offering #2 is a part. The existing authorizations for the existing equity crowdfunding strategy permit the Company to raise up to $5 million of new capital pursuant to Regulation Crowdfunding offerings (including the final amount raised in the recently concluded Series CF Crowdfunding Offering #1 and the final amount raised in this crowdfunding campaign, also referred to herein as the Series CF Crowdfunding Offering #2) through 17 November 2025, so long as the total shares of Series CF Non-Voting Preferred Stock allocated to funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, for all applicable offerings, does not exceed 200,000 shares of Series CF Non-Voting Preferred Stock (which is equivalent to $500,000 in value and liquidation preference at the $2.50 per share issue price of the Series CF Non-Voting Preferred Stock). Based upon changes in market terms for equity crowdfunding campaigns since the October 2022 authorizations, including increases in equity compensation fees and allocations for bonus shares perks, Company management believes that the maximum amount to be raised under the current authorizations (i.e., without a requirement to obtain new voting shareholder approvals) is between $3.2 and $3.5 million, and not $5 million.

## How do the funds of the Company's crowdfunding campaign factor into the Company's financial resources? (Are these funds critical to your company operations? Or do you have other funds or capital resources available?)

As of the date of this Offering Memorandum, funds raised via the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum), are critical to company operations.

The first crowdfunding campaign of the Company's existing equity crowdfunding strategy is the Series CF Crowdfunding Offering #1, which was hosted by a different funding portal, Wefunder Portal, LLC, and launched on 17 November, 2022 and concluded on 28 April, 2024. At conclusion of such offering, the Company had issued 188,904 shares of the Series CF Non-Voting Preferred Stock (including 17,170 "bonus shares," equivalent to 10% "bonus shares") in exchange for $429,335 aggregate cash consideration (approximately 21.5% of the $2 million maximum amount for such offering).

Although the $2 million maximum offering amount was not fully raised at conclusion of the Series CF Crowdfunding Offering #1, Company management continues to believe that executing this Offering as part of the existing equity crowdfunding strategy provides the Company with the best available opportunity to continue to raise additional capital in the near term, including for the planned start-up funding for its new services division, "IX Water Reclamation" (also referred to in this Offering Memorandum as the "Reclamation LOB"). In addition, our crowdfunding investors are some of our most passionate and engaged stakeholders. Equity crowdfunding continues to be integral to the Company's mission so we would like to offer our existing owners the opportunity to invest in this Offering, whether they did or did not invest in the Series CF Crowdfunding Offering #1 hosted by Wefunder Portal, LLC, in addition to growing and expanding our crowdfunding community.

This crowdfunding campaign (which is sometimes referred to in this Offering Memorandum as Series CF Crowdfunding Offering #2) is the second crowdfunding campaign pursuant to the Company's existing equity crowdfunding strategy, and is being hosted by StartEngine Primary LLC, an affiliate of StartEngine Capital LLC, the funding portal/intermediary for the Company's

IX Water Offering Memorandum (8 April 2025)
Page 41

Initial Crowdfunding Offering. The maximum offering amount for this Series CF Crowdfunding Offering #2 is $2.75 million, which if fully raised, will result in aggregate gross cash proceeds for both the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2, on a combined basis, of $3,179,335.00. Such amount aligns with the $2 million minimum amount of a next equity crowdfunding campaign that is part of the Company's updated six-year projected operating plan referenced above in the section of this Offering Memorandum titled "The Company and its Business: Updated Projected Operating Plan" (pp. 8-9 of this Offering Memorandum) (revised from the prior iterations of such projected operating plan, as further described in such section).

As a recent update, the Company's Board of Directors has authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with (i) approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and (ii) an additional $10 million credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days as well as provide an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws.

The Company is relying on its existing and pending revenue streams as well as fund raising to sustain and increase its pace of operations.

## Are the funds from the Company's crowdfunding campaign necessary to the viability of the Company? (Of the total funds that your company has, how much of that will be made up of funds raised from the crowdfunding campaign?)

As of the date of this Offering Memorandum, the Company is executing its existing equity crowdfunding strategy authorized in October 2022 and further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). As stated in the previous response, it is the belief of Company management and the Company's Board of Directors that, as of the date of this Offering Memorandum, executing this Offering as part of the existing equity crowdfunding strategy provides the Company with the best available opportunity to continue to raise additional capital in the near term, including for the planned start-up funding for its new IX Water Reclamation services division (also referred to in this Offering Memorandum as the "Reclamation LOB").

The Company's ability to continue as a going concern for the foreseeable future and to achieve the targeted exit/liquidity event is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations and/or to obtain additional external capital financing. Management plans to utilize any unspent funds raised in the Series CF Crowdfunding Offering #1 and any and all funds raised in this crowdfunding campaign (also referred to herein as the Series CF Crowdfunding Offering #2) and, if applicable, any additional future equity crowdfunding campaigns utilizing the legally available Series CF Non-Voting Preferred Stock, to produce revenues to support cash flow, and to continue to cut and control costs as necessary to ensure the business is able to meet its obligations as they come due.

IX Water Offering Memorandum (8 April 2025)
Page 42

The Company continually evaluates the maximum amount it seeks to raise via such strategy, based on market conditions, progress of revenues, and other applicable factors. As stated in the section of this Offering Memorandum title and "Updated Overall Capital Raising Strategy" (p. 37 of this Offering Memorandum), the Company's Board of Directors has recently authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with securing (i) approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and (ii) an additional $10 million credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days as well as provide an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws.

No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

## How long will you be able to operate the company if you raise your minimum in the crowdfunding campaign? What expenses is this estimate based on?

This crowdfunding campaign is launching with a $20,000 minimum offering. Such $20,000 minimum offering amount, if raised, will be applied in full to certain costs and expenses associated with the launch of this crowdfunding campaign which include (i) the fees payable to funding portal/intermediary StartEngine Primary LLC and the escrow agent for the Series CF Crowdfunding Offering #2, (ii) advertising/marketing/promotion spend related to such launch (including advertising and marketing/PR services), and (iii) legal and accounting costs associated with such launch. As noted above, the current Company "burn" or cash run-rate varies from $20,000 to $35,000 per month, excepting non-recurring start-up costs for the new Reclamation division. As a result, the $20,000 minimum offering amount is not expected to extend, and will not extend, any operating period for the Company.

## How long will you be able to operate the company if you raise your maximum funding goal? What expenses is this estimate based on?

The maximum offering amount of this Offering (also referred to herein as the Series CF Crowdfunding Offering #2) is $2,750,000.00. This Offering is executed as part of the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum).

As stated elsewhere in this Offering Memorandum, if the $2.75 million maximum offering amount for this Series CF Crowdfunding Offering #2 is fully raised, the aggregate gross cash proceeds for both the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2, on a combined basis, will be $3,179,335.00; and such amount aligns with the minimum $2 million maximum amount of a next equity crowdfunding campaign to be raised prior to 17 November, 2025 that is part of the Company's updated six-year projected operating plan referenced above in the section of this Offering Memorandum titled "The Company and its Business: Updated

IX Water Offering Memorandum (8 April 2025)

Projected Operating Plan" (pp. 8-9 of this Offering Memorandum) (revised from the prior iterations of such projected operating plan, as further described in such section).

The Company's existing projected operating plan assumes an estimated net available funds figure of approximately $1.6 million, if the $2.75 million maximum amount of this Offering is fully raised (this is an estimate to the actual estimated net available funds figure, if such maximum amount is fully raised, could be higher or lower). Subject to final determinations of the Company's officers with respect to application of uses of proceeds, the intended uses of proceeds for such net available funds are: (i) providing start-up capital for the IX Water Reclamation service business, (ii) expanding the Company's current sales and marketing activities with respect to its treatment systems, (iii) paying for ongoing fees and expenses associated with the Company using equity crowdfunding to raise capital, including compliance with ongoing Regulation CF reporting requirements and maintaining a third party stock transfer agent, and (iv) other working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.

Considering revenue projections, this Offering, and the Company's recent expansion of its overall capital raising strategy discussed in the previous responses (including subject to requisite additional Board and stockholder approvals pertaining to such strategy, where applicable), Company management currently projects a cash out date between December 2026 and December 2028 (which cash out date is updated and adjusted from previously published cash out dates).

In addition, as part of its business planning updates, the Company is now targeting an exit/liquidity event to occur four to five years (adjusted from the previously published three to four years) following the launch of the Series CF Crowdfunding Offering #1 (which launch occurred on 17 November 2022) (see the section of this Offering Memorandum titled "The Company and its Business: Targeted Future Sale of the Company / Speculative Nature of Exit Events" (p. 13 of this Offering Memorandum)).

Please refer to our earlier disclosure regarding the speculative nature of exit events ("The Company and its Business: Targeted Future Sale of the Company / Speculative Nature of Exit Events" (p. 13 of this Offering Memorandum)). Further, for clarity, projections, including as related to the Company's revenue projections and projected cash out dates and the Company's targeted exit/liquidity event, are only projections; see the risk factors sections of this Offering Memorandum and the forward-looking statements disclosure in Part I of Addendum 1 to this Exhibit A.

## Are there any additional future sources of capital available to your company? (Required capital contributions, lines of credit, contemplated future capital raises, etc...)

As described elsewhere in this Offering Memorandum, this Offering - also referred to as the Series CF Crowdfunding Offering #2 - is executed as part of the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). The existing authorizations for the existing equity crowdfunding strategy permit the Company to raise up to $5 million of new capital pursuant to Regulation Crowdfunding offerings (including the final amount raised in the recently concluded Series CF Crowdfunding Offering #1 and the final amount raised in this crowdfunding campaign, also referred to herein as the Series CF Crowdfunding Offering #2) through 17 November 2025, so long as the total shares of Series CF Non-Voting Preferred Stock allocated to funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, for all applicable offerings, does not exceed 200,000 shares of Series CF Non-Voting Preferred Stock (which is equivalent to $500,000

IX Water Offering Memorandum (8 April 2025)
Page 44

in value and liquidation preference at the $2.50 per share issue price of the Series CF Non-Voting Preferred Stock). Based upon changes in market terms for equity crowdfunding campaigns since the October 2022 authorizations, including increases in equity compensation fees and allocations for bonus shares perks, Company management believes that the maximum amount to be raised under the current authorizations (i.e., without a requirement to obtain new voting shareholder approvals) is between $3.2 and $3.5 million, and not $5 million.

As stated in the section of this Offering Memorandum title and "Updated Overall Capital Raising Strategy" (p. 37 of this Offering Memorandum), the Company's Board of Directors has recently authorized Company management to expand the overall capital raising strategy of the Company beyond crowdfunding, during 2025. Such authorizations include retaining a qualified investment banker or other qualified capital-raising services provider, to assist the Company with securing (i) approximately $2.5 million in equity capital via a private offering (separate, and in addition, to the proceeds raised in this Offering) and (ii) an additional $10 million credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows) to fund customer builds and shorten delivery times from around 90 days to 30 to 45 days as well as provide an additional source of liquidity for working capital needs. The Company may retain such investment banker or other capital-raising services provider while this Offering is in process; however, any activities involving the offer or sale or securities will be deferred until after conclusion of this Offering, including for compliance with applicable securities laws.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 45

IX Water Offering Memorandum (8 April 2025)
Page 46

# Indebtedness

- **Creditor**: Dr. L. Robert (Bob) Libutti (deceased; Mary Tendall, surviving spouse and personal representative)

**Amount Owed**: $137,227*

*Approximate amount, calculated as of 31 March, 2025, which includes approximately $121,599 of principal (reduced from the previously stated $128,000 principal balance of this Note Payable) and $15,628 of accrued but unpaid interest. These amounts reflect a $18,302 payment against this Note Payable in January 2022, of which approximately $11,901 was applied to accrued and unpaid interest as of the payment date and $6,401 was applied to principal. Interest continues to accrue after the date of this Offering Memorandum until this obligation is paid in full.

**Interest Rate**: 4.0%

**Maturity Date**: December 31, 2025 (extended from the prior maturity dates of December 31, 2023 and December 31, 2021)

The Company has executed a second amended and restated promissory note (unsecured), dated effective December 31, 2023, in favor of Dr. Libutti (deceased; Mary Tendall, surviving spouse and personal representative), a former officer and director the Company, to memorialize $128,000 of loans made by Dr. Libutti to the Company between August 1, 2018 and December 11, 2019. Such second amended and restated promissory note amends and supersedes, without novation, and, solely for convenience of reference, restates, the amended and restated promissory note, dated December 31, 2021, in favor of Dr. Libutti (which amended and restated promissory note amended and restated promissory note amended and superseded, without novation, and, solely for convenience of reference, restates, the original promissory note, dated April 10, 2020, in favor of Dr. Libutti). All unpaid amounts owed pursuant to the terms of the note bear interest at a rate of interest equal to 4% per annum; such interest rate increases to 6% if a default occurs in the future under the note. Interest is computed on the basis of a 365-day year for the actual number of days elapsed in the period during which it accrues, and unpaid interest does not compound. The scheduled maturity date of the note is the earliest to occur of (a) 31 December 2025 (extended from the prior maturity dates of December 31, 2023 and December 31, 2021) or (b) consummation of a "Sale of the Company," as defined in the Company's Stockholder Agreement (see Addendum 1 to this Exhibit A for a description of such Stockholder Agreement). No payments of interest or principal are required prior to maturity. The Company may prepay the indebtedness of the note in part or in full at any time without the imposition of any penalty. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). The events of default are payment defaults (failure to pay amounts when due, subject to a 21-day day grace period) and bankruptcy/insolvency defaults. The principal amount of this note obligation as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Notes payable line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The principal amount of this note obligation as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

# Indebtedness (continued)

- **Creditor**: Dr. Otis (Pete) Peterson
**Amount Owed**: $5,000
**Interest Rate**: 0.0%
**Maturity Date**: N/A

Prior to the Company's first disbursement of funds from its initial crowdfunding campaign (which launched in May 2020), Dr. Peterson, a current officer of the Company, advanced funds on behalf of the Company for payment of Company expenses. This is an expense reimbursement obligation/payable that does not bear interest and will be reimbursed at a date mutually agreed to by the Company and Dr. Peterson. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). This obligation as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. This obligation as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

- **Creditor**: IX Power Foundation, Inc.
**Amount Owed**: $4,000
**Interest Rate**: 0.0%
**Maturity Date**: N/A

In late January 2025, IX Power Foundation, Inc. advanced funds on behalf of the Company for payment of Company expenses. Deborah A. (Deal) Blackwell, a member of the Company's management team, serves as CEO of IX Power Foundation. This is an expense reimbursement obligation/payable that does not bear interest and will be reimbursed at a date mutually agreed to by the Company and IX Power Foundation, Inc. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). This obligation is a Current Liabilities/Accounts payable line item, but will not be included in the financial statements published with the Form C Offering Statement of which this Offering Memorandum forms a part as it was recently incurred during 2025.

IX Water Offering Memorandum (8 April 2025)

IX Water Offering Memorandum (8 April 2025)
Page 48

# Indebtedness (continued)

- **Creditor**: Corporate/Securities Counsel
- **Amount Owed**: $175,000 (over 90 days as of the date of this Offering Memorandum)*
- **Interest Rate**: 0.0% (an interest rate could apply in the future)
- **Maturity Date**: N/A

As of the date of this Offering Memorandum, interest is not accruing on the balance of the obligation owed, but an interest term could become applicable based upon the period of time this obligation remains outstanding. To the extent not paid from other sources (such as sales revenue or proceeds of any separate and prior or future securities offerings of Company securities), the Company intends to use a portion of the proceeds of equity offerings, including this Series CF Crowdfunding Offering #2 for repayment of existing liabilities, including this indebtedness (or a portion of this indebtedness).

*The $175,000 Amount Owed is comprised of the following separate balances:

- $30,000 - this amount is for legal services related to corporate and securities transactions prior to the launch of the Company's initial crowdfunding campaign (which launched in May 2020) and does not include fees and costs for legal services related to such initial crowdfunding campaign. The amount of this obligation was reduced from $55,000 to $30,000 based upon payments remitted during 2021, and Corporate/Securities Counsel waived any requirement for the payment of interest on the obligations repaid.

- $45,000 - this amount is a balance owed for legal work related to the Company's initial crowdfunding campaign which commenced in May 2020 and concluded earlier in 2022 (including all closings, extensions and amendments to date, and legal work for such campaign). The total amount for such legal work was $75,000 (reflecting a discounted/fixed fee arrangement), with $45,000 outstanding as of the date of this Offering Memorandum.

- $3,000 - this amount is a balance owed for legal work during 2022, 2023 and 2024 related to required SEC and state "blue sky" law filings for the Company's outstanding warrants issued as part of the Company's Rule 506(b) offering that occurred in April 2020 prior to commencement of the Company's initial crowdfunding campaign.

- $6,500 - this amount is a balance owed for legal work during 2022 related to the Company's Rule 506(b) offering that occurred in May 2022.

- $80,000 - this amount is a balance owed for legal work related to the Company's Series CF Crowdfunding Offerings, including a portion of the fees and costs of legal work related to this Offering.

- $10,500 - this amount is a balance owed for legal work related to corporate governance and general business matters.

The above amount owed does include a portion of the fees and costs of legal work related to this particular crowdfunding campaign, which are referenced in the "Use of Proceeds" section of this Offering Memorandum (pp. 61-62 of this Offering Memorandum) and are estimated at approximately $20,000 - $25,000 in the aggregate.

The relevant portion of the above amount outstanding as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The relevant portion of the above amount outstanding as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 49

# Indebtedness (continued)

- **Creditor**: Intellectual Property Counsel

**Amount Owed**: $33,000 original balance (and $19,246 asserted interest/finance charges as of 28 February, 2025, which equates to an asserted total balance of $52,246)

**Interest Rate**: 18.0% (1.5% per month) (asserted)

**Maturity Date**: N/A

To the extent not paid from other sources (such as sales revenue or proceeds of any separate and prior or future securities offerings of Company securities), the Company has reserved a portion of the proceeds of this crowdfunding campaign for repayment of existing liabilities, including this indebtedness (or a portion of this indebtedness). The amount of this obligation (before interest) was reduced from $44,000 to $33,000 based upon payments remitted during 2021 and 2022, and Intellectual Property Counsel waived any requirement for the payment of interest on the obligations repaid at such time. As of the date of this Offering Memorandum, Intellectual Property Counsel has reasserted an interest/finance charge term at a rate of 18.0% per annum (1.5% per month). Company management is negotiating with Intellectual Property Counsel regarding the asserted interest/finance charge term with such negotiations in process and not resolved as of the date of this Offering Memorandum.

The relevant portion of the above amount outstanding as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The relevant portion of the above amount outstanding as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

- **Creditor**: Receivables Factoring

**Amount Owed**: If/when applicable - Varies

**Interest Rate**: If/when applicable - 0.0%-Varies

**Maturity Date**: If/when applicable - Varies.

The Company may, from time to time, leverage its accounts receivable (AR) to insure cash flow. The Company has existing relationships with various non-bank entities under which AR may be purchased for a discount based on the nature of the accounts receivable and Company creditworthiness. A lien against Company assets may also be filed to further ensure collection of AR. Previously outstanding obligations with respect to receivables factoring, for the years ended December 31, 2023 and/or December 31, 2022, respectively, and as applicable, are included in the Current Liabilities/Factoring loans payable line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The relevant portion of receivables factoring outstanding as of December 31, 2024, if and as applicable, will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 50

# Indebtedness (continued)

- **Creditor**: Existing Stockholders and persons affiliated, related, or connected to existing stockholders, including existing stockholders John (Michael) Bell and Robert S. Bednarz, Ph.D. each of whom holds a current director position with the Company

**Amount Owed**: $237,500.00 (of which $122,000.00 was outstanding as of 31 December 2023 and $237,500.00 was outstanding as of 31 December 2024 and remains outstanding as of the date of this Offering Memorandum); the portion of this $237,500.00 advanced by existing stockholder and current director John (Michael) Bell is $5,500, the portion of this $237,500.00 advanced by existing stockholder and current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse, is $66,000; and the portion of this $237,500.000 advanced by existing stockholder and recently appointed non-voting board observer Robert C. Rowe, individually or jointly with his spouse, is $25,000). The amounts advanced range from $1,000 to $66,000 per existing stockholder or other person affiliated, related, or connected to the existing stockholder. Current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse, was paid a nominal fee in the amount of $250 for expedited processing of a $12,500 advance made in mid-January 2024 that was repaid in late January 2024 and is not reflected in the $237,500.00 amount owed.

**Interest Rate**: 0.0%

**Maturity Date**: N/A

To manage cash flow needs prior to or during the Company's crowdfunding campaigns, existing stockholders of the Company, including existing stockholder John (Michael) Bell who holds a current director position with the Company, and other persons affiliated, related or connected to existing stockholders, advanced funds on behalf of the Company for payment of Company expenses. These are expense reimbursement obligations/payables that do not bear interest and will be reimbursed at a date mutually agreed to by the Company and each relevant existing stockholder. The Company may repay these obligations from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). These obligations as of December 31, 2023 and December 31, 2022, respectively, are included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. These obligations as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

- **Creditor**: Existing Stockholders and persons affiliated, related, or connected to existing stockholders

**Amount Owed**: Up to $250,000.00 (principal amount)*, of which $0.00 was outstanding as of 31 December 2023; approximately $59,410 ($58,500 in principal and approx. $910 in accrued interest) was outstanding as of 31 December 2024; and approximately $149,532 ($144,000 in principal and approx. $5,532 in accrued interest) is outstanding as of 31 March 2025, with the amounts advanced as of 31 March 2025 ranging from $2,500.00 to $50,000.00 per existing

stockholder or other person affiliated, related, or connected to the existing stockholder ($5,000 has been advised by existing stockholder and current director John (Michael) Bell and $3,000 has been advanced by existing stockholder and current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse). This leaves up to $106,000 (principal amount) available to be borrowed by the Company, including any amounts borrowed between 31 March 2025 and the date of this Offering Memorandum.

*$250,000 is the maximum principal amount authorized by the Company's Board of Directors as of the date of this Offering Memorandum. This maximum principal amount may be increased by supplemental Board authorization after the date of this Offering Memorandum.

Interest Rate: 16.0%

Maturity Date: May 31, 2025

To facilitate the launch of this Series CF Crowdfunding Offering #2, existing stockholders of the Company and other persons affiliated, related, or connected to existing stockholders of the Company, have made short-term loans to the Company for working capital purposes, which loans are evidenced by written promissory notes executed by the Company. The Company anticipates it will continue to incur additional indebtedness on these terms after the date of this Offering Memorandum, estimated at between $50,000 to $122,000 (principal amount, excluding interest), for maximum total indebtedness of $250,000 (principal amount, excluding interest), pending outcome of the Series CF Crowdfunding Offering #2 and timing of disbursements of capital raised pursuant to the Series CF Crowdfunding Offering #2. As noted above, maximum principal amount may be increased by supplemental Board authorization after the date of this Offering Memorandum. All unpaid amounts owed pursuant to the terms of these notes bear interest at a rate of interest equal to 16% per annum (compounded annually, although such compounding feature will not apply if the obligations are paid in full by the scheduled maturity date); such interest rate increases to the maximum interest rate permitted by applicable law (currently, 45% per annum under Colorado law) if a payment default occurs in the future under the note. The scheduled maturity date of each note is May 31, 2025. No payments of interest or principal are required prior to maturity. The Company may prepay the indebtedness of the note in part or in full at any time, provided that, prepayment shall accrue at least three months of interest. Each note states that it shall be secured with Company assets as well as guaranteed personally by the Company CEO. The Company may repay these obligations from proceeds of equity offerings, including this Series CF Crowdfunding Offering #2.

The principal amount of each of these notes is an obligation that is included in the Current Liabilities/Notes payable line item in the Company's financial statements (balance sheets). Since these notes were issued during 2024 and 2025 (to the date of this Offering Memorandum) the indebtedness evidenced by these notes is not reflected in the financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part as of the date of the launch of this crowdfunding campaign. The principal amount of each of these notes, to the extent outstanding as of December 31, 2024, will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 51

# Related Party Transactions

- **Name of Entity**: IX Power LLC
Names of 20% owners: IX Power LLC is the Company's founder and is owned by the following members of the Company's management team (each owning 20% of IX Power LLC as of the date of this Offering Memorandum): John R. (Grizz) Deal, CEO; Randall (Randy) Wilson, CFO; Deborah A. (Deal) Blackwell, CMO; Dr. Otis (Pete) Peterson, CTO, and Dr. L. Robert (Bob) Libutti, former Chief Product Strategist (deceased; Mary Tendall, surviving spouse and personal representative).
Relationship to Company: 20%+ Owner
Nature / amount of interest in the transaction: Intellectual Property License
Material Terms: The Company's success is dependent, in large part, upon the patent rights acquired from Los Alamos National Security, LLC ("LANS"). LANS conducts research and development at Los Alamos National Laboratory for the U.S. Government under a contract with the U.S. Department of Energy. The technology underlying these patent rights was originally jointly developed by LANS, The Board of Regents of the University of Texas System ("UT"), and New Mexico Tech Research Foundation ("NMTRF"). The Company's founder, IX Power LLC, acquired LANS' rights and interest in such patent rights in April 2013, and entered into a Royalty-Sharing Agreement and Joint Invention Management Agreement with UT and NMTRF (NMTRF's interests in such agreement were subsequently assigned to Karen Bailey-Bowman) (the "Joint Invention RSA"). From the Company's incorporation until 2017, the Company was licensing the patent rights from IX Power LLC. In 2017, IX Power LLC and the Company completed an outright assignment of the IX Power patent rights from IX Power LLC to the Company, and the Company assumed IX Power LLC's obligations under the Joint Invention RSA. The patent rights are currently jointly owned by the Company, UT and Ms. Bowman (as assignee of NMTRF), subject to the Joint Inventions RSA.

- **Name of Entity**: IX Power Foundation, Inc.
Names of 20% owners: Not applicable - IX Power Foundation, Inc. is an IRS designated 501(c)(3) entity.
Relationship to Company: Other - Non-governmental organization (NGO) established under the IX Power brand to support people, new technologies, services and projects for a better world. IX Power Foundation's fundraising mission includes fundraising to support the Company's products and services. Deborah A. (Deal) Blackwell, a member of the Company's management team, serves as CEO of IX Power Foundation.
Nature / amount of interest in the transaction: Expense Reimbursement - $12,819
Material Terms: The Company previously incurred expenses that benefitted not only the Company but also IX Power Foundation. The Company and IX Power Foundation have agreed that IX Power Foundation will reimburse the Company for a portion of such expenses, in the amount of $12,819. Such expense reimbursement is payable on demand and does not bear interest. The receivable associated with such expense reimbursement as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Assets/Due from related party line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The receivable associated with such expense reimbursement as of as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 52

# Related Party Transactions (continued)

- **Name of Entity**: IX Power Foundation, Inc.
**Names of 20% owners**: Not applicable - IX Power Foundation, Inc. is an IRS designated 501(c)(3) entity.
**Relationship to Company**: Other - Non-governmental organization (NGO) established under the IX Power brand to support people, new technologies, services and projects for a better world. IX Power Foundation's fundraising mission includes fundraising to support the Company's products and services. Deborah A. (Deal) Blackwell, a member of the Company's management team, serves as CEO of IX Power Foundation.
**Amount owed**: $4,000
**Material Terms**: In late January 2025, IX Power Foundation, Inc. advanced funds on behalf of the Company for payment of Company expenses. Deborah A. (Deal) Blackwell, a member of the Company's management team, serves as CEO of IX Power Foundation. This is an expense reimbursement obligation/payable that does not bear interest and will be reimbursed at a date mutually agreed to by the Company and IX Power Foundation, Inc. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). This obligation is a Current Liabilities/Accounts payable line item, but will not be included in the financial statements published with the Form C Offering Statement of which this Offering Memorandum forms a part as it was recently incurred during 2025.

- **Name of Individual**: Dr. L. Robert (Bob) Libutti (deceased; Mary Tendall, surviving spouse and personal representative)
**Relationship to Company**: Former Officer and Director
**Amount Owed**: $137,227*
*Approximate amount, calculated as of 31 March, 2025, which includes approximately $121,599 of principal (reduced from the previously stated $128,000 principal balance of this Note Payable) and $15,628 of accrued but unpaid interest. These amounts reflect a $18,302 payment against this Note Payable in January 2022, of which approximately $11,901 was applied to accrued and unpaid interest as of the payment date and $6,401 was applied to principal. Interest continues to accrue after the date of this Offering Memorandum until this obligation is paid in full.

**Maturity Date**: December 31, 2025 (extended from the prior maturity dates of December 31, 2023 and December 31, 2021)

**Material Terms**: The Company has executed a second amended and restated promissory note (unsecured), dated effective December 31, 2023, in favor of Dr. Libutti (deceased; Mary Tendall, surviving spouse and personal representative), a former officer and director the Company, to memorialize $128,000 of loans made by Dr. Libutti to the Company between August 1, 2018 and December 11, 2019. Such second amended and restated promissory note amends and supersedes, without novation, and, solely for convenience of reference, restates, the amended and restated promissory note, dated December 31, 2021, in favor of Dr. Libutti (which amended and restated promissory note amended and restated promissory note amended and superseded, without novation, and, solely for convenience of reference, restates, the original promissory note, dated April 10, 2020, in favor of Dr. Libutti). All unpaid amounts owed pursuant to the terms of the note bear interest at a rate of interest equal to 4% per annum; such interest rate increases to 6% if a default occurs in the future under the note. Interest is computed

IX Water Offering Memorandum (8 April 2025)
Page 53

on the basis of a 365-day year for the actual number of days elapsed in the period during which it accrues, and unpaid interest does not compound. The scheduled maturity date of the note is the earliest to occur of (a) 31 December 2025 (extended from the prior maturity dates of December 31, 2023 and December 31, 2021) or (b) consummation of a "Sale of the Company," as defined in the Company's Stockholder Agreement (see Addendum 1 to this Exhibit A for a description of such Stockholder Agreement). No payments of interest or principal are required prior to maturity. The Company may prepay the indebtedness of the note in part or in full at any time without the imposition of any penalty. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). The events of default are payment defaults (failure to pay amounts when due, subject to a 21-day day grace period) and bankruptcy/insolvency defaults. The principal amount of this note obligation as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Notes payable line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. The principal amount of this note obligation as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

- Name of Individual: Dr. Otis (Pete) Peterson
- Relationship to Company: Director &amp; Officer
- Nature / amount of interest in the transaction: Reimburse Company expenses - $5,000
- Material Terms: Prior to the Company's first disbursement of funds from its initial crowdfunding campaign (which launched in May 2020), Dr. Peterson, a current officer of the Company, advanced funds on behalf of the Company for payment of Company expenses. This is an expense reimbursement obligation/payable that does not bear interest and will be reimbursed at a date mutually agreed to by the Company and Dr. Peterson. The Company may repay this obligation from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). This obligation as of December 31, 2023 and December 31, 2022, respectively, is included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. This obligation as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 54

# Related Party Transactions (continued)

- **Name of Individual:** Related Persons (as described below)

**Relationship to Company:** Existing Stockholders, including existing stockholders holding current or former officer and/or director positions with the Company - specifically former officer and director Dr. L. Robert (Bob) Libutti (deceased) and former director Paul Gatzemeier (deceased)

**Nature / amount of interest in the transaction:** Stock Issuance / $122,433.75

**Material Terms:**

- **Type of security sold:** Equity - Series B Non-Voting Preferred Stock
- **Final amount sold:** $122,433.75 (debt conversion; $87,475 of principal and $34,958.75 of interest)
- **Number of Securities Sold:** 97,947
- **Use of proceeds:** Go-to-market strategy and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company.

**Date:** May 31, 2022

**Offering exemption relied upon:** 506(b)

**Additional Information, Related Party Debt Conversion:** All Series B Non-Voting Preferred Stock shares issued in this offering were issued in exchange for conversion of indebtedness (including interest) owed by the Company to certain existing stockholders/investors, including existing stockholders/investors currently holding positions as directors and/or officers of the Company. The indebtedness that was converted included indebtedness owing by the Company (1) under the existing bridge loan facility authorized by the Company prior to the launch in May 2020 of the Company's Regulation Crowdfunding campaign, and still outstanding, and (2) in connection with loans or advances previously made by existing stockholders/investors (including existing stockholders/investors currently holding positions as directors and/or officers of the Company) to, or on behalf of, the Company for payment of Company expenses. Indebtedness converted in this offering was, by its stated terms, non-convertible. Accordingly, the conversion of indebtedness in this offering occurred by voluntary conversion of indebtedness with mutual agreement of the Company and each applicable holder of the indebtedness that is converted.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 55

IX Water Offering Memorandum (8 April 2025)
Page 56

# Related Party Transactions (continued)

- **Name of Individual**: Related Persons (as described below)

**Relationship to Company**: Existing Stockholders, including existing stockholders holding current or former officer and/or director positions with the Company - specifically current directors John (Michael) Bell (through an affiliated entity) and former director Paul Gatzemeier (deceased)

**Nature / amount of interest in the transaction**: Stock Issuance / $610,083.75; Warrant Issuance / up to $600,000 contingent consideration

**Material Terms**:

**Type of security sold**: Equity - Series B Non-Voting Preferred Stock &amp; Warrants to acquire Class B Non-Voting Common Stock

**Final amount sold**: $610,083.75 (combination of principal/outstanding balances and interest)

**Warrants Issued**: Class B Non-Voting Common Stock Warrants, up to 480,000 warrant shares. The exercise price of such warrants is $1.25 per share. The warrant expiration date is April 1, 2025, subject to early termination upon an initial public offering of the Company's capital stock and certain corporate transaction events as described in the warrants.

**Use of proceeds**: Go-to-market strategy and general working capital, inclusive of payments to service providers and payments to officers, directors, and consultants, some of whom are affiliates of the Company. NOTE: Such amount raised excludes the up to $600,000 of contingent proceeds receivable, if and when the warrants issued as part of the offering are exercised.

**Date**: April 10, 2020

**Offering exemption relied upon**: 506(b)

**NOTE**-*additional information, related party debt conversion*: This Rule 506(b) offering was a limited offering for the purposes of restructuring and satisfying certain related party liabilities through conversion to equity in lieu of cash payment.

- **Name of Individual**: John R. (Grizz) Deal

**Relationship to Company**: Director &amp; Officer

**Nature / amount of interest in the transaction**: Cash advance for equipment purchases on behalf of the Company - Varies

**Material Terms**: The Company from time to time makes cash advances to Mr. Deal, through an entity controlled by Mr. Deal, for the purposes of facilitating equipment purchases on behalf of the Company. The aggregate amount of such cash advances, for planned equipment purchases not yet completed, was $20,047 as of December 31, 2020, $30,121 as of December 31, 2021, $60,692 as of December 31, 2022, $58,922 as of December 31, 2023 and is not more than $58,922 as of December 31, 2024 and as of the date of this Offering Memorandum. The equipment purchases subject to these cash advances may be funded from proceeds of equity offerings, including the recently concluded crowdfunding campaign. The receivable(s) associated with these advances as of December 31, 2023 and December 31, 2022, respectively, are included in the Current Assets/Due from related party line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C

Offering Statement of which this Offering Memorandum forms a part. The receivable(s) associated with these advances as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

- **Name of Individual:** Related Persons (as described below)

**Relationship to Company:** Existing Stockholders and persons affiliated, related, or connected to existing stockholders, including existing stockholders John (Michael) Bell and Robert S. Bednarz, Ph.D. each of whom holds a current director position with the Company.

**Nature / amount of interest in the transaction:** Reimbursement of Company expenses - $237,500.00 in total (of which $122,000.00 was outstanding as of 31 December 2023 and $237,500.00 was outstanding as of 31 December 2024 and remains outstanding as of the date of this Offering Memorandum). The amounts advanced range from $1,000 to $66,000 per existing stockholder or other person affiliated, related, or connected to the existing stockholder. The portion of this $237,500.00 advanced by existing stockholder and current director John (Michael) Bell is $5,500, the portion of this $237,500.00 advanced by existing stockholder and current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse, is $66,000, and the portion of this $237,500.000 advanced by existing stockholder recently appointed non-voting board observer Robert C. Rowe, individually or jointly with his spouse, is $25,000. Current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse, was paid a nominal fee in the amount of $250 for expedited processing of a $12,500 advance made in mid-January 2024 that was repaid in late January 2024 and is not reflected in the $237,500.00 amount owed.

**Material Terms:** To manage cash flow needs prior to or during the Company's crowdfunding campaigns, existing stockholders of the Company, including existing stockholders John (Michael) Bell and Robert S. Bednarz, Ph.D. who hold current director positions with the Company, and other persons affiliated, related or connected to existing stockholders, advanced funds on behalf of the Company for payment of Company expenses. These are expense reimbursement obligations/payables that do not bear interest and will be reimbursed at a date mutually agreed to by the Company and each relevant existing stockholder. The Company may repay these obligations from proceeds of equity offerings, including the initial crowdfunding campaign and any one or more of the crowdfunding campaigns pursuant the Company's existing equity crowdfunding strategy, as further described in the section of this Offering Memorandum titled "Preferred Stock Crowdfunding Offerings" (pp. 35-36 of this Offering Memorandum). These obligations as of December 31, 2023 and December 31, 2022, respectively, are included in the Current Liabilities/Due to related parties line item in the Company's financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. These obligations as of December 31, 2024 will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 57

# Related Party Transactions (continued)

- **Name of Individual**: Related Persons (as described below)

**Relationship to Company**: Existing Stockholders and persons affiliated, related, or connected to existing stockholders

**Nature / amount of interest in the transaction**: Short-term term loans for working capital purposes: Up to $250,000.00 (principal amount)*, of which $0.00 was outstanding as of 31 December 2023; approximately $59,410 ($58,500 in principal and approx. $910 in accrued interest) was outstanding as of 31 December 2024; and approximately $149,532 ($144,000 in principal and approx. $5,532 in accrued interest) is outstanding as of 31 March 2025, with the amounts advanced as of 31 March 2025 ranging from $2,500.00 to $50,000.00 per existing stockholder or other person affiliated, related, or connected to the existing stockholder ($5,000 has been advised by existing stockholder and current director John (Michael) Bell and $3,000 has been advanced by existing stockholder and current director Robert S. Bednarz, Ph.D., individually or jointly with his spouse). This leaves up to $106,000 (principal amount) available to be borrowed by the Company, including any amounts borrowed between 31 March 2025 and the date of this Offering Memorandum.

*$250,000 is the maximum principal amount authorized by the Company's Board of Directors as of the date of this Offering Memorandum. This maximum principal amount may be increased by supplemental Board authorization after the date of this Offering Memorandum.

- **Material Terms**: To facilitate the launch of this Series CF Crowdfunding Offering #2, existing stockholders of the Company and persons affiliated, related, or connected to existing stockholders have made short-term loans to the Company for working capital purposes, which loans are evidenced by written promissory notes executed by the Company. The Company anticipates it will continue to incur additional indebtedness on these terms after the date of this Offering Memorandum, estimated at between $50,000 to $122,000 (principal amount, excluding interest), for maximum total indebtedness of $250,000 (principal amount, excluding interest), pending outcome of the Series CF Crowdfunding Offering #2 and timing of disbursements of capital raised pursuant to the Series CF Crowdfunding Offering #2. As noted above, maximum principal amount may be increased by supplemental Board authorization after the date of this Offering Memorandum. All unpaid amounts owed pursuant to the terms of these notes bear interest at a rate of interest equal to 16% per annum, compounded annually; such interest rate increases to the maximum interest rate permitted by applicable law (currently, 45% per annum under Colorado law) if a payment default occurs in the future under the note. The scheduled maturity date of each note is May 31, 2025. No payments of interest or principal are required prior to maturity. The Company may prepay the indebtedness of the note in part or in full at any time, provided that, prepayment shall accrue at least three months of interest. Each note states that it shall be secured with Company assets as well as guaranteed personally by the Company CEO. The Company may repay these obligations from proceeds of equity offerings, including this Series CF Crowdfunding Offering #2. The principal amount of each of these notes is an obligation that is included in the Current Liabilities/Notes payable line item in the Company's financial statements (balance sheets). Since these notes were issued during 2024 and 2025 (to the date of this Offering Memorandum) the indebtedness evidenced by these notes is not reflected in the financial statements (balance sheets) included as Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part. These obligations, to the extent outstanding as of December 31, 2024, will be included in the Current Liabilities/Accounts payable line item in the Company's pending financial statements for the most recent fiscal year ending December 31, 2024, which financial statements are expected to be published no later than the Regulation Crowdfunding annual report filing deadline at the end of April 2025 and, if published while this Offering is active, will be included via amendment and update to Exhibit B to the Form C Offering Statement of which this Offering Memorandum forms a part.

IX Water Offering Memorandum (8 April 2025)
Page 58

# Related Party Transactions (continued)

- Name of Individual: John R. (Grizz) Deal &amp; Deborah A. (Deal) Blackwell
Relationship to Company: John R. (Grizz) Deal, Director &amp; Officer; Deborah A. (Deal) Blackwell, Officer
Nature / amount of interest in the transaction: Disclosure of family relationships among management team members.
Material Terms: John R. (Grizz) Deal, a director and officer of the Company, and Deborah A. (Deal) Blackwell, an officer of the Company, are siblings.

- Name of Individual: All Directors &amp; Officers of the Company
Relationship to Company: Director and/or Officer
Nature / amount of interest in the transaction: Disclosure of interests of current directors and officers in the Company's securities.
Material Terms: All directors and officers of the Company have direct or indirect interests in the Company's securities. Investment/purchase amounts vary.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)

# Valuation

Pre-Money Valuation: $33,202,075

## Valuation Details:

The valuation for the Offering has been determined arbitrarily by the Company. We did not seek or obtain an opinion of a financial advisor or third-party valuation firm in establishing the purchase price. The factors considered to determine such pre-money valuation included: (1) the value of the estimated funds, effort, and innovation achieved in the original licensed intellectual property (the Company estimates that such intellectual property is worth approximately $10 million, but according to GAAP, it cannot be booked as an asset); (2) the amount of capital and unpaid founder effort ("sweat equity") put into designing, developing, and testing the commercial product suite (the Company estimates this to be triple the invested capital, or about $6 million at the time of the determination); and (3) research of Company Management, which focused on comparable firms, in the same phase of development as the Company with respect to the Company's treatment systems business - product complete, testing, initial marketing and sales begun - and with similar service offerings as the Company's new IX Water Reclamation service line of business. The Company reviewed such factors and assumptions, and determined a pre-money valuation, after discounting, that resulted in the $2.50 price per share. The $33,202,075 pre-money valuation equates to the Company's fully diluted share capital at the time of the authorization of the Series CF Non-Voting Preferred Stock in October 2022, which was 13,280,830 fully diluted shares, multiplied by $2.50. In determining the fully diluted share capital of the Company, we assume: (i) all preferred stock is converted to common stock; (ii) all outstanding options, warrants, and other securities with a right to acquire shares are exercised; and (iii) all shares reserved for stock options or other equity compensation awards issuable to employees or directors of, or consultants or advisors to, the Company, whether or not subject to a formal written plan, are issued.

The purchase price is not related to earnings, book value, or net worth of the Company and should not be considered to be an indication of the actual value of the Company or either the Series CF Non-Voting Preferred Stock or the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein, or any other securities of the Company. There is not now nor is there expected to be a public market for any of the Company's securities, including the Series CF Non-Voting Preferred Stock offered in this crowdfunding campaign and the Class B Non-Voting Common Stock into which the Series CF Non-Voting Preferred Stock is convertible as described herein; and the Company makes no representations or warranties, actual or implied that any of such securities can be resold at the $2.50 price per share or any other price.

Before making an investment decision, you should carefully consider this valuation and the factors used to reach such valuation. Such valuation may not be accurate, and you are encouraged to determine your own independent value of the Company prior to investing.

[Remainder of this page intentionally left blank.]

IX Water Offering Memorandum (8 April 2025)
Page 60

Use of Proceeds

## Target Offering Amount

If we raise the Target Offering Amount of $20,000.00 we plan to use these proceeds as follows:

- StartEngine Platform Fees, Cash Commission
7.5%
The compensation and fees payable to StartEngine include a cash commission fee equal to 7.5% of the total amount of investments raised in the offering, payable from disbursements of funds at each applicable closing.

- StartEngine Platform Fees, Fixed Services Fee
25.0%
The compensation and fees payable to StartEngine include a $10,000 fixed services fee, of which $5,000 has been paid to StartEngine prior to the date of this Offering Memorandum and the $5,000 balance is payable from the first disbursement of funds to the Company from escrow.

- Other Offering Expenses, Launch of Crowdfunding Campaign (estimated)
67.5%
Other offering expenses include, without limitation, (i) advertising/marketing/promotion spend related to such launch (including advertising and marketing/PR services), and (ii) state "blue sky" notice filing fees, legal, accounting and other miscellaneous expenses. It is noted that these categories, which are tracked as offering expenses for the Company's internal tracking purposes, are not necessarily treated as costs of capital for accounting purposes.

## Maximum Offering Amount

If we raise the overallotment amount of $2,750,000.00, we plan to use these proceeds as follows:

- StartEngine Platform Fees, Cash Commission
7.5%
The compensation and fees payable to StartEngine include a cash commission fee equal to 7.5% of the total amount of investments raised in the offering, payable from disbursements of funds at each applicable closing.

- StartEngine Platform Fees, Fixed Services Fee
0.2%
The compensation and fees payable to StartEngine include a $10,000 fixed services fee, of which $5,000 has been paid to StartEngine prior to the date of this Offering Memorandum and the $5,000 balance is payable from the first disbursement of funds to the Company from escrow.

- Other Offering Expenses, Launch of Crowdfunding Campaign (estimated)
12.0%
Other offering expenses include, without limitation, (i) advertising/marketing/promotion spend related to such launch (including advertising and marketing/PR services), and (ii) state "blue sky" notice filing fees, legal, accounting and other miscellaneous expenses. It is noted that these categories, which are tracked as offering expenses for the Company's internal tracking purposes, are not necessarily treated as costs of capital for accounting purposes.

IX Water Offering Memorandum (8 April 2025)

Use of Proceeds (continued)

Maximum Offering Amount (continued)

- IX Water Reclamation Start-Up Capital
24.5%
Start-up capital for the IX Water Reclamation service business. This includes raw materials and components to construct IX Water machines, heavy haul trailers with which to transport those machines, initial (pre-cash flow positive) salaries, expenses, and establishment of the initial customer service area for the Reclamation division in Bakersfield, California.

- Other IX Water Business Operations &amp; Expansion of Sales of IX Water Treatment Systems
31.8%
Includes the following categories of expenses, which are consistent with business operations to date:
1) Operations - Essentially a general and administrative category, including purchasing, rent, utilities, travel expenses and costs for management team members, employees and outside consultants not assigned to the Engineering or Sales &amp; Marketing sub-categories below and not assigned to the IX Water Reclamation Start-Up Capital category above.
2) Sales and Marketing - Operations and activities involved in promoting and selling IX Water machines. Excludes the advertising/marketing/promotion spend for this crowdfunding campaign, which are included in the Other Offering Costs (Estimated) category above.
3) Engineering - Primarily costs for employees and outside consultants that create IX Water implementation plans and also do analysis of site waters and local requirements for treatment. Excludes engineering costs assigned to the IX Water Reclamation Start-Up Capital category above.
4) CapEx - Computers and small tools/equipment; no large manufacturing equipment required since components are currently made by vendors.

- Repayment of Existing Liabilities
24.0%
Reserved for repayment of the existing liabilities, including outstanding indebtedness to corporate/securities counsel and intellectual property counsel and related parties, as described in the "Indebtedness" section of this Offering Memorandum, to the extent not paid from other sources (such as sales revenue or proceeds of any separate and prior or future securities offerings of Company securities). If all or any portion of these existing liabilities are paid from such other sources, the offering proceeds allocated to this category will be re-allocated to any one or more of the categories or other uses as is believed to be in the best interests of the Company. For additional information on outstanding indebtedness, see the "Indebtedness" section of this Offering Memorandum.

The Company may change the intended use of proceeds if our officers believe it is in the best interests of the Company.

IX Water Offering Memorandum (8 April 2025)

IX Water Offering Memorandum (8 April 2025)
Page 63

# Regulatory Information

## Disqualification

No disqualifying event has been recorded in respect to the Company or its officers or directors.

## Compliance Failure

The Company has not previously failed to comply with the requirements of Regulation Crowdfunding.

## Ongoing Reporting

The Company will file a report electronically with the SEC annually and post the report on its website no later than April 30 (120 days after Fiscal Year End). Once posted, the annual report may be found on the Company's website at http://www.ixwater.com/investor.

The Company must continue to comply with the ongoing reporting requirements until:

1. it is required to file reports under Section 13(a) or Section 15(d) of the Exchange Act;
2. it has filed at least one (1) annual report pursuant to Regulation Crowdfunding and has fewer than three hundred (300) holders of record and has total assets that do not exceed $10,000,000;
3. it has filed at least three (3) annual reports pursuant to Regulation Crowdfunding;
4. it or another party repurchases all of the securities issued in reliance on Section 4(a)(6) of the Securities Act, including any payment in full of debt securities or any complete redemption of redeemable securities; or
5. it liquidates or dissolves its business in accordance with state law.

## Updates

Updates on the status of this Offering may be found at: https://www.startengine.com/offering/ix-water

## Investing Process

See Exhibit E to the Form C Offering Statement of which this Offering Memorandum forms a part.

## Attachments to this Exhibit A Offering Memorandum

Addendum 1, Additional Risk Factors
Addendum 2, Description of Capital Stock
Addendum 3, Summary of Special Dividend Entitlement - Issued Shares of Series CF Non-Voting Preferred Stock

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

# ADDENDUM 1
TO THE EXHIBIT A OFFERING MEMORANDUM,
WHICH FORMS A PART OF THE FORM C OFFERING STATEMENT FILED ON 8 APRIL 2025

# SUPPLEMENT TO RISK FACTORS SECTION OF SUCH EXHIBIT A AMENDED AND RESTATED OFFERING MEMORANDUM

The terms "IX Water," "Nine Power," the "Company," "we," "us," and "our" refer to IX Power Clean Water, Inc.

All references in this Addendum 1 to "the Form C" or "this Form C" refer to the Company's Form C Offering Statement filed on 8 April 2025, including all exhibits and addendums thereto. This Addendum 1 is attached to and made a part of Exhibit A of such Form C (which Exhibit A is titled "Offering Memorandum: Part II of Offering Document"). All references to in this Addendum 1 to "this Addendum" mean this Addendum 1.

The crowdfunding campaign/offering described in the Form C is referred to in this Addendum as "the Series CF Crowdfunding Offering #2" or "this Series CF Crowdfunding Offering #2" (as such term Series CF Crowdfunding Offering #2 is defined below).

In addition, as used in this Addendum, the following terms have the following meanings:

a) "Applicable Crowdfunding Securities" means, collectively, the shares of Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering), and the shares of the Class B Non-Voting Common Stock issuable upon conversion of such shares of Series CF Non-Voting Preferred Stock as described in Section VIII of Part I of the separate Addendum 2 to this Exhibit A of this Form C;

b) "Class B Non-Voting Common Stock" means shares of the Company's Class B Non-Voting Common Stock, par value $0.001 per share;

c) "Series CF Crowdfunding Offering(s)" means any one or more Regulation Crowdfunding offerings (an offering in reliance on Section 4(a)(6) of the Securities Act of 1933, as amended, and pursuant to Regulation Crowdfunding (§ 227.100 et seq.)) pursuant to which the security offered, sold and/or issued, as applicable, is the Company's Series CF Non-Voting Preferred Stock. As of the date of this Form C, the Series CF Crowdfunding Offering(s) includes the following offering(s): the Series CF Crowdfunding Offering #1 and the Series CF Crowdfunding Offering #2;

d) "Series CF Crowdfunding Offering #1" means the Regulation Crowdfunding offering hosted by Wefunder Portal that launched on 17 November 2022 and is concluding on 29 April 2024. This Series CF Crowdfunding Offering #1 has previously been referred to in the Company's Regulation Crowdfunding filings as the "additional crowdfunding campaign" or "the Additional Crowdfunding Offering";

e) "Series CF Crowdfunding Offering #2" means the Regulation Crowdfunding offering hosted by StartEngine Primary LLC that is launching on or about the date of this Form C. This Series CF Crowdfunding Offering #2 is sometimes referred to in this Form C as "this crowdfunding campaign," "the Offering" or "this Offering";

f) "Series CF Crowdfunding Offering Investors" means the persons who/that acquire shares of the Company's Series CF Non-Voting Preferred Stock pursuant to any one or more Series CF Crowdfunding Offerings (whether the shares are issued in exchange for cash consideration or are issued as equity compensation for services provided to the Company in connection with the applicable Series CF Crowdfunding Offering and in compliance with Regulation Crowdfunding); and

g) "Series CF Non-Voting Preferred Stock" means collectively, all shares of the Company's Series CF Non-Voting Preferred Stock, par value $0.001 per share.

All references in this Addendum to "$" or "dollars" are to United States dollars unless specifically stated otherwise.

The order in which the risks are presented in the Form C, including in this Addendum, is not intended to represent the magnitude of the risks described.

This Addendum is comprised of six parts:

- Part I, Forward-Looking Statements Disclosure (page 2 of this Addendum)
- Part II, Additional Risk Factors Related to the Company's Securities (including the Applicable Crowdfunding Securities) and the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2) (pages 2 to 9 of this Addendum).
- Part III, Additional Risk Factors Related to the Company's Business and Industry (pages 9 to 17 of this Addendum).
- Part IV, Tax Risks (page 17 of this Addendum).
- Part V, Conflicts of Interest (pages 18 to 19 of this Addendum)
- Part VI, Statement as to Indemnification (page 19 of this Addendum)

## Addendum 1, Part I - Forward-Looking Statements Disclosure:

Certain information contained in this Form C and the documents incorporated by reference herein or therein contain forward-looking statements and are subject to risks and uncertainties. The statements herein which are not historical reflect the Company's current expectations and projections about the Company's future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to the Company and their management and their interpretation of what is believed to be significant factors affecting the businesses, including many assumptions regarding future events. Such forward looking statements include statements regarding, among other things, (i) the Company's projected sales and profitability; (ii) the Company's growth strategies; (iii) anticipated trends in the Company's industry; (iv) the Company's future financing plans; and (v) the Company's anticipated needs for working capital. Forward looking statements, which involve assumptions and describe the Company's future plans, strategies, and expectations, are generally identifiable by use of the words "may," "should," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology.

These statements are not guarantees of future performance and involve a number of risks, uncertainties, and assumptions relating to our operations and business environment, all of which are difficult to predict and many of which are beyond the Company's control. Accordingly, actual results or performance of the Company may differ significantly, positively or negatively, from forward-looking statements made herein. Unanticipated events and circumstances are likely to occur. Factors that might cause such differences include, but are not limited to, those discussed in the risk factors sections of this Form C and matters described in this Form C generally, which prospective investors should carefully review and consider. This list of factors is not exclusive; it is impossible to list all of the risks that the Company will face. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this Form C will in fact occur or be substantially realized. Even if the results and developments in such forward-looking statements occur or are substantially realized, there is no assurance that they will have the expected consequences on the Company or its business or operations.

The Company cautions prospective investors not to put undue reliance on any forward-looking statements, which speak only as of the date of this Form C, and not to make an investment decision based solely on the Company's projections, estimates or expectations.

The statements in this Form C are made as of the date of this Form C, unless another time is specified. There may have been a change in the facts set forth in this Form C since the date hereof and the Company undertakes no obligation to update or revise any statements in this Form C.

## Addendum 1, Part II - Additional Risk Factors Related to the Company's Securities (including the Applicable Crowdfunding Securities) and the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2):

There is no assurance that purchasers of the Applicable Crowdfunding Securities will receive a return on their investment. The Applicable Crowdfunding Securities are highly speculative and any return on an investment in the Applicable Crowdfunding Securities is contingent upon numerous circumstances, many of which (including legal and regulatory conditions) are beyond the Company's control. There is no assurance that purchasers of the Applicable Crowdfunding Securities will realize any return on their investments or that their entire investments will not be lost. For this reason, prospective investors should carefully read this Form C and should consult with their own independent personal advisors prior to making any investment decision with respect to the Applicable Crowdfunding Securities. Prospective investors should only make an investment in the Applicable Crowdfunding Securities if they are prepared to lose the entirety of such investment.

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

The Applicable Crowdfunding Securities may not be suitable for all investors. An investment in the Applicable Crowdfunding Securities may not be suitable for all prospective investors. Prospective investors should carefully read this Form C and should consult with their own independent legal counsel, accountant and other professionals prior to making any investment decision with respect to the Applicable Crowdfunding Securities.

None of the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2) nor any of the Applicable Crowdfunding Securities being offered, sold and/or issued, as the case may be, pursuant to the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2), have been registered under federal or state securities laws, leading to an absence of certain regulation applicable to the Company. No governmental agency has reviewed or passed upon any of the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2), the Company or any securities of the Company (including the Applicable Crowdfunding Securities). The Company also has relied on exemptions from securities registration requirements under applicable state securities laws. Investors in the Company, therefore, will not receive any of the benefits that such registration would otherwise provide. Prospective investors must therefore assess the adequacy of disclosure and the fairness of the terms of a particular Series CF Crowdfunding Offering, including this Series CF Crowdfunding Offering #2, on their own or in conjunction with their personal advisors.

All Applicable Crowdfunding Securities are equity interests in the Company and will not constitute indebtedness, and Series CF Crowdfunding Offering Investors' liquidation rights are subordinate to the holders of our indebtedness (including related party debt), as well as the Company's other series of existing preferred stock and any additional senior debt or equity securities we may issue in the future.

With the exception of preferential payment of certain unpaid "Accrued Reclamation Dividends" with respect to issued shares of the Company's Series CF Non-Voting Preferred Stock at the time of defined liquidation events (as such term "Accrued Reclamation Dividends" is defined in the separate Addendum 3 to this Exhibit A to this Form C, which Addendum 3 also describes in further detail such payment priority), the Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) rank junior to (1) all existing and future indebtedness and other non-equity claims on the Company, as well as (2) the liquidation rights and preferences of the Company's other series of existing preferred stock (which is the Series A Preferred Stock and Series B Non-Voting Preferred Stock), and any senior equity securities that we may issue in the future (including, if applicable, any such senior equity securities that may be authorized and issued in connection with the Company's updated overall capital raising strategy described in the "Updated Overall Capital Raising Strategy" section of this Form C), with respect to assets available to satisfy claims on the Company, including in a liquidation of the Company.

The issued shares of the Company's Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) do have a special dividend entitlement, as further described in the separate Addendum 3 to this Exhibit A to this Form C. However, unlike indebtedness, for which principal and interest would customarily be payable on specified due dates, the special dividend entitlement is sourced only from collected revenues of the Company's newly created "IX Water Reclamation" services offering, if such revenues are generated. The terms of the special dividend entitlement do not guarantee that the Company will, or require the Company to, generate such IX Water Reclamation revenues at any given time(s) or during any given period(s), or in any minimum or other specified amount. The special dividend entitlement is also subject to a payout cap and early termination upon defined liquidation events and any voluntary or automatic conversion of the shares of Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) into shares of the Company's Class B Non-Voting Common Stock. To extent of available IX Water Reclamation revenues and accrual of the special dividends as described in the separate Addendum 3, the Company may not be able to declare or pay the accrued special dividends promptly or at specified times. Unlike repayment of indebtedness, payment of cash dividends by the Company is governed by the Delaware General Corporation Law, which requires the Company to meet certain statutory test based on the Company's financial condition in order to pay cash dividends. The Company may also from time to time by subject to contractual restrictions on its ability to pay cash dividends pursuant to contractual restrictions in any credit agreement, guarantee, financing or security agreement or other agreements or instruments governing indebtedness of the Company or any existing or future subsidiaries of the Company. If the Company cannot satisfy the Delaware legal requirements at any particular time or times, or is subject to contractual restrictions for payment of cash dividends, this will delay the declaration and/or payment of any special dividends that have otherwise accrued from available IX Water Reclamation revenues as described in the separate Addendum 3.

Historically, the Company has never declared or paid any dividends on its capital stock. With the exception of the special dividend entitlement applicable issued shares of the Company's Series CF Non-Voting Preferred Stock that is referenced in the preceding paragraph (and is further described in the separate Addendum 3 to this Exhibit A to this Form C): (i) the Company does not currently intend to declare or pay any dividends on any of its capital stock; (ii) for

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

the foreseeable future, the Company intends to retain excess future earnings, if any, to support development and growth of its business; and (iii) any future determination to declare and pay dividends will be at the discretion of the Company's Board of Directors and will be dependent on the Company's financial condition, results of operations, cash requirements, plans for expansion, legal limitations, contractual restrictions and other factors deemed relevant by the Company's Board of Directors.

As described elsewhere in this Form C, the Company has indebtedness outstanding as of the date of this Form C and the Company has existing preferred stock (the Series A Preferred Stock and the Series B Non-Voting Preferred Stock) with liquidation rights and preferences that are senior to the liquidation rights of the Applicable Crowdfunding Securities, whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering (excepting the preferential payment of certain unpaid "Accrued Reclamation Dividends" with respect to issued shares of the Company's Series CF Non-Voting Preferred Stock at the time of defined liquidation events, as such term "Accrued Reclamation Dividends" is defined in the separate Addendum 3 to this Exhibit A to this Form C, which Addendum 3 also described in further detail such payment priority). In addition, there are no restrictions in the terms of the Applicable Crowdfunding Securities on our ability to incur indebtedness or issue additional debt or equity securities that rank equally with or senior to the Applicable Crowdfunding Securities upon liquidation (although the issuance of additional debt or equity securities is subject to the Series CF Non-Voting Preferred Stock price-based anti-dilution protections, to the extent applicable). We may incur additional indebtedness in the future to finance our operations or take a number of other actions that are not limited by the terms of the Applicable Crowdfunding Securities. Any such future indebtedness may be subject to restrictive covenants or other provisions that may delay, prevent or otherwise limit our ability to make dividend or liquidation payments on the Applicable Crowdfunding Securities.

If we were to liquidate our business, we would be required to repay all of our outstanding indebtedness (including outstanding indebtedness to related parties) and other non-equity claims, as well as any and all senior debt or equity securities that we may issue in the future, before making liquidation payments to the Company's stockholders. We could have insufficient cash available to do so, in which case the Company's stockholders, including all of the Series CF Crowdfunding Offering Investors (whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering), would not receive any liquidation payment. In the case of a liquidation where there are proceeds available for distribution to the Company's stockholders, the terms and priorities of the liquidation rights and preferences of the different series of existing Preferred Stock, also pay prevent or otherwise limit our ability to make dividend or liquidation payments on the Applicable Crowdfunding Securities. For a more detailed discussion of the provisions of the Company's certificate of incorporation that govern a liquidation of the Company's business, see Section VII (Liquidation Rights/Liquidation Waterfall for a Liquidation Event) of Part I of the separate Addendum 2 to this Exhibit A to this Form C.

**In certain circumstances holders of the Applicable Crowdfunding Securities will not have dissenters' rights.**

As a condition to the issuance of any Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering), the purchaser thereof is required to become a party to and be bound by the Company's stockholder agreement. Such stockholder agreement contains a "drag-along" provision whereby all of the stockholders of the Company, including all purchasers/holders of the Applicable Crowdfunding Securities, agree to refrain from exercising any dissenters' rights or rights of appraisal under applicable law in the event of a sale of the Company or other change of control transaction. Specifically, and without limitation, if the majority holders of our voting classes of stock determine to sell the Company, depending on the nature of the transaction, all of the Series CF Crowdfunding Offering Investors (whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering), will be forced to sell their Applicable Crowdfunding Securities in that transaction regardless of whether they believe the transaction is the best or highest value for their Applicable Crowdfunding Securities, and regardless of whether they believe the transaction is in their best interests.

**The rights and terms of the Applicable Crowdfunding Securities may be waived on behalf of all holders of Applicable Crowdfunding Securities by the holders of a majority in interest of the Company's Class CF Non-Voting Preferred Stock.**

The Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) are part of a particular class of the Company's securities referred to as the Series CF Non-Voting Preferred Stock. Currently, there are 2,200,000 legally authorized shares of Series CF Non-Voting Preferred Stock. 188,904 shares of Series CF Non-Voting Preferred Stock (including 17,170 "bonus shares," equivalent to 10% "bonus shares") were previously issued pursuant to Series CF Crowdfunding Offering #1. Up to 1,182,830 shares of the Series CF Non-Voting Preferred Stock are reserved for offer, sale and/or issuance, as the case may be, pursuant to this Series CF Crowdfunding Offering #2. This number includes: (i) up to 1,100,000 subscribable shares based on the maximum offering amount of $2,750,000.00 (determined by dividing $2,750,000.00 by the per share price of the offering of $2.50 per share); (ii) up to 11,000

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

shares allocated to equity compensation payable by the Company to StartEngine Primary LLC for services provided to, or for the benefit of, the Company in connection with the Series CF Crowdfunding Offering #2 (which is shares of Series CF Non-Voting Preferred Stock of the Company equal to one percent (1%) of the $2,750,000.00 maximum offering amount of the Series CF Crowdfunding Offering #2), and (iii) up to 171,830 shares allocated to "bonus shares" for the Series CF Crowdfunding Offering #2, which represents a maximum "bonus shares" allocation of approximately 15.6% "bonus shares" for this particular offering). This is a maximum share reservation; not all of the reserved shares may end up being issued in this Series CF Crowdfunding Offering #2. The number of reserved shares actually issued depends on the number of investors who/that meet the eligibility criteria for "bonus shares" in this Series CF Crowdfunding Offering #2. The 188,904 shares of Series CF Non-Voting Preferred Stock previously issued pursuant to Series CF Crowdfunding Offering #1, together with the 1,282,830 maximum share reservation for this Series CF Crowdfunding Offering #2, are less than the 2,200,000 legally authorized shares of Series CF Non-Voting Preferred Stock. The Company may issue additional shares of Series CF Non-Voting Preferred Stock from time to time separate from this Series CF Crowdfunding Offering #2, which means that the Applicable Crowdfunding Securities issued pursuant to this Series CF Crowdfunding Offering #2, at any given time, may not represent all, or even a majority in interest of, the Company's Series CF Non-Voting Preferred Stock issued pursuant to all applicable Series CF Crowdfunding Offerings.

Except as specifically provided in the Company's certificate of incorporation or as otherwise required by the Delaware General Corporation Law or other applicable law which cannot be superseded by the provisions of such certificate of incorporation: (a) the Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) have no voting rights attached to them; and (b) the holders of the Company's Class A Common Stock and Series A Preferred Stock possess exclusively all voting power. See the description of voting rights contained in Section VII (Liquidation Rights/Liquidation Waterfall for a Liquidation Event) of Part I of the separate Addendum 2 to this Exhibit A to this Form C. If and to the extent that voting rights are provided to the holders of the Company's Series CF Non-Voting Preferred Stock (including the Applicable Crowdfunding Securities) by the Company's certificate of incorporation or as otherwise required by the Delaware General Corporation Law or other applicable law which cannot be superseded by the provisions of such certificate of incorporation, the affirmative written consent or vote of the holders of a majority in interest of the outstanding shares of Series CF Non-Voting Preferred Stock will be sufficient to bind all holders of Series CF Non-Voting Preferred Stock. See also the description of such waiver provisions contained in Section XIII (Waiver of the Preferred Stock Rights and Preferences set forth in the Existing Certificate of Incorporation - Majority Vote Effects Waiver) of Part I of the separate Addendum 2 to this Exhibit A to this Form C. If a particular Series CF Crowdfunding Offering Investor (whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) is not part of the majority voting group, including based upon disagreement with the decision, such Series CF Crowdfunding Offering Investor will still be bound by the vote and decision of the majority voting group.

## Limitations on Cash Dividends.

The issued shares of the Company's Series CF Non-Voting Preferred Stock do have a special dividend entitlement, as further described in the separate Addendum 3 to this Exhibit A to this Form C. However, unlike indebtedness, for which principal and interest would customarily be payable on specified due dates, the special dividend entitlement is sourced only from collected revenues of the Company's newly created "IX Water Reclamation" services offering, if such revenues are generated. The terms of the special dividend entitlement do not guarantee that the Company will, or require the Company to, generate such IX Water Reclamation revenues at any given time(s) or during any given period(s), or in any minimum or other specified amount. The special dividend entitlement is also subject to a payout cap and early termination upon defined liquidation events and any voluntary or automatic conversion of the shares of Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) into shares of the Company's Class B Non-Voting Common Stock. To extent of available IX Water Reclamation revenues and accrual of the special dividends as described in the separate Addendum 3, the Company may not be able to declare or pay the accrued special dividends promptly or at specified times. Unlike repayment of indebtedness, payment of cash dividends by the Company is governed by the Delaware General Corporation Law, which requires the Company to meet certain statutory test based on the Company's financial condition in order to pay cash dividends. The Company may also from time to time by subject to contractual restrictions on its ability to pay cash dividends pursuant to contractual restrictions in any credit agreement, guarantee, financing or security agreement or other agreements or instruments governing indebtedness of the Company or any existing or future subsidiaries of the Company. If the Company cannot satisfy the Delaware legal requirements at any particular time or times, or is subject to contractual restrictions for payment of cash dividends, this will delay the declaration and/or payment of any special dividends that have otherwise accrued from available IX Water Reclamation revenues as described in the separate Addendum 3.

Historically, the Company has never declared or paid any dividends on its capital stock. With the exception of the special dividend entitlement applicable issued shares of the Company's Series CF Non-Voting Preferred Stock

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

(whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) that is referenced in the preceding paragraph (and is further described in the separate Addendum 3 to this Exhibit A to this Form C): (i) the Company does not currently intend to declare or pay any dividends on any of its capital stock; (ii) for the foreseeable future, the Company intends to retain excess future earnings, if any, to support development and growth of its business; and (iii) any future determination to declare and pay dividends will be at the discretion of the Company's Board of Directors and will be dependent on the Company's financial condition, results of operations, cash requirements, plans for expansion, legal limitations, contractual restrictions and other factors deemed relevant by the Company's Board of Directors.

The Company has relied upon private offering exemptions for past issuances of securities and is relying upon a private offering exemption for each of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2. If it is later determined that the private offering exemption is not available in any such case, purchasers of the securities would be entitled to rescind their purchase agreements. To date, the Company has not registered any offering of its outstanding securities (including all outstanding Applicable Crowdfunding Securities) with either the Securities and Exchange Commission ("SEC") or any state securities commission or regulatory authority. Rather, the Company has relied on private offering exemptions from registration under the Securities Act of 1933, as amended (the "Securities Act") and applicable rules or regulations promulgated thereunder. For each of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, the Company is also relying on the private offering exemption provided by Section 4(A)(6) of the Securities Act and Regulation Crowdfunding (Regulation CF) promulgated thereunder and applicable state exemptions or notice filing provisions related to private offerings. Regulation CF contains limitations and requirements (including as to ongoing reporting obligations under Regulation CF) that may result in any one or more of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, being unsuccessful. Additionally, should the SEC determine that any one or more of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, was not in compliance with Regulation Crowdfunding or that any prior offering of existing securities was not in compliance with the relevant private offering exemption relied upon by the Company for the relevant offering, the Company may be forced to refund all purchases by investors in the applicable offering(s), which could occur after a closing in the applicable Series CF Crowdfunding Offering (including this Series CF Crowdfunding Offering #2), and after the Company has used some or all of the proceeds from the applicable Series CF Crowdfunding Offering (including this Series CF Crowdfunding Offering #2). In such an event, you could lose some or all of your investment. A similar situation prevails under state law in those states where the Company securities may be offered without registration in reliance on the partial preemption from the registration or qualification provisions of such state statutes under the National Securities Markets Improvement Act of 1996, which does not preempt compliance with certain filing and notice requirements and other conditions that rarely, but in some instances, must be satisfied prior to making an offer in a specific state. If a number of investors under any one or more of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, or any prior offering of other existing securities were successful in seeking rescission, the Company would face severe financial demands that could adversely affect our business and, thus, the non-rescinding investors. In as much as the basis for relying on exemptions is factual, depending on our conduct and the conduct of persons contacting prospective investors and making the offering, as with past offerings of existing securities, the Company has not received, and will not receive, a legal opinion to the effect that any one or more of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, is exempt from registration under any federal or state law. Instead, the Company will rely on the operative facts as documented by us as our basis for these exemptions.

The Company's founder, IX Power LLC, effectively controls the Company. The Company's founder is IX Power LLC, a Colorado limited liability company. IX Power LLC is owned by the following members of the Company's management team (each owning 20% of IX Power LLC as of the date of this Form C): John R. (Grizz) Deal, CEO; Randall (Randy) Wilson, CFO; Deborah A. (Deal) Blackwell, CMO; Dr. Otis (Pete) Peterson, CTO, and Dr. L. Robert (Bob) Libutti, former Chief Product Strategist (deceased; Mary Tendall, surviving spouse and personal representative). IX Power LLC owns, and will continue to own following the Offering, a majority of the issued and outstanding shares of the voting stock of the Company. As a result, IX Power LLC and its owners will effectively control and direct the affairs of the Company, subject to certain limited voting protections granted to the holders of the Company's Series A Preferred Stock. The interest of IX Power LLC and its owners may conflict with those of other securities holders. This concentration of ownership may also delay, defer or prevent a future sale of the Company or other change of control transaction and some transactions may be difficult or impossible without the support of the Company's founder and its owners.

The Company's holders of its Series A Preferred Stock have special voting protections and influence over certain material decisions affecting the Company. For so long as the total number of shares of Series A Preferred Stock that are issued and outstanding represent at least 10.0% (recently reduced from 15.0%) of the capital stock of the Company calculated on a fully-diluted basis, the holders of the Series A Preferred Stock have the right to

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

designate and elect one member of the Company's Board of Directors. In addition, for so long as at least 1,010,925 shares of Series A Preferred Stock remain outstanding (which share number is equivalent to approximately 50% of the shares of Series A Preferred Stock that are issued and outstanding as of the date of this Form C), subject to appropriate adjustment of such share number in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock, the holders of the Series A Preferred Stock have special voting rights to approve certain material decisions affecting the Company, including a future sale of the Company or other change of control transaction. The interest of the holders of the Series A Preferred Stock may conflict with those of the Company's Board of Directors and/or those of other securities holders. These special voting rights may also delay, defer or prevent a future sale of the Company or other change of control transaction and some transactions may be difficult or impossible without the support of the holders of the Series A Preferred Stock.

**Decisions of certain holders of the Company's other series of existing Preferred Stock bind the Applicable Crowdfunding Securities as to certain material matters.** Pursuant to the Company's certificate of incorporation, certain decisions affecting and binding on all of the Company's Preferred Stock are reserved to the holders of the Company's Series A Preferred Stock and Series B Non-Voting Preferred Stock, and the holders of the Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offerings) do not have a right to participate in such decisions. Such decisions relate to:

(1) Whether an event otherwise qualifying as a "Deemed Liquidation Event" (which relates to company sale events and is defined in Section 1 of Part I of the separate Addendum 2 to this Exhibit A to this Form C) will or will not be treated as a Deemed Liquidation Event under the Company's certification of incorporation and, accordingly, will or will not be subject to the negotiated liquidation waterfall set forth the Company's certificate of incorporation for proceeds available for distribution to the Company's stockholders upon any such Deemed Liquidation Event; and

(2) An automatic conversion of all outstanding Preferred Stock (currently, all outstanding Series A Preferred Stock, Series B Non-Voting Preferred Stock, and the Series CF Non-Voting Preferred Stock, whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) into Common Stock (Class A Common Stock in the case of a conversion of the Series A Preferred Stock and Class B Non-Voting Common Stock in the case of a conversion of the Series B Non-Voting Preferred Stock and the Series CF Non-Voting Preferred Stock) upon the vote or consent of Company stockholders.

See also subsection IV(c)(ii)(2) of Part I of the separate Addendum 2 to this Exhibit A to this Form C.

The interest of the holders of the Series A Preferred Stock and Series B Non-Voting Preferred Stock may conflict with those of the Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) with respect to the above matters.

**The Company is not required to have independent management.** The Company may, but is not required to, have independent directors on its Board of Directors. The individuals currently serving on the Company's Board of Directors are either (a) principals of the Company's founder, IX Power LLC, who also serve as officers of the Company, or (b) existing investors who own shares of the Company's voting stock (Class A Common Stock and/or Series A Preferred Stock). The Company does not anticipate having an independent director serve on its Board of Directors in the foreseeable future.

**Our officers' and directors' allocation of their time to other business interests could have a negative impact.** The Company's existing management team is comprised of individuals who own the Company's founder, IX Power LLC. Such individuals are: John R. (Grizz) Deal, CEO; Randall (Randy) Wilson, CFO; Deborah A. (Deal) Blackwell, CMO; and Dr. Otis (Pete) Peterson, CTO. Dr. L. Robert (Bob) Libutti, former Chief Product Strategist and now deceased, is the fifth original owner of the Company's founder, IX Power LLC. Mr. Deal and Mr. Wilson also currently serve as directors of the Company. Such individuals have signed confidentiality agreements but do not have employment agreements (or non-competition agreements) and are not required to devote substantially all of their business time and attention to the performance of their duties for the Company. Each such individual devotes such business time and attention to the Company's business as he or she in his or her sole discretion deems reasonably necessary. As of the date of the Form C, each of Mr. Deal and Ms. (Deal) Blackwell are devoting substantially all of their business time and attention to the performance of their duties for the Company. Such individuals may have conflicts of interest in allocating time, services, and functions between the Company's business and their other business and professional interests and commitments, which could have a negative impact on the Company and its business.

**The Company is not subject to Sarbanes-Oxley Regulations and lack the financial controls and safeguards required of public companies.** We do not have the internal infrastructure necessary, and are not required, to

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

complete an attestation about our financial controls that would be required under Section 404 of the Sarbanes-Oxley Act of 2002. There can be no assurance that there are no significant deficiencies or material weaknesses in the quality of our financial controls. We expect to incur additional expenses and diversion of management's time if and when it becomes necessary to perform the system and process evaluation, testing and remediation required in order to comply with the management certification and auditor attestation requirements.

**Our financial audit includes a going concern note.** In their report accompanying our financial statements, which financial statements and accompanying report are attached as Exhibit B to this Form C, our independent auditors stated that such financial statements were prepared assuming that we would continue as a going concern, and that they have substantial doubt as to our ability to continue as a going concern. Our auditors have noted that our limited liquid assets, accumulated deficit, net losses, negative cash flows from operating activities and default on various debt obligations, including secured debts, as of years covered by such report, among other factors, raise substantial doubt about our ability to continue as a going concern. Management's plans in regard to these matters are described in Note 3 of the report accompanying such financial statements (see Exhibit B to this Form C) and are also restated in the next paragraph of this risk factor.

The Company's ability to continue as a going concern for the next twelve months is dependent upon its ability to generate sufficient cash flows from operations to meet its obligations and/or to obtain additional external capital financing. Management plans are to utilize funds raised in the equity funding under this Series CF Crowdfunding Offering #2, produce revenues to support cash flow, extend maturities on existing debt obligations, and continue to cut and control costs as necessary to ensure the business is able to meet its obligations as they come due. The Company also will pursue its updated overall capital raising strategy discussed in the "Updated Overall Capital Raising Strategy" section of this Form C, which contemplates seeking additional equity capital (separate from the Regulation Crowdfunding campaigns) and a credit facility (which may be a straightforward debt facility or a debt facility with equity, and also could be increased in amount with supplemental Board authorization at the outset and/or as the Company grows). No assurance can be given that the Company will be successful in these efforts. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Holders of the Applicable Crowdfunding Securities will have limited information and inspection rights.** The information and inspection rights of the purchasers of Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) are limited to the information and inspection rights available under the Delaware General Corporation Law and the financial reporting requirements of Regulation Crowdfunding, so long as the Company is and remains subject to such requirements. Other security holders may have such broader information and inspection rights. This lack of information could put the purchasers of Applicable Crowdfunding Securities at a disadvantage in general and with respect to other security holders.

**There can be no assurance that we will ever provide liquidity to the Series CF Crowdfunding Offering Investors through either a sale of the Company or a registration of the Applicable Crowdfunding Securities.** There can be no assurance that any form of merger, combination, or sale of the Company will take place, or that any merger, combination, or sale would provide liquidity for the Series CF Crowdfunding Offering Investors (whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering). Furthermore, we may be unable to register the Applicable Crowdfunding Securities (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) for resale by the Series CF Crowdfunding Offering Investors for legal, commercial, regulatory, market-related or other reasons. In the event that we are unable to effect a registration, the Series CF Crowdfunding Offering Investors could be unable to sell their Applicable Crowdfunding Securities unless an exemption from registration is available.

**There has been no representation of prospective Series CF Crowdfunding Offering Investors in the preparation of any of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2.** The Company has not obtained any independent opinion on behalf of prospective Series CF Crowdfunding Offering Investors (whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering), regarding the fairness of the terms on which the Applicable Crowdfunding Securities are offered. Prospective investors will be relying entirely on their own business experience and acumen, and the experience of their advisers, as the basis for their investment decision together with the disclosures set forth in this Form C and the additional materials referenced directly.

**Our legal counsel will not represent the interests of prospective or actual Series CF Crowdfunding Offering Investors.** Our legal counsel has not, and will not, represent the interests of prospective or actual Series CF Crowdfunding Offering Investors, whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering. Further, our counsel will not review or determine the accreditation of any Series CF Crowdfunding Offering Investor or the suitability of an investment in us for any prospective or actual Series CF Crowdfunding Offering Investor, or any other person,

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering. Our counsel will not monitor or oversee our activities.

**The Company's equity crowdfunding strategy increases the risk the Company may inadvertently, or prematurely, become a public reporting company.** The very nature of crowdfunding, including crowdfunding pursuant to a Regulation Crowdfunding (Regulation CF) offering, is to obtain small investments from a broad investor base. After conclusion of the Company's initial crowdfunding campaign (which launched in May 2020 and concluded earlier in 2022), the Company's stockholder base increased to almost 3,000 stockholders, thousands of which may be non-accredited investors under U.S. federal securities laws. This Series CF Crowdfunding Offering #2 and any future crowdfunding campaigns, including with respect to available authorized but unissued shares of the Company's Series CF Non-Voting Preferred Stock, will likely result in the additional increases to the Company's stockholder base. In addition to the increased administrative costs and burden of managing such a large stockholder base, the larger number of stockholders increases the risk that the Company will inadvertently, or prematurely, become a fully reporting public company under the U.S. Securities and Exchange Commission rules. Conditional exemptions to such reporting company requirements are available to companies utilizing Regulation CF for capital raising; however, under current laws, the conditional exemption becomes unavailable at such time as the Company's assets reach $25 million at the end of any fiscal year (regardless of whether the Company maintains compliance with Regulation CF). It is the Company's present intent to manage growth toward an exit/liquidity event prior to Exchange Act registration becoming an issue for the Company; however, there is no guarantee this will occur. If the Company inadvertently, or prematurely, becomes a reporting company, compliance may be burdensome, time consuming, and expensive, which could have a material adverse effect on the Company's operations and financial conditions.

## Addendum 1, Part III - Additional Risk Factors Related to the Company's Business and Industry:

**We have a limited operating history which makes it difficult to evaluate our business and prospects.** The Company was initially incorporated in New Mexico in September 2012 in order to commercialize a specific technology for treating contaminated waters developed at the Los Alamos National Laboratory located in New Mexico, U.S.A. Since then, the Company has been completing a technical validation of the technology and developing and field testing its water treatment systems that have not yet gained market acceptance. In addition, as described elsewhere in this Form C, the Company is launching a new "IX Water Reclamation" services offering, including with start-up capital to be provided by the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2), which is not yet proven. As such, we have a limited operating history upon which you can base an evaluation of our business and prospects. Since we have not been profitable, there are substantial risks, uncertainties, expenses and difficulties that we are subject to. To address these risks and uncertainties, we must do among the following:

- Obtain sufficient capital to support the expenses of (1) developing and commercializing our technology, systems, and services offerings and (2) developing and growing the new IX Water Reclamation services offering;
- Successfully implement our business model and strategies;
- Successfully transition from a Company with a research and development focus to a Company capable of supporting commercial activities;
- Develop a market and attract customers for our products and services;
- Maintain favorable relationships with customers and other third parties with whom we will do business, including manufacturers, suppliers, resellers, licensees and other strategic partners;
- Respond to regulatory changes, competition and technological developments in the market competitive developments as well as general economic conditions;
- Manage our growth; and
- Attract, integrate, retain and motivate qualified personnel.

There can be no assurance that at this time we will operate profitably, that our new IX Water Reclamation services offering will be implemented and adopted by the market as we have planned, or that we will have adequate working capital to meet our obligations as they become due. Prospective investors must consider the risks and difficulties frequently encountered by early-stage companies, particularly in rapidly evolving markets. We cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event that we do not successfully address these risks, our business, prospects, financial condition, and results of operations could be materially and adversely affected.

**We have a history of losses and can provide no assurance of our future operating results.** Since incorporation, we have generated limited operational revenues and we may not succeed in commercializing our technology and products which will generate revenues. Until recently, our primary activity has been research and development and

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

product validation. We have experienced net losses and negative cash flows from operating activities since inception and we expect such losses and negative cash flows to continue in the foreseeable future. In addition, as described elsewhere in this Form C, the Company is launching a new "IX Water Reclamation" services offering, including with start-up capital to be provided by the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2), which is not yet proven. Our business model and strategies may not be successful and there is no assurance that we will ever become profitable in any future period. Our ability to achieve profitability and continue as a going concern is dependent upon raising capital from financing transactions and current and future sales.

**Our revenues are dependent upon acceptance of our technology, systems and services offerings; the failure of which would cause us to curtail or cease operations.** When we launched our initial crowdfunding campaign in May 2020 our initial business plan and strategies contemplated that: (1) most of our future revenues would initially come from the sale of our water treatment systems; and (2) thereafter, as we implemented our business model and strategies, revenues were expected to be generated from the license of our water treatment systems and/or from strategic alliances and collaborations, such as joint ventures, we would enter into with third parties. As described elsewhere in this Form C, at the time of the launch of the Series CF Crowdfunding Offering #1, the Company had created a new "IX Water Reclamation" service line of business and now generates revenue in two operating units (divisions) - the existing treatment systems business, and the new "IX Water Reclamation" service line of business. We will continue to incur substantial operating losses until such time as we are able to generate revenues from these activities. There can be no assurance that prospective customers, licensees and other third parties will adopt our technology and systems, or the IX Water Reclamation services offerings, or that prospective customers, licensees and other third parties will agree to pay for or license our technology and systems, enter into collaborations with us, or contract with us for our services offerings. Market acceptance depends on many factors, including demonstrating to prospective customers, licensees and other third parties that our technology, systems, and services offerings are superior to and more cost-effective than other technologies, systems, and services offerings which are available now or which may become available in the future. In the event that we are not able to develop a customer base that purchases or licenses our technology and systems, and contracts for our IX Water Reclamation services offerings, or if we are unable to charge the necessary prices or license fees or enter into strategic alliances and collaborations with third parties on favorable terms, our financial condition and results of operations will be materially and adversely affected and may require us to curtail significantly or cease operations.

**We may not be able to successfully develop and commercialize our technology and systems which would result in continued losses and may require us to curtail or cease operations.** We are currently commercializing our technology and implementing our business model and strategies, including launching and developing the Company's recently created "IX Water Reclamation" service line of business. We are unable to project when we will achieve profitability, if at all. As is the case with any new technology, we expect the research and development process for the Company's treatment systems, which are also utilized for the Company's Reclamation services offerings, to continue. We cannot assure that our engineering and/or manufacturing resources will be able to develop our technology and systems fast enough to meet market requirements. We also cannot assure that our technology, systems, and services offerings will gain market acceptance, that we will be able to successfully commercialize the technology and implement our business strategies, that we will be able to establish, defend, maintain or increase prices for our products and services, or that we will be able to differentiate the value delivered by our products and services from our competitors' products and services. We face a number of challenges, including a lack of meaningful historical financial data upon which to plan future budgets, competition from a wide range of sources (including both similar or early stage companies, particularly those with collaborative arrangements with large and established companies, competitors have significantly greater financial, technical and human resources than we have and superior expertise in research and development and marketing approved products/services and thus may be better equipped than us to develop and commercialize products/services), the need to develop customer relationships and other risks. The failure to successfully commercialize our technology, systems, and services offerings and implement our business strategies would result in continued losses and may require us to curtail significantly or cease operations.

**Our ability to produce and distribute commercially viable water treatment systems on a commercially viable basis is unproven, which could have a detrimental effect on our ability to generate or sustain revenues.** The technology and systems we use to treat contaminated waters have never been utilized on a full-scale commercial basis. We have only recently completed our technical validation of licensed technology and the final commercial product design and testing of our IX Water OGTM and IX Water BlüTM systems. All of the tests conducted to date by us with respect to the technology and systems have been performed in a limited scale or small commercial scale environment and the same or similar results may not be obtainable at competitive costs on a large-scale commercial basis. We have never employed our technology and systems under the conditions or in the volumes that will be required for us to be profitable and cannot predict all of the difficulties that may arise. Accordingly, our technology

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

and systems may not perform successfully on a commercial basis and may never generate any revenues or be profitable.

**Our new IX Water Reclamation Line of Business is unproven, which could have a detrimental effect on our ability to generate or sustain revenues.** As described elsewhere in this Form C, the Company is launching a new "IX Water Reclamation" services offering, including with start-up capital to be provided by the Series CF Crowdfunding Offerings (including this Series CF Crowdfunding Offering #2), which is not yet proven. Our growth projections are based on an assumption that the IX Water Reclamation line of business will be able to gain traction in the marketplace and contribute to Company revenues. It is possible that IX Water Reclamation will fail to gain market acceptance for any number of reasons. If this new line of business fails to achieve significant sales and acceptance in the marketplace, this could materially and adversely impact the value of your investment.

**Our operations involve a variety of operating hazards and risks that could cause losses; risks of uninsured losses.** The products that we manufacture and the services that we will market and provide are complex, and the failure of our equipment to operate properly or to meet specifications may greatly increase our customers' costs. In addition, many of these products are used in inherently hazardous industries, such as the offshore oilfield business. These hazards include blowouts, explosions, fires, collisions, capsizing's, and severe weather conditions. We may incur substantial liabilities or losses as a result of these hazards. Our insurance and contractual indemnity protection may not be sufficient or effective to protect us under all circumstances or against all risks. The occurrence of a significant event, against which we were not fully insured or indemnified or the failure of a customer to meet its indemnification obligations to us, could materially and adversely affect our results of operations and financial condition.

**Our failure to expand our management systems and controls to support anticipated growth and to hire qualified personnel could seriously harm our business.** Our inability to manage our growth effectively could affect our ability to pursue business opportunities and expand our business. We currently have limited management and administrative resources. As we begin to commercialize our products and new services offerings and our operations grow, we will need to hire a significant number of additional employees. This growth may place strain on our management and operations. Our ability to manage growth will depend on the ability of our officers and key employees to implement and improve our operational, management information, sales and marketing and financial control systems and to expand, train and manage our work force. We believe that competition for qualified technical, sales, marketing and managerial personnel will be intense. Our ability to implement our business model and strategies could be adversely affected if we are unable to hire and retain qualified personnel as needed.

**We rely on others for our production, and any interruptions of these arrangements could disrupt our ability to fill customers' orders and services contracts and have a material impact on our ability to operate.** We obtain components for our water treatment systems from third party suppliers. Any increase in labor, equipment, or other production costs could adversely affect our cost of sales. Qualifying new manufacturers is time-consuming and might result in unforeseen manufacturing and operations problems and also negatively impact the IX Water Reclamation services offerings which rely on availability of our treatment systems. The loss of our relationships with our manufacturers or our inability to conduct our manufacturing services for us as anticipated in terms of cost, quality, and timeliness could adversely affect our ability to fill customer orders and to perform contracted IX Water Reclamation services in accordance with required delivery, quality, and performance requirements. If this were to occur, the resulting decline in revenue, or failure to achieve revenue, would harm the business.

We depend on manufacturers to maintain high levels of productivity and satisfactory delivery schedules. Our manufacturers serve many other customers, a number of which have greater production requirements than we do. As a result, our manufacturers could determine to prioritize production capacity for other customers or reduce or eliminate deliveries to us on short notice. We may encounter manufacturing delays and longer delivery schedules in commencing volume production of new products. Any of these problems could result in our inability to deliver products and services in a timely manner and adversely affect our operating results.

**Any material increase in the cost of the raw materials used to manufacture our treatment systems would have a material adverse effect on our cost of sales.** We do not have contracts with many of our suppliers for the raw materials used in the production of our water treatment systems. We are subject to variations in the prices of the raw materials used in the manufacture of our products. We may not be able to pass along any cost increases to our customers. As a result, any material increase in the cost of raw materials used in the manufacture of our products could have a material adverse effect on our cost of sales.

**If a competitor were to achieve a technological breakthrough, our operations and business could be negatively impacted.** There currently exist a number of businesses that are pursuing novel processes to treat contaminated waters, including the oil and gas produced and community waters treatable by our IX Water OGTM and

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

IX Water BlüTM systems, and new competitors can be expected to enter this market in the future. Should a competitor achieve a research and development, technological or biological breakthrough where process costs are significantly reduced, efficiency greatly increased over ours, or if the costs of similar competing products were to fall substantially, we may have difficulty attracting customer sales or licensees and strategic partners. In addition, competition from other technologies considered "green" (environmental) or "blue" (water technology) could lessen the demand for the end-products produced by our technology. Furthermore, competitors may have access to larger resources (capital or otherwise) that provide them with an advantage in the marketplace, which could result in a negative impact on our business. Any competing technology that treats waters at a superior scale and more cost efficient than ours could render our technology and water treatment solutions obsolete. Any of these competitive forces may inhibit or materially adversely affect our ability to attract customers and licensees and other strategic partners. This could have a material adverse effect on our business, prospects, results of operation and financial condition.

**We intend to form or seek strategic alliances or enter into acquisitions or licensing arrangements in the future.** We may be unable to form or enter into such alliances, acquisitions or licensing arrangements on our anticipated timeline, and we may not realize the expected benefits of any such transaction. We intend to form or seek strategic alliances, create joint ventures or collaborations or be acquired by or enter into licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our technology, systems, and services offerings. Any of these transactions and relationships may require us to incur non-recurring and other charges, increase our near and long-term expenditures, issue securities that dilute our existing stockholders or disrupt our management and business. These transactions and relationships also may result in a delay in the development of our technology, systems, and services offerings if we become dependent upon the other party and such other party does not prioritize the development of our technology, systems, and services offerings relative to its other development activities. In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our technology, systems, and services offerings on our anticipated timeline, or all, because our technology, systems, and services offerings may be deemed to be at too early of a stage of development for collaborative effort and third parties may not view our technology, systems, and services offerings as having the requisite potential to demonstrate efficacy. If we license products or acquire businesses, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction.

**The Company's new IX Water Reclamation services offerings will be launched and operate in a highly competitive environment, which may adversely affect our ability to succeed.**

The Company's initial customer service area for the IX Water Reclamation line of business - Southern California - is a highly competitive marketplace, and the Company will compete with a variety of organizations that offer products and services offerings competitive with those we offer. We believe that the principal competitive factors in the industries in which we compete with respect to the Reclamation division include: innovation and the evolution of water treatment technologies; charging a "by the barrel" fee instead of forcing customers to buy and operate capital equipment; elimination of chemical additives and long biologic degradation processes; and smaller infrastructure and land use. The driving force for the industry, besides treatment efficacy, is lowering costs. As noted elsewhere in this Form C, we believe our primary competitors in the Reclamation business are local well and water service operators that have traditionally moved produced water from well-head to disposal well or evaporation pond. In our view, both methods lose the valuable water resource that could be treated and used for regional agricultural purposes. We believe IX Water Reclamation can offer these businesses the opportunity to partner with the Company to evolve their business into treatment services. However, these businesses may not agree with the Company that there is mutual value in these partnering opportunities.

Our ability to continually provide competitive products and services can impact our ability to defend, maintain or increase prices for our products and services, maintain market share, and negotiate acceptable contract terms with our customers. In order to be competitive, we must provide new and differentiating technologies, reliable products and services that perform as expected and that create value for our customers. In addition, our investments in new technologies, equipment, and facilities may not provide competitive returns. Our ability to defend, maintain or increase prices for our products and services is in part dependent on the industry's capacity relative to customer demand, and on our ability to differentiate the value delivered by our products and services from our competitors' products and services. Managing development of competitive technology and new product introductions on a forecasted schedule and at a forecasted cost can impact our financial results. If we are unable to continue to develop and produce competitive technology or deliver it to our clients in a timely and cost-competitive manner in various markets in which we operate, or if competing technology accelerates the obsolescence of any of our products or services, any competitive advantage that we may hold, and in turn, our business, financial condition and results of operations could be materially and adversely affected.

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

Volatility of oil and natural gas prices can adversely affect demand for our products and services. Prices of oil and gas products are set on a commodity basis. As a result, the volatility in oil and natural gas prices can impact our customers' activity levels and spending for our products and services. Current energy prices are important contributors to cash flow for our customers and their ability to fund water treatment and recycling as a service. Expectations about future prices and price volatility are important for determining future spending levels.

If we lose key employees and consultants or are unable to attract or retain qualified personnel, our business could suffer. Our success is highly dependent on our ability to attract and retain qualified scientific, engineering and management personnel. We are highly dependent on our management, including our CEO, John R. (Grizz) Deal, who has been critical to the development of our technology and business. The efforts of Mr. Deal and our other management personnel will be critical to us as we continue to develop our technology, systems, and services offerings and as we attempt to transition to a company with profitable company commercialized technology, systems, and services offerings. The loss of our CEO or any of our other officers or key employees, and our inability to find suitable replacements, could have a material adverse effect on our financial condition, existing business, or anticipated growth. Our management personnel have signed confidentiality agreements, but we have not entered into any employment agreements (or non-competition agreements) with any of our management personnel. The Company also does not have any "key man" life insurance on any of the lives of our management personnel; therefore, if any of our management personnel die or become disabled, the Company will not receive any compensation to assist with such person's absence.

We may be held liable for the actions and errors of our management. Under most conditions, our officers and directors may not be held liable for errors in judgment or other acts or omissions made by them as representatives of the Company because of provisions in our certificate of incorporation and bylaws holding them harmless and providing them with indemnification against liabilities or losses that arise from such acts or omissions. To the extent that such indemnification provisions are invoked, our assets could be reduced, and our business could be impaired.

We may incur substantial liabilities and may be required to limit commercialization of our products in response to product liability lawsuits. We could be the subject of complaints or litigation from customers, licensees or other business partners alleging product quality or operational concerns. Litigation or adverse publicity resulting from these allegations could materially and adversely affect our business, regardless of whether the allegations are valid or whether we are liable. We do not currently maintain product liability insurance. We anticipate obtaining product liability insurance covering our products in amounts reasonable for the risks to be incurred before we begin to market our products. However, no guarantee can be given that we will be able to obtain products liability insurance coverage in amounts sufficient to cover and pay for all product risks that might be incurred. Further, claims of this type, whether substantiated or not, may divert our financial and management resources from revenue generating activities and the business operation.

The potential impact of failing to deliver products or perform services on time could adversely impact our business and operations. In certain instances, we may be required to guarantee that we will deliver a product by a scheduled date or perform services through the IX Water Reclamation line of business pursuant to specified deadlines. If we subsequently fail to deliver the product as scheduled or perform services as contracted, we may be held responsible for cost impacts and/or other damages resulting from any delay. To the extent that these failures to deliver occur, the total damages for which we could be liable could significantly increase the cost of the products and/or adversely affect the Company's business and operations; as such, we could experience reduced profits or, in some cases, a loss for that contract. Additionally, failure to deliver products on time or perform services as contracted could result in damage to customer relationships, the potential loss of customers, and reputational damage which could impair our ability to attract new customers.

The Company could bear legal or social responsibility for environmental problems. The Company strives to manufacture its products to the highest standards, to educate its customers on the proper use of its products, and, if providing water treatment and recycling as a service, to have well-trained personnel complete their tasks to the highest quality possible. There is the possibility that, regardless of whether there is negligence in its pursuit of business activities, the Company could bear legal or social responsibility for environmental problems. Should such an event occur, the burden of expenses for resolution could potentially be high, and the Company could suffer erosion in social trust.

Federal, state and local authorities have promulgated various environmental control regulations relating to air, water and noise pollution that will impact our business and operations. The Company faces risks of environmental liability arising from its current, historical, and future manufacturing activities. The Company endeavors to comply with laws and government policies, establishing self-management norms and conducting daily inspections and environmental auditing in accordance with its internal environmental policies. However, the Company cannot

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025
13

guarantee that we will operate in full compliance with the complex system of federal, state, and local environmental regulations applicable to our industry. Such regulations govern, among other things, air emissions, wastewater discharges, the use and handling of hazardous substances, waste disposal, chemical substances in products, product recycling, as well as soil and ground water contamination. In the event of any non-compliance, we may not be able to distribute, market or sell our technology, systems, and services offerings, and we could be subject to regulatory or civil actions that result in substantial monetary penalties or damage awards. To the extent the applicable laws or regulations change, or if we introduce new technologies, systems and/or services offerings in the future, we may have to adjust our compliance efforts, and some or all of our technologies, systems and/or services offerings may fail to comply. Our compliance program may be burdensome, time consuming, and expensive.

**Government regulations and legal uncertainties could affect the growth of the commercial water treatment products and services industry.** A number of legislative and regulatory proposals under consideration by federal, state, local and foreign governmental organizations may lead to laws or regulations concerning various aspects of the water treatment products and services industry in oilfield applications. The adoption of new laws or the application of existing laws may decrease the growth in the water treatment products and services industry, which could in turn decrease the usage and demand for the Company's services or increase the cost of doing business.

**Changes in employment laws or regulation could harm our performance.** Our business expansion plan relies upon the Company hiring and retaining employees. Various federal and state labor laws govern our relationship with our employees and affect operating costs. These laws include minimum wage requirements, overtime pay, healthcare reform and the implementation of the Patient Protection and Affordable Care Act, unemployment tax rates, workers' compensation rates, citizenship requirements, union membership and sales taxes. A number of factors could adversely affect our operating results, including additional government-imposed increases in minimum wages, overtime pay, paid leaves of absence and mandated health benefits, mandated training for employees, increased tax reporting and tax payment requirements, changing regulations from the National Labor Relations Board and increased employee litigation including claims relating to the Fair Labor Standards Act.

**The Company's foreign operations are subject to various unique risks.** The Company's future operations and earnings will depend, in part, on the results of its operations in European Union markets and other foreign markets into which the Company may choose to expand, including China. Accordingly, our business is subject to risks associated with doing business internationally, including:

- differing regulatory requirements in foreign countries;
- unexpected changes in tariffs, trade barriers, price/exchange controls and other regulatory requirements;
- economic weakness, including inflation, or political instability in particular foreign economies/markets;
- compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;
- foreign taxes, including withholding of payroll taxes;
- foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;
- difficulties staffing and managing foreign operations;
- workforce uncertainty in countries where labor unrest is more common than in the United States;
- differing payor reimbursement regimes, governmental payors or patient self-pay systems and price controls;
- potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations;
- potential liability under the General Data Protection Regulation (GDPR);
- challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect and protect intellectual property rights to the same extent as the United States;
- production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad;
- production shortages and/or business interruptions resulting from outbreaks of epidemic, pandemic, or contagious diseases, such as the recent novel coronavirus or, historically, the Ebola virus, Middle East Respiratory Syndrome, Severe Acute Respiratory Syndrome, or the H1N1 virus; and
- business interruptions resulting from geo-political actions, including war and terrorism.

These and other risks associated with our international operations may materially adversely affect our ability to attain or maintain profitable operations.

**A violation of privacy or data protection laws could have a material adverse effect on the Company and the value of the Applicable Crowdfunding Securities.** We are subject to applicable United States and foreign privacy and data protection laws and regulations, which are constantly changing. New laws or changes in current laws could

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025
14

increase the cost of compliance, which could adversely affect our business, revenues and competitive position. Any violations of laws and regulations relating to the safeguarding of private information could subject the Company to fines, penalties or other regulatory actions, as well as to civil actions by affected parties. Any such violations could adversely affect the ability of the Company to operate its business, which could have a material adverse effect on the Company's operations and financial conditions.

**Security breaches and other disruptions could compromise our information and expose us to liability, which would cause our business and reputation to suffer.** In the ordinary course of our business, we collect and store sensitive data, including intellectual property, our proprietary business information and that of our customers, suppliers and business partners, and personally identifiable information of our customers and employees, in our data centers and on our networks. The secure processing, maintenance and transmission of this information is critical to our operations and business strategy. Despite our security measures, our information technology and infrastructure may be vulnerable to attacks by hackers or breached due to employee error, malfeasance or other disruptions. Any such breach could compromise our networks and the information stored there could be accessed, publicly disclosed, lost or stolen. Any such access, disclosure or other loss of information could result in legal claims or proceedings, liability under laws that protect the privacy of personal information, and regulatory penalties, disrupt our operations and the services we provide to customers, damage our reputation, and cause a loss of confidence in our products and services, which could adversely affect our business, revenues and competitive position.

**Certain of our core technology is co-owned with third parties.** The Company's success is dependent, in large part, upon the patent rights acquired from Los Alamos National Security, LLC ("LANS"), which conducts research and development at Los Alamos National Laboratory for the U.S. Government under a contract with the U.S. Department of Energy. The technology underlying these patent rights was originally jointly developed by LANS, The Board of Regents of the University of Texas System ("UT"), and New Mexico Tech Research Foundation ("NMTRF"). The Company's founder, IX Power LLC, acquired LANS' rights and interest in such patent rights in April 2013, and entered into a Royalty-Sharing Agreement and Joint Invention Management Agreement with UT and NMTRF (NMTRF's interests in such agreement were subsequently assigned to Karen Bailey-Bowman) (the "Joint Invention RSA"). From the Company's incorporation until 2017, the Company was licensing the patent rights from IX Power LLC. In 2017, IX Power LLC and the Company completed an outright assignment of the patent rights from IX Power LLC to the Company. The patent rights (hereinafter, the "Joint Invention") are currently jointly owned by the Company, UT and Ms. Bowman (as assignee of NMTRF), subject to the Joint Inventions RSA. The Company serves as the "Managing Party" under the Joint Invention RSA, with exclusive management rights and responsibilities for the Joint Invention, including with respect to patent prosecution and licensing.

The Joint Invention RSA provides for royalty payments to the other owners in the event the Company generates direct sales revenues or license revenues from water treatment systems developed based upon the Joint Invention, and certain associated reporting and accounting requirements for royalties that become due. While the Company intends to comply with its obligations under the Joint Invention RSA, an uncured breach by the Company of its obligations under the Joint Inventions RSA gives the other owners the right to remove us as "Managing Party" under the Joint Invention RSA or terminate the agreement. While the Company believes such removal or termination is unlikely, if either occurred, the Company would lose its exclusive right to control commercialization of the Joint Invention. If the agreement is terminated, the Company retains its ownership interest in the Joint Invention but any limitations on activities of the other co-owners of the Joint Invention (including those that may be competitive to the Company's business) are eliminated. Thus, a removal of us as "Managing Party" under the Joint Invention RSA or a termination of the Joint Invention RSA, if either were ever to occur, could harm the Company's business, financial condition, operations and cash flows.

**If we are unable to protect our intellectual property, the value of our brand and other intangible assets may be diminished, and our business may be seriously harmed. If we need to license or acquire new intellectual property, we may incur substantial costs.** We aim to protect our confidential proprietary information, in part, by entering into confidentiality agreements and invention assignment agreements with our employees, consultants, advisors, and any third parties who access or contribute to our proprietary know-how, information, or technology. We also rely on trademark, copyright, patent, trade secret, and domain-name-protection laws to protect our proprietary rights. At the time, the only patent held by the Company is the Joint Invention, which is a jointly owned invention subject to the Joint Invention RSA as described above. In the future we may acquire additional patents or patent portfolios, which could require significant cash expenditures. Third parties may knowingly or unknowingly infringe our proprietary rights, third parties may challenge proprietary rights held by us, and pending and future trademark and patent applications may not be approved. In addition, effective intellectual property protection may not be available in every country in which we operate or intend to operate our business. In any of these cases, we may be required to expend significant time and expense to prevent infringement or to enforce our rights. Although we have taken measures to protect our proprietary rights, there can be no assurance that others will not offer products or concepts that are substantially similar to ours and compete with our business. If we are unable to protect our

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025
15

proprietary rights or prevent unauthorized use or appropriation by third parties, the value of our brand and other intangible assets may be diminished, and competitors may be able to more effectively mimic our service and methods of operations. Any of these events could seriously harm our business.

**Our success will depend partly on our ability to operate without infringing on or misappropriating the proprietary rights of others.** To date, we have received no notices alleging that we are infringing the patents of any third party. Nonetheless, we may in the future be sued for infringing the patent rights of others. Intellectual property litigation is costly, and, even if we prevail, the cost of such litigation could adversely affect our business, financial condition, results of operations and cash flows. In addition, litigation is time-consuming and could divert management attention and resources away from our business. If we do not prevail in any litigation, in addition to any damages we might have to pay, we could be required to cease the allegedly infringing activity or to obtain a license. Such a required license may not be available to us or may not be available on acceptable terms, if at all. In addition, some licenses may be non-exclusive, so that our competitors may have access to the same technology licensed to us. If we fail to obtain a required license, or are unable to design around a third-party patent, ceasing an allegedly infringing activity could have a materially adverse effect on our business, financial condition, operations and cash flows.

**Indemnity provisions in various agreements potentially expose us to substantial liability for intellectual property infringement and other losses.** Our agreements with customers, licensees and other third parties may include indemnification provisions under which we agree to indemnify them for losses suffered or incurred as a result of claims of intellectual property infringement, damages caused by us to property or persons, or other liabilities relating to or arising from our products, services or other contractual obligations. The term of these indemnity provisions generally survives termination or expiration of the applicable agreement. Large indemnity payments would harm our business, financial condition and results of operations. In addition, any type of intellectual property lawsuit, whether initiated by us or a third party, would likely be time consuming and expensive to resolve and would divert management's time and attention.

**Our long-term success may depend on future royalties paid to us by licensees, and we would face the risks inherent in a royalty-based business model.** Beyond direct product sales for the treatment systems line of business, we may generate some revenue in the future through the licensing of our technology, systems, and services offerings, and our long-term success depends on future royalties paid to us by prospective customer licensees. The amount of royalty payments we may receive is expected to be based upon the revenues generated by our prospective customer licensees' operations, and so we will be dependent on the successful operations of our prospective customer licensees for a significant portion of our revenues. We face risks inherent in a royalty-based business model, many of which are outside of our control, including those arising from our reliance on the management and operating capabilities of our customer licensees and the cyclicality of supply and demand for end-products produced using our technology. Should our prospective customer licensees fail to achieve sufficient profitability in their operations, our royalty payments would be diminished and our results of operations, cash flows and financial condition could be adversely affected, and any such effects could be material.

**Seasonal and weather conditions could adversely impact our business.** Variation from normal weather patterns, such as cooler or warmer summers and winters, can have a significant impact on demand for our services and operations. Adverse weather conditions, such as hurricanes in the Gulf of Mexico, may interrupt or curtail our operations, or our customers' operations, cause supply disruptions and result in a loss of revenue and damage to our equipment and facilities, which may or may not be insured.

**Natural disasters and other events outside of our control could adversely impact our business.**

Variation from normal weather patterns, such as cooler or warmer summers and winters, can have a significant impact on demand for our services and operations. Adverse weather conditions, such as hurricanes in the Gulf of Mexico, may interrupt or curtail our operations, or our customers' operations, cause supply disruptions and result in a loss of revenue and damage to our equipment and facilities, which may or may not be insured.

Natural disasters such as earthquakes, tsunamis, typhoons, and floods, accidents such as fires, power outages, and system failures, acts of terror, war, infectious diseases, and other unpredictable factors could adversely affect the Company's business operation. As the Company owns or will purchase facilities and equipment in areas where earthquakes occur at a frequency higher than the global average, the effects of earthquakes and other events could damage the Company's facilities and equipment and force a halt to manufacturing and other operations, and such events could consequently cause severe damage to the Company's business. Similar situations may also occur due to other types of natural disasters, accidents such as fires, power outages, and system failures, acts of terror, war, infectious diseases, and other similar events. However, in the future, the Company's business, results of operations and financial condition could be materially adversely affected by, among other things, the burden of costs to restore damaged plant facilities and equipment, a decrease in sales and operating income due to a decrease in plant utilization or stop, and a deterioration in gross margins.

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025
16

In preparation for these risks, the Company will develop and manage a BCP (Business Continuity Plan), which defines preventive plans and contingency plans etc., and purchase various insurances; however, such plans and insurances may not fully hedge the risks or cover the losses and damages from events we could not anticipate.

Public health epidemics or outbreaks could adversely impact our business. The current global spread of the COVID-19 virus has and may continue to materially and adversely affect our results of operations, cash flows, and financial condition for an indeterminate amount of time. In December 2019, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally. The current spread of COVID-19 infections worldwide and the continuing unstable social, economic, fiscal, and working environments have affected the Company's business performance and business activities. The Company puts top priority to ensure the health and safety of employees, customers, and other related parties, and strives to develop a system that allows the Company to continue its business even in the face of various difficulties caused by the pandemic. However, the spread of the COVID-19 pandemic is not a factor the Company can directly control, so development of such countermeasures does not guarantee the Company's business continuity. In addition, since there is no clear prospect of the COVID-19 pandemic subsiding, and since the timing and future impact of the end of the pandemic remain uncertain at this stage, it is not possible to predict with certainty the final impact of the COVID-19 pandemic on the Company, including whether there are any other impacts. If the COVID-19 situation becomes more serious or prolonged in the future, the Company's business, results of operations and financial condition may be significantly adversely affected.

## Addendum, 1 Part IV - Tax Risks:

No tax returns have been filed to date. No tax returns have been filed to date since the Company is only this year generating revenue, which raises risks of penalties/interest and potential loss of tax benefits from historical losses.

We are faced with increasingly complex tax issues in many jurisdictions, and we could be obligated to pay additional taxes in various jurisdictions. We may be subject to taxation in many jurisdictions in the United States and around the world with increasingly complex tax laws, the application of which can be uncertain. The amount of taxes we pay in these jurisdictions could increase substantially as a result of changes in the applicable tax laws, including increased tax rates or revised interpretations of existing tax laws and precedents, which could have a material adverse effect on our liquidity and operating results. In addition, the taxing authorities in these jurisdictions could review our tax returns, or authorities in jurisdictions in which we do not file tax returns could assert that we are subject to tax in such jurisdiction, and in either case could impose additional tax, interest and penalties. Further, the authorities could claim that various withholding requirements apply to us or assert that benefits of tax treaties are not available to us, any of which could have a material impact on us and the results of our operations.

## PROSPECTIVE INVESTORS SHOULD CONSULT THEIR OWN ADVISORS REGARDING TAX MATTERS

An investment in the Applicable Crowdfunding Securities, whether pursuant to or in connection with the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering, involves certain material tax risks. A discussion of tax considerations which may be relevant to the Company and to prospective investors with respect to their investment in the Company is beyond the scope of this Form C. The aspects of each Series CF Crowdfunding Offering, including this Series CF Crowdfunding Offering #2, are complex and certain of the tax consequences may differ depending on individual circumstances. Accordingly, all prospective investors should independently satisfy themselves regarding the potential federal, state, local, foreign or other tax consequences of a purchase of the Applicable Crowdfunding Securities and of an investment and participation in the Company. You must not construe the contents of this Form C or any communications from the Company, its officers, directors, employees, agents, OR representatives, as legal, accounting, regulatory, or tax advice. Prior to investing in the Applicable Crowdfunding Securities, you should consult with and rely upon your attorney and your investment, accounting, regulatory, and tax advisors to independently evaluate the appropriateness of such an investment for you, in light of your particular investment and tax situation, including the applicability of any legal restrictions.

## TREASURY DEPARTMENT CIRCULAR 230 DISCLOSURE

To ensure compliance with Treasury Department Circular 230, prospective investors in each of the Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2, are hereby notified that: (a) any discussion of federal tax issues in this Form C is not intended or written to be relied upon, and cannot be relied upon, by prospective or actual Series CF Crowdfunding Offering Investors for the purpose of avoiding penalties that may be imposed on Investors under the Internal Revenue Code of 1986, as amended; (b) such discussion is included herein by the Company in connection with the promotion or sale (within the meaning of Circular 230) by the Company of the Applicable Crowdfunding Securities; and (c) prospective investors should seek advice for their particular circumstances from an independent tax advisor.

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

# Addendum, 1 Part V - Conflicts of Interest:

It is possible that conflicts may arise between the Company and its officers, directors or stockholders. These potential conflicts include, but are not limited to, the items discussed below:

1) The Company may, but is not required to, have independent directors on its Board of Directors. The individuals currently serving on the Company's Board of Directors are either (a) principals of the Company's founder, IX Power LLC, who also currently serve, or have served, as officers of the Company or (b) existing investors who owns shares of the Company's voting stock (Class A Common Stock and/or Series A Preferred Stock). The Company does not anticipate having an independent director serve on its Board of Directors in the foreseeable future.

2) The Company's existing management team is comprised of the five individuals who own the Company's founder, IX Power LLC. Such individuals are: John R. (Grizz) Deal, Director, Executive Chairman &amp; CEO; Randall (Randy) Wilson, Director &amp; CFO; Deborah A. (Deal) Blackwell, CMO; and Dr. Otis (Pete) Peterson, CTO. Dr. L. Robert (Bob) Libutti, former Chief Product Strategist and now deceased, is the fifth original owner of the Company's founder, IX Power LLC. Mr. Deal and Mr. Wilson also currently serve as directors of the Company. Such individuals have signed confidentiality agreements but do not have employment agreements (or non-competition agreements) and are not required to devote substantially all of their business time and attention to the performance of their duties for the Company. Each such individual devotes such business time and attention to the Company's business as he or she in his or her sole discretion deems reasonably necessary. As of the date of the Form C, each of Mr. Deal and Ms. Blackwell are devoting substantially all of their business time and attention to the performance of their duties for the Company. Such individuals may have conflicts of interest in allocating time, services, and functions between the Company's business and their other business and professional interests and commitments, which could have a negative impact on the Company and its business.

3) Under most conditions, the Company's officers and directors may not be held liable for errors in judgment or other acts or omissions made by them as representatives of the Company because of provisions in the Company's certificate of incorporation and bylaws holding them harmless and providing them with indemnification against liabilities or losses that arise from such acts or omissions. To the extent that such indemnification provisions are invoked, conflicts will exist between the officer or director invoking the indemnification and the Company.

4) In the future, the Company may negotiate certain employment agreements with the officers of the Company for salary and other benefits to the officers. Such negotiations between the Company and such officers may not be considered as being negotiated at "arm's length."

5) In the future, officers, directors and shareholders of the Company may make or arrange loans for the Company, or render services, or sell goods to the Company, or engage in other transactions with the Company. Such negotiations between the Company and such officers may not be considered as being negotiated at "arm's length."

6) The Company's officers and directors are now and may in the future become stockholders or other equity owners, officers or directors of other companies, which may be formed for the purpose of engaging in business activities similar to ours. Accordingly, direct conflicts of interest may arise in the future with respect to such individuals acting on behalf of us or other entities. Moreover, additional conflicts of interest may arise with respect to opportunities which come to the attention of such individuals in the performance of their duties or otherwise. Currently, the Company does not have a right of first refusal pertaining to opportunities that come to their attention and may relate to our business operations.

7) The Company's founder, IX Power LLC owns, and will continue to own following the Offering, a majority of the issued and outstanding shares of the voting stock of the Company. See the section of this Form C titled "Principal Securities Holders." As a result, IX Power LLC and its owners will effectively control and direct the affairs of the Company, subject to certain limited voting protections granted to the holders of the Company's Series A Preferred Stock. The interest of IX Power LLC and its owners may conflict with those of other securities holders. This concentration of ownership may also delay, defer or prevent a future sale of the Company or other change of control transaction and some transactions may be difficult or impossible without the support of the Founder and its owners.

8) For so long as the total number of shares of Series A Preferred Stock that are issued and outstanding represent at least 10.0% (reduced recently from 15%) of the capital stock of the Company calculated on a fully-diluted basis, the holders of the Series A Preferred Stock have the right to designate and elect one member of the Company's Board of Directors. In addition, for so long as at least 1,010,925 shares of Series A Preferred Stock remain outstanding (which share number is equivalent to approximately 50% of the shares of Series A Preferred Stock that are issued and outstanding as of the date of this Form C), subject to appropriate adjustment of such share number in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock, the holders of the Series A Preferred Stock have special voting rights to approve certain

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025
18

material decisions affecting the Company, including a future sale of the Company or other change of control transaction. The interest of the holders of the Series A Preferred Stock may conflict with those of the Company's Board of Directors and/or those of other securities holders. These special voting rights may also delay, defer or prevent a future sale of the Company or other change of control transaction and some transactions may be difficult or impossible without the support of the holders of the Series A Preferred Stock.

## Addendum, 1 Part VI - Statement as to Indemnification:

Our certificate of incorporation and bylaws provide for indemnification of directors and officers under certain circumstances, which could include liabilities relating to securities laws. The Securities and Exchange Commission (the "SEC") mandates the following disclosure of its position on indemnification for liabilities under the federal securities laws:

"Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to directors, officers or persons controlling an issuer, the Company has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933, as amended, and is therefore unenforceable.

IX Power Clean Water, Inc. - Addendum 1 to Exhibit A of the Form C filed 8 April 2025

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

# ADDENDUM 2
TO THE EXHIBIT A OFFERING MEMORANDUM,
WHICH FORMS A PART OF THE FORM C OFFERING STATEMENT FILED ON 8 APRIL 2025

## DESCRIPTION OF CAPITAL STOCK; TRANSFER RESTRICTIONS; STOCKHOLDER AGREEMENT

The terms "IX Water," "Nine Power," the "Company," "we," "us," and "our" refer to IX Power Clean Water, Inc.

All references in this Addendum 2 to "the Form C" or "this Form C" refer to the Company's Form C Offering Statement filed on 8 April 2025, including all exhibits and addendums thereto. This Addendum 2 is attached to and made a part of Exhibit A of such Form C (which Exhibit A is titled "Offering Memorandum: Part II of Offering Document"). All references to in this Addendum 2 to "this Addendum" mean this Addendum 2.

The crowdfunding campaign/offering described in the Form C is referred to in this Addendum as "the Series CF Crowdfunding Offering #2" or "this Series CF Crowdfunding Offering #2" (as such term Series CF Crowdfunding Offering #2 is defined below).

All references in this Addendum to "$" or "dollars" are to United States dollars unless specifically stated otherwise.

This Addendum is comprised of three Parts:

- Part I - Description of Capital Stock (pages 1 to 21 of this Addendum)
- Part II - Transfer Restrictions (page 22 of this Addendum).
- Part III - Stockholder Agreement (pages 23 to 30 of this Addendum).

## PART I, DESCRIPTION OF CAPITAL STOCK

Our current certificate of incorporation is the Second Amended and Restated Certificate of Incorporation filed with the Delaware Secretary of State on 25 October, 2022, a copy of which is attached as Exhibit F to this Form C (the "Existing Certificate of Incorporation"). Our current bylaws are our bylaws adopted September 17, 2014 and amended February 3, 2020, a copy of which are available to prospective investors upon request to the Company (the "Bylaws"). The current stockholder agreement in effect among the Company and its stockholders is the Third Amended and Restated Stockholder Agreement, dated as of 26 October, 2022, by and among the Company and its stockholders from time to time party thereto, a copy of which agreement as in effect on date of this Form C is attached as Exhibit G to this Form C (the "Existing Stockholder Agreement").

The following is a summary of the rights of the Company's Common Stock and Preferred Stock and certain provisions of our Existing Certificate of Incorporation, Existing Bylaws and Existing Stockholder Agreement, as in effect on the date of this Form C and as they are expected to be in effect at the completion of this Series CF Crowdfunding Offering #2 (provided, however, that nothing in this Form C prevents or limits the Company, with any requisite Board of Director and/or stockholder approvals, from amending, restating, supplementing or otherwise modifying any such documents and agreements after the date of this Form C). This summary does not purport to be complete and is qualified in its entirety by the provisions of our Existing Certificate of Incorporation, Existing Bylaws and Existing Stockholder Agreement, and to the applicable provisions of Delaware law.

## I. CERTAIN DEFINITIONS

The terms "this Addendum," "Bylaws," "Company," "Existing Certificate of Incorporation," "Existing Stockholder Agreement," "the Form C," "this Form C", "IX Water," "Nine Power," "our," "we," and "us," have the meanings given to such terms above on this p. 1 of this Addendum. In addition, the following terms, when used in this Addendum, have the following meanings:

"A/B Preferred Stock" means, collectively, the Series A Preferred Stock and the Series B Non-Voting Preferred Stock (for clarity, the A/B Preferred Stock is limited to the Series A Preferred Stock and the Series B Non-Voting Preferred Stock only and does not include the Series CF Non-Voting Preferred Stock).

"Class A Common Stock" means shares of the Company's Class A Common Stock, par value $0.001 per share.

"Class B Non-Voting Common Stock" means shares of the Company's Class B Non-Voting Common Stock, par value $0.001 per share.

"Common Stock" means shares of the Company's common stock, par value $0.001 per share, including all shares of the Company's Class A Common Stock and Class B Non-Voting Common Stock.

"Company Securities" means "securities" as defined in Section 2(a)(1) of the Securities Act of 1933, as amended, and includes capital stock or other equity interests or any options, warrants or other Company Securities that are directly or indirectly convertible into, or exercisable or exchangeable for, capital stock or other equity or equity-linked interests, including phantom stock and stock appreciation rights.

"Crowdfunding Investors" means:

(i) the Initial Crowdfunding Offering Investors;
(ii) the Series CF Crowdfunding Offering Investors; and
(iii) as applicable, any and all of such persons' respective successor(s) or permitted assignee(s) in accordance with the Prior Stockholder Agreement or the Existing Stockholder Agreement.

All Crowdfunding Investors either have joined or otherwise become a party to and are referred to, or will join or otherwise become a party to and will be referred to, as "Additional Stockholders" in the Existing Stockholder Agreement and are not part of the defined "Investors" stockholder group for purposes of the Existing Stockholder Agreement. See Part III of this Addendum ("Stockholder Agreement"; pp. 23-30 of this Addendum).

"Deemed Liquidation Event" means, unless otherwise agreed by the written consent or affirmative vote of the Requisite A/B Preferred Holders (as defined below) and the Company, any the following events:

**Acquisition.** Any (i) consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, which results in the voting securities of the Company outstanding immediately prior thereto representing immediately thereafter (either by remaining outstanding or by being converted into voting securities of the surviving or acquiring entity) less than 50% of the combined voting power of the voting securities of Company or such surviving or successor entity outstanding immediately after such consolidation, merger or reorganization, or any transaction or series of related transactions in which more than 50% of the Company's voting power is transferred, but excluding any consolidation or merger effected solely for the purpose of reincorporating the Company in another state or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company's securities immediately prior to such transaction; or (ii) sale of shares of capital stock of the Company, in a single transaction or series of related transactions, representing more than 50% of the voting power of the voting securities of the Company, but excluding any transaction or series of transactions principally for bona fide equity financing purposes in which the Company issues new securities primarily for cash or the cancellation or conversion of indebtedness of the Company or a combination thereof for the purpose of financing the operations and business of the Company; or

**Asset Transfer.** A sale, lease, transfer, exclusive license or other disposition of all or substantially all of the assets of the Company, in a single transaction or series of related transactions (excluding, however, any license (whether or not exclusive) that is granted or entered into in the ordinary course).

provided, however, that an event that triggers automatic conversion of the Company's outstanding Preferred Stock into Common Stock in accordance with the Existing Certificate of Incorporation is not a Deemed Liquidation Event.

"DGCL" means the General Corporation Law of the State of Delaware.

"Founder" means IX Power LLC, a Colorado limited liability company. IX Power LLC is owned by the following members of the Company's existing management team (each owning 20% of IX Power LLC as of the date of this Form C: John R. (Grizz) Deal; Randall (Randy) Wilson; Deborah A. (Deal) Blackwell; Dr. Otis (Pete) Peterson; and Dr. L. Robert (Bob) Libutti (deceased; Mary Tendall, surviving spouse and personal representative).

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

"Initial Crowdfunding Offering" means the Regulation Crowdfunding offering (an offering in reliance on Section 4(a)(6) of the Securities Act of 1933, as amended, and pursuant to Regulation Crowdfunding (§ 227.100 et seq.)) of the Company hosted on funding portal StartEngine Capital LLC. Such offering was launched in May 2020 and concluded earlier in 2022. The security that was offered, sold and issued in such initial crowdfunding campaign is the Company's Class B Non-Voting Common Stock.

"Initial Crowdfunding Offering Investors" means:

(i) The persons who/that acquired shares of Class B Non-Voting Common Stock pursuant to the Initial Crowdfunding Offering in exchange for cash consideration. As of the date of this Form C, such persons hold 1,672,899 shares of the Class B Non-Voting Common Stock; and

(ii) StartEngine Capital LLC, the intermediary/funding portal for the Initial Crowdfunding Offering. 31,368 shares of the Class B Non-Voting Common Stock have been issued to StartEngine Capital LLC as equity compensation payable by the Company to StartEngine Capital LLC for services provided by StartEngine Capital LLC to the Company in connection with the Initial Crowdfunding Offering.

"Liquidation Event" means the voluntary or involuntary liquidation, dissolution or winding up of the Company, or a Deemed Liquidation Event.

"Preferred Stock" means collectively, all shares of the Company's preferred stock, par value $0.001 per share, including all shares of the Company's Series A Preferred Stock, Series B Non-Voting Preferred Stock, and Series CF Non-Voting Preferred Stock.

"Prior Stockholder Agreement" means the Second Amended and Restated Stockholder Agreement, dated as of May 17, 2018, by and among the Company and its stockholders from time to time party thereto, which agreement has been amended and modified, and for convenience restated in its entirety, by and pursuant to the Existing Stockholder Agreement.

"Requisite A/B Preferred Holders" means the holders of a majority of the outstanding shares of the A/B Preferred Stock, given in writing or by vote at a meeting, consenting or voting (as the case may be) together as a single class (and not as separate series), and on an as-converted basis (provided that, for so long as any shares of Series A Preferred Stock remain outstanding, such majority shall include the holders of at least 20% of the outstanding shares of Series A Preferred Stock).

"Seed Round Investors" means (i) the persons who/that acquired their shares in the Company's "seed round" (that is, such persons acquired convertible securities in 2012 and 2013 and the indebtedness evidenced by such securities was converted into voting common shares of the Company in late 2013 and early 2014) (see also the section of this Form C titled "Recent Securities Offerings"), and (ii) as applicable, any and all of such persons' respective successor(s) or permitted assignee(s) in accordance with the Prior Stockholder Agreement or the Existing Stockholder Agreement. As of the date of this Form C: (A) the Seed Round Investors hold shares of the Class A Common Stock; (B) the total number of issued and outstanding shares of the Class A Common Stock held by the Seed Round Investors as of the date of this Form C is 1,504,601 shares of Class A Common Stock; and (C) the Seed Round Investors were referred to and known as the "Common Investors" under the Prior Stockholder Agreement and are now referred to and known as the Seed Round Investors under Existing Stockholder Agreement, and the Seed Round Investors are also part of the defined "Investors" group for purposes of the Existing Stockholder Agreement.

"Series A Investors" means (i) the persons who/that acquired shares of the Company's Series A Preferred Stock pursuant to the Company's Series A Preferred Stock financing at one or more closings for such financing occurring between (and including) the initial closing date of October 6, 2014 and the final closing date of February 14, 2018 (see also the section of this Form C titled "Recent Securities Offerings"), and (ii) as applicable, any and all of such persons' respective successor(s) or permitted assignee(s) in accordance with the Prior Stockholder Agreement or the Existing Stockholder Agreement. As of the date of this Form C: (A) the total number of issued and outstanding shares of the Series A Preferred Stock held by the Series A Investors is 2,021,850 shares of Series A Preferred Stock; (B) certain Series A Investors hold shares of Class A Common Stock (as of the date of this Form C, 48,660 shares of Class A Common Stock in the aggregate for all such Series A Investors), acquired in September/October 2019 upon exercise of certain "Early Investor Warrants" issued as part of the Company's Series A Preferred Stock

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

financing; and (C) the Series A Investors were referred to and known as the "Series A Investors" under the Prior Stockholder Agreement and continue to be referred to and known as the Series A Investors under Existing Stockholder Agreement, and the Series A Investors are also part of the defined "Investors" group for purposes of the Existing Stockholder Agreement.

"Series A Preferred Stock" means collectively, all shares of the Company's Series A Preferred Stock, par value $0.001 per share.

"Series B Investors" means (i) the persons who/that acquired shares of the Series B Non-Voting Preferred Stock pursuant to any one or more of (x) the first and only closing of the Company's Rule 506(c) offering of its Series B Non-Voting Preferred Stock that occurred in May 2018, (y) closings of the Company's Rule 506(b) offering of its Series B Non-Voting Preferred Stock and certain Class B Non-Voting Common Stock warrants that occurred in April 2020 prior to commencement of the Initial Crowdfunding Offering, and/or (z) the closing of the Company's Rule 506(b) offering of its Series B Non-Voting Preferred Stock that occurred in May 2022 (see also the section of this Form C titled "Recent Securities Offerings"), and (ii) as applicable, any and all of such persons' respective successor(s) or permitted assignee(s) in accordance with the Prior Stockholder Agreement or the Existing Stockholder Agreement. As of the date of this Form C: (A) the total number of issued and outstanding shares of the Series B Non-Voting Preferred Stock held by the Series B Investors is 626,014 shares of Series B Non-Voting Preferred Stock; (B) certain Series B Investors hold warrants to acquire shares of the Class B Non-Voting Common Stock (up to a total of 480,000 shares of the Class B Non-Voting Common Stock are reserved for such warrants as of the date of this Form C, but a portion of such 480,000 is expected to be released from such reservation after the date of this Form C upon completion of the Company's reconciliation of shares issued pursuant to warrant exercise elections, occurring in connection with the April 1, 2025 warrant expiration date for all of such warrants) as part of the Company's Rule 506(b) offering that occurred in April 2020 prior to commencement of the Initial Crowdfunding Offering; and (C) the Series B Investors were referred to and known as the "Series B Investors" under the Prior Stockholder Agreement and continue to be referred to and known as the Series B Investors under Existing Stockholder Agreement, and the Series B Investors are also part of the defined "Investors" group for purposes of the Existing Stockholder Agreement.

"Series B Non-Voting Preferred Stock" means collectively, all shares of the Company's Series B Non-Voting Preferred Stock, par value $0.001 per share.

"Series CF Crowdfunding Offering(s)" means any one or more Regulation Crowdfunding offerings (an offering in reliance on Section 4(a)(6) of the Securities Act of 1933, as amended, and pursuant to Regulation Crowdfunding (§ 227.100 et seq.)) pursuant to which the security offered, sold and/or issued, as applicable, is the Company's Series CF Non-Voting Preferred Stock. As of the date of this Form C, the Series CF Crowdfunding Offering(s) includes the following offering(s): the Series CF Crowdfunding Offering #1 and this Series CF Crowdfunding Offering #2.

"Series CF Crowdfunding Offering #1" means the Regulation Crowdfunding offering hosted by Wefunder Portal that launched on 17 November 2022 and concluded on 29 April 2024. This Series CF Crowdfunding Offering #1 has previously been referred to in the Company's Regulation Crowdfunding filings as the "additional crowdfunding campaign" or "the Additional Crowdfunding Offering."

"Series CF Crowdfunding Offering #2" means the Regulation Crowdfunding offering hosted by StartEngine Primary LLC that is launching on or about the date of this Form C. This Series CF Crowdfunding Offering #2 is sometimes referred to in this Form C as "this crowdfunding campaign," "the Offering" or "this Offering."

"Series CF Crowdfunding Offering Investors" means the persons who/that acquire shares of the Company's Series CF Non-Voting Preferred Stock pursuant to any one or more Series CF Crowdfunding Offerings (whether the shares are issued in exchange for cash consideration or are issued as equity compensation for services provided to the Company in connection with the applicable Series CF Crowdfunding Offering and in compliance with Regulation Crowdfunding).

"Series CF Non-Voting Preferred Stock" means collectively, all shares of the Company's Series CF Non-Voting Preferred Stock, par value $0.001 per share.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

"Stock Reclassification" means the 8.2-for-1 forward stock split and stock reclassification effected on May 16, 2018 and more fully described in the Existing Certificate of Incorporation. Such Stock Reclassification included: (i) the reclassification of the original common stock of the Company (all of such original common stock being of a single class) into two separate classes of Common Stock - the Class A Common Stock and the Class B Non-Voting Common Stock; (ii) an 8.2-for-1 forward stock split of all the shares of the Company's original common stock that were issued and outstanding on May 16, 2018 immediately prior to the effectiveness of the Stock Reclassification, with such shares of original common stock being subdivided, reclassified and changed into shares of an authorized Class A Common Stock; and (iii) an 8.2-for-1 forward stock split of all the shares of the Company's Series A Preferred Stock that were issued and outstanding on May 16, 2018 immediately prior to the effectiveness of the Stock Reclassification.

## II. AUTHORIZED CAPITAL

As of the date of this Form C, the authorized capital of the Company consists of:

- 11,000,000 shares of Class A Common Stock, 8,366,699 shares of which are issued and outstanding as of the date of this Form C;
- 6,666,014 shares of Class B Non-Voting Common Stock, of which 1,704,267 are issued and outstanding as of the date of this Form C and 605,000 additional shares are reserved for issuance for outstanding warrants (480,000 shares, but a portion of such 480,000 is expected to be released from such reservation after the date of this Form C upon completion of the Company's reconciliation of shares issued pursuant to warrant exercise elections, occurring in connection with the April 1, 2025 warrant expiration date for all of such warrants) and equity compensation awards reserved for, but not yet granted (125,000 shares), as described below in subsection II(B) of this Part I of this Addendum; and
- 4,847,864 shares of Preferred Stock, of which (i) 2,021,850 shares have been designated Series A Preferred Stock, all of which 2,021,850 shares are issued and outstanding as of the date of this Form C; (ii) 626,014 shares have been designated Series B Non-Voting Preferred Stock (which is a reduction from the 2,160,000 shares of Series B Non-Voting Preferred Stock initially authorized and designated), all of which 626,014 shares are issued and outstanding as of the date of this Form C; and (iii) 2,200,000 shares have been designated Series CF Non-Voting Preferred Stock, of which 188,904 shares are issued and outstanding as of the date of launch of this Series CF Crowdfunding Offering #2 (all of which 188,904 shares of Series CF Non-Voting Preferred Stock were issued pursuant to Series CF Crowdfunding Offering #1).

The following additional information in this "Authorized Capital" section of this Addendum is provided as of the date of this Form C, and all of the share numbers and price per share figures described herein take into account, and have been adjusted for, the Stock Reclassification.

## A. Class A Common Stock (11,000,000 shares currently authorized)

### i. Issued Shares:

The 8,366,699 issued and outstanding shares of Class A Common Stock are held as follows:

- 6,813,438 shares are held by the Founder.
- 1,504,601 shares are held by the Seed Round Investors. The original issue price for such shares is $0.3246 per share (which per share price reflects adjustment for the Stock Reclassification), subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to such stock.
- 48,660 shares are held by certain Series A Investors, who acquired such shares upon exercise of common stock warrants that were issued as part of the early closings of the Series A Preferred Stock financing (October 6, 2014 through the end of January 2015). The maximum number of shares of Class A Common Stock that could have been issued upon exercise of such warrants was 68,832 shares, but only 48,660 shares were actually issued upon exercise of such warrants. The exercise price for such warrants was $0.3246 per share. The warrants expired on October 6, 2019 (the 5th anniversary of the initial closing date of the Series A Preferred Stock financing), so no additional shares of Class A Common Stock will be issued in connection with these warrants.

### ii. Options/Warrants: None at this time.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

iii. Authorized but Unissued Shares - Share Reservation for Series A Preferred Stock:
The Series A Preferred Stock is convertible into the Class A Common Stock, so the Company has reserved 2,021,850 of the 2,633,301 authorized but unissued shares of Class A Common Stock for conversion of the Series A Preferred Stock in accordance with the provisions of the Existing Certificate of Incorporation.

iv. Authorized but Unissued Shares - No Share Reservations: Available for Issuance:
After taking into account the share reservations described above, the Company has 611,451 of its authorized but unissued shares of Class A Common Stock available for issuance. See also the subsection II(F) below of this Part I of this Addendum titled "Authorized but Unissued Shares - Additional Information/Dilution."

B. Class B Non-Voting Common Stock (6,666,014 shares currently authorized)

i. Issued Shares: The 1,704,267 issued and outstanding shares of Class B Non-Voting Common Stock are held as follows:

- 1,672,899 shares of Class B Non-Voting Common Stock are held by the Initial Crowdfunding Offering Investors (excluding StartEngine Capital, LLC, the intermediary/funding portal for the Initial Crowdfunding Offering), including certain directors and officers who invested personal funds in the Initial Crowdfunding Offering. Such 1,672,899 shares were issued in exchange for approximately $1,960,512.50 cash consideration. 104,489 of such 1,672,899 shares are "bonus shares" that were issued in the Initial Crowdfunding Offering (which equates to approx. 6.7% of the 1,568,410 total subscribable shares issued in the Initial Crowdfunding Offering).
- 31,368 shares of Class B Non-Voting Common Stock are held by StartEngine Capital, LLC, the intermediary/funding portal for the Initial Crowdfunding Offering. Such 31,368 shares constitute the equity compensation payable by the Company to StartEngine Capital, LLC for services provided to, or for the benefit of, the Company in connection with the Initial Crowdfunding Offering (which is shares of Class B Non-Voting Common Stock of the Company equal to two percent (2%) of the $1,960,512.50 total amount of investments raised in the Initial Crowdfunding Offering).

ii. Options/Warrants:

- 480,000 shares of Class B Non-Voting Common Stock are reserved by the Company for warrants issued to certain Series B Investors as part of the Company's Rule 506(b) offering that occurred in April 2020 prior to commencement of the Initial Crowdfunding Offering. The exercise price of such warrants is $1.25 per share. The warrant expiration date is April 1, 2025, subject to early termination upon an initial public offering of the Company's capital stock and certain corporate transaction events as described in the warrant. As of the date of this Form C, the Company is completing a reconciliation of shares issued pursuant to warrant exercise elections that are occurring in connection with the April 1, 2025 warrant expiration date for all of such warrants. The 480,000 shares currently reserved for these warrants will, upon completion of the Company's reconciliation of warrant exercise elections, be reduced to equal the total number of shares for which the warrants are exercised. The Company expects that the warrants will be exercised, in the aggregate, for a number of shares less than 480,000.
- 125,000 shares (increased from the most recent share reserve of 82,000 shares) of Class B Non-Voting Common Stock are reserved by the Company for stock options or other equity compensation awards issuable to employees or directors of, or consultants or advisors to, the Company, reserved but unissued and not yet outstanding.

iii. Authorized but Unissued Shares - Share Reservation for Series B Non-Voting Preferred Stock:
Since the Series B Non-Voting Preferred Stock is convertible into the Class B Non-Voting Common Stock, the Company has reserved up to 626,014 of the authorized but unissued shares of Class B Non-Voting Common Stock (equivalent to the total number of legally authorized shares of Series B Non-Voting Preferred Stock) for conversion of the Series B Non-Voting Preferred Stock in accordance with the provisions of the Existing Certificate of Incorporation. The 626,014 total authorized share figure reflects a reduction from the 2,160,000 shares of Series B Non-Voting Preferred Stock initially authorized and designated.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

iv. Authorized but Unissued Shares - Share Reservation for Series CF Non-Voting Preferred Stock:
Since the Series CF Non-Voting Preferred Stock is convertible into the Class B Non-Voting Common Stock, the Company has reserved up to 2,200,000 of the authorized but unissued shares of Class B Non-Voting Common Stock (equivalent to the total number of legally authorized shares of Series CF Non-Voting Preferred Stock) for conversion of the Series CF Non-Voting Preferred Stock in accordance with the provisions of the Existing Certificate of Incorporation.

v. Authorized but Unissued Shares - No Share Reservations: Available for Issuance:
After taking into account the share reservations described above, the Company has a minimum of 1,530,733 of its authorized but unissued shares of Class B Non-Voting Common Stock available for issuance. See also the subsection II(F) below of this Part I of this Addendum titled "Authorized but Unissued Shares - Additional Information/Dilution." This number could increase if any of the above-described share reservations are eliminated or reduced. For example, if less than all of the 2,200,000 legally authorized shares of Series CF Non-Voting Preferred end up being issued by the Company pursuant to the applicable Series CF Crowdfunding Offerings, the total number of shares of Class B Non-Voting Common Stock reserved for conversion of the Series CF Non-Voting Preferred would be reduced.

C. Series A Preferred Stock (2,021,850 shares currently authorized)
All of the 2,021,850 issued and outstanding shares of Series A Preferred Stock are held by the Series A Investors, and there are no authorized but unissued shares of the Series A Preferred Stock.

The original issue price of the Series A Preferred Stock (including for calculating liquidation preferences and for purposes of price-based anti-dilution protection) is $0.749512 per share (which per share price reflects adjustment for the Stock Reclassification), subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to such stock.

D. Series B Non-Voting Preferred Stock (626,014 shares currently authorized)
All of the 626,014 issued and outstanding shares of Series B Non-Voting Preferred Stock are held by the Series B Investors, and, as of the date of the filing of the Existing Certificate of Incorporation (pursuant to which the number of authorized shares of the Series B Non-Voting Preferred Stock was reduced from 2,160,000 shares to 626,014 shares), there are no authorized but unissued shares of the Series B Non-Voting Preferred Stock.

The original issue price of the Series B Non-Voting Preferred Stock (including for calculating liquidation preferences and for purposes of price-based anti-dilution protection) is $1.25 share, subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to such stock.

E. Series CF Non-Voting Preferred Stock (2,200,000 shares currently authorized)
i. Issued Shares - Series CF Crowdfunding Offering #1: As of the date of launch of this Series CF Crowdfunding Offering #2, there are 188,904 issued and outstanding shares of the Series CF Non-Voting Preferred Stock all of which shares were issued pursuant to the Series CF Crowdfunding Offering #1 (including 17,170 "bonus shares," equivalent to 10% "bonus shares") and in exchange for $429,335 aggregate cash consideration.

ii. Authorized but Unissued Shares - Series CF Crowdfunding Offerings:
- The Series CF Non-Voting Preferred Stock has been approved by the Company's Board of Directors and its requisite stockholders for use in equity crowdfunding campaigns for the foreseeable future (designated as three years from the launch of the Series CF Crowdfunding Offering #1, so through 17 November 2025), to raise up to $5 million of new capital across all Series CF Crowdfunding Offerings. This is sometimes referred to in the Company's recent Regulation Crowdfunding filings, and the Form C, as the Company's "existing equity crowdfunding strategy." Any shares reserved for a particular Series CF Crowdfunding Offering that are not actually issued in such offering become available for offer, sale and/or issuance, as the case may, pursuant to any one or more other applicable Series CF Crowdfunding Offerings. The 2,200,000 total authorized share figure for the Series CF Non-Voting Preferred Stock includes an allocation of up to a total of 200,000 shares of

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

Series CF Non-Voting Preferred Stock (approximately $500,000 equivalent value at the $2.50 per share price), to be allocated toward funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, in each case as is approved by Company management (subject to any limitations or conditions imposed by the Company's Board of Directors, if applicable).

- Up to 880,000 shares of the Series CF Non-Voting Preferred Stock were originally reserved for, and allocated to, the offer, sale and/or issuance, as the case may be, to qualified purchasers in the Series CF Crowdfunding Offering #1 (this number included up to 80,000 shares allocated to "bonus shares" for such Series CF Crowdfunding Offering #1, which represents a maximum "bonus shares" allocation of 10% "bonus shares"). This was a maximum share reservation. No equity compensation was issuable to the intermediary/funding portal for the Series CF Crowdfunding Offering #1. The Series CF Crowdfunding Offering #1 concluded 29 April 2024 and the $2 million maximum offering amount was not fully raised at conclusion of the offering; accordingly, the actual number of shares issued in the Series CF Crowdfunding Offering #1, including "bonus shares," was less than the reserved shares figure. All shares reserved for the Series CF Crowdfunding Offering #1, but not actually issued, have become available for offer, sale and/or issuance, as the case may, pursuant to any one or more other applicable Series CF Crowdfunding Offerings, including this Series CF Crowdfunding Offering #2.

- Following the conclusion of the Series CF Crowdfunding Offering #1, the number of authorized but unissued shares of Series CF Non-Voting Preferred Stock is 2,011,096 shares, of which 182,830 shares (approximately $457,075 equivalent value at the $2.50 per share price) are reserved and authorized for Series CF Crowdfunding Offerings other than the Series CF Crowdfunding Offering #1, to be allocated toward funding portal equity compensation and any portal owners' bonus programs and/or other bonus/perk programs, in each case as is approved by Company management (subject to any limitations or conditions imposed by the Company's Board of Directors, if applicable).

- For this Series CF Crowdfunding Offering #2, up to 1,282,830 shares of the Series CF Non-Voting Preferred Stock are reserved for, and allocated to, the offer, sale and/or issuance, as the case may be, to qualified purchasers in this Series CF Crowdfunding Offering #2. This number includes: (i) up to 1,100,000 subscribable shares based on the maximum offering amount of $2,750,000.00 (determined by dividing $2,750,000.00 by the per share price of the offering of $2.50 per share); (ii) up to 11,000 allocated to equity compensation payable by the Company to StartEngine Primary LLC for services provided to, or for the benefit of, the Company in connection with the Series CF Crowdfunding Offering #2 (which is shares of Series CF Non-Voting Preferred Stock of the Company equal to one percent (1%) of the $2,750,000.00 maximum offering amount of the Series CF Crowdfunding Offering #2), and (iii) up to 171,830 shares allocated to "bonus shares" for the Series CF Crowdfunding Offering #2, which represents a maximum "bonus shares" allocation of approximately 15.6% "bonus shares" for this particular offering). This is a maximum share reservation; not all of the reserved shares may end up being issued in this Series CF Crowdfunding Offering #2. The number of reserved shares actually issued depends on the number of investors who/that meet the eligibility criteria for "bonus shares" in this Series CF Crowdfunding Offering #2.

## F. Authorized but Unissued Shares - Additional Information/Dilution

i. Series CF Non-Voting Preferred Stock: As discussed above in subsection II(E) of this Part I of this Addendum, the Series CF Non-Voting Preferred Stock has been approved by the Company's Board of Directors and its requisite stockholders for use in equity crowdfunding campaigns for the foreseeable future (designated as three years from the launch of the Series CF Crowdfunding Offering #1, so through 17 November 2025), to raise up to $5 million of new capital across all Series CF Crowdfunding Offerings. This is sometimes referred to in the Company's recent Regulation Crowdfunding filings, and the Form C, as the Company's "existing equity crowdfunding strategy." It is noted that, as of the date of this Form C, the Company has adopted an updated overall capital raising strategy, discussed in the section of the Form C titled "Updated Overall Capital Raising Strategy."

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

ii. Common Stock. In addition, after taking into account the share reservations described above in subsections I(A) and 1(B) of this Part I of this Addendum, the Company has the following authorized but unissued shares available for issuance: (i) 611,451 authorized but unissued shares of Class A Common Stock; and (ii) a minimum of 1,530,733 authorized but unissued shares of Class B Non-Voting Common Stock. The Company may issue and sell any or all of these authorized but unissued shares of Common Stock on such terms and conditions as the Company's Board of Directors, in its sole discretion, may determine without consent of any of the Series CF Crowdfunding Offering Investors or any of the other stockholders of the Company. For example, but without limitation, the Company's Board of Directors may determine to issue shares of such Common Stock, or options or other securities convertible or exercisable into shares of such Common Stock (a) in connection with future offerings of its debt or equity securities (whether now existing or authorized in the future, and including any and all securities that may be authorized and issued in connection with the Company's updated overall capital raising strategy described in the "Updated Overall Capital Raising Strategy" section of this Form C), (b) pursuant to equity incentive awards to qualified employees, non-employee directors, consultants or advisors, (c) pursuant to the acquisition of another company by the Company by merger, consolidation, purchase of substantially all of the assets or similar business combination, (d) in connection with sponsored research, collaboration, technology license, development, OEM, marketing or other similar agreements or strategic partnerships, or (e) to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction. All of the issuances described in the foregoing clauses (b) through (e) are exempt from the price-based anti-dilution protection for the Preferred Stock. If the Company's Board of Directors authorizes an issuance of any such authorized but unissued shares of Common Stock that is not exempt from the price-based anti-dilution protection for the Preferred Stock (or any series of the Preferred Stock), then the issuance would be subject to and trigger (unless waived) such price-based anti-dilution protection. The price-based anti-dilution protection of the Preferred Stock, including the Series CF Non-Voting Preferred Stock (which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings), is summarized in subsection IX(B) of this Part 1 of this Addendum.

iii. Dilution. Any issuance of additional shares or other securities of the Company, including any and all securities that may be authorized and issued in connection with the Company's updated overall capital raising strategy described in the "Updated Overall Capital Raising Strategy" section of this Form C, has the potential for dilution. See the "Dilution" section of this Form C.

## III. COMMON STOCK - EQUAL STATUS AND RELATIONSHIP TO THE PREFERRED STOCK

Except as provided in the Existing Certificate of Incorporation (see Section B of Article IV of the Existing Certificate of Incorporation; for example, in respect of voting rights), the Class A Common Stock and Class B Non-Voting Common Stock have the same rights and privileges and rank equally, share ratably and are identical in all respects as to all matters. The voting, dividend and liquidation rights of the holders of each class of Common Stock are subject to and qualified by the rights, powers and preferences of the holders of the Preferred Stock.

## IV. VOTING RIGHTS

### A. Voting Rights - Overview

Except as set forth in the Existing Certificate of Incorporation or as otherwise required by the DGCL or other applicable law which cannot be superseded by the provisions of the Existing Certificate of Incorporation:

- the holders of the Class A Common Stock and, so long as any shares of the Series A Preferred Stock remain outstanding the holders of the Series A Preferred Stock, possess exclusively all voting power; and
- the holders of shares of each of the following Company Securities have no voting rights: (1) the Series CF Non-Voting Preferred Stock (which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings); (2) the Series B Non-Voting Preferred Stock; and (3) Class B Non-Voting Common Stock (which is the Common Stock security into which shares of the Series B Non-Voting Preferred Stock are convertible are convertible as described in Section VIII of Part I of this Addendum), have no voting rights.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

B. Voting Stock

(i) Voting Rights Generally.

(1) Class A Common Stock. The holders of the Class A Common Stock are entitled to one vote for each share of Class A Common Stock held at all meetings of stockholders (and written actions in lieu of meetings); provided, however, that, except as otherwise required by the DGCL or other applicable law, holders of Class A Common Stock, as such, are not entitled to vote on any amendment to the Existing Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Existing Certificate of Incorporation or pursuant to the DGCL.

(2) Series A Preferred Stock. Each holder of Series A Preferred Stock is entitled to one vote for each share of Class A Common Stock into which such share of Preferred Stock could be converted. Fractional votes are not permitted, and any fractional voting rights available on an as-converted to Class A Common Stock basis will be rounded to the nearest whole number (with one-half being rounded upward). Except as set forth in the Existing Certificate of Incorporation or as otherwise required by the DGCL or other applicable law which cannot be superseded by the provisions of the Existing Certificate of Incorporation, holders of Series A Preferred Stock are entitled to vote on all matters submitted to a vote of the stockholders, including the election of directors, as a single class with the holders of Class A Common Stock.

(ii) No Cumulative Voting. The Company has not provided for cumulative voting for the election of directors.

(iii) Composition of Board of Directors. There are agreements in place for the holders of voting stock of the Company to vote such stock to achieve a particular structure of the Company's Board of Directors. These agreements are set forth in Section C(2) of Article IV of the Existing Certificate of Incorporation and in Section 3.2 of the Existing Stockholder Agreement. These agreements remain in effect for so long as the total number of shares of Series A Preferred Stock that are issued and outstanding represent at least 10.0% (reduced, in connection with the authorization of the Series CF Non-Voting Preferred Stock, from 15.0%) of the capital stock of the Company calculated on a fully-diluted basis. The agreements pertaining to the structure of the Board of Directors are:

(1) The size of the Board is fixed at five (5) directors.

(2) The holders of the Company's Series A Preferred Stock, exclusively and as a separate class, are entitled to elect one director of the Company (the "Series A Director"), and to remove and fill vacancies in the Series A Director seat. The individual to serve as the Series A Director from time to time is designated and elected by the holders of a majority of the outstanding shares of Series A Preferred Stock (voting together separately as a single class).

(3) The holders of the Company's Class A Common Stock, exclusively and as a separate class, are entitled to elect three directors of the Company (the "Class A Common Directors"), and to remove and fill vacancies in the Class A Common Director seats. The Founder has the right to designate the individuals to serve in two of the Class A Common Director seats, and the holders of a majority of the outstanding shares of Class A Common Stock (voting together separately as a single class), have the right to designate the individual to serve in the third Class A Common Director seat.

(4) The holders of the shares of Class A Common Stock and of any other class or series of voting stock (including the Series A Preferred Stock), exclusively and voting together as a single class, are entitled to elect the balance of the total number of directors of the Company. Pursuant to the Existing Stockholder Agreement, the individual to serve as the fifth director is designated by agreement of the remaining directors.

(iv) Series A Voting Protective Provisions. As part of the Series A Preferred Stock financing, the Series A Investors were granted certain special voting rights, which give the holders of the Series A Preferred Stock the right to approve, as a separate class, the matters set forth below. These special voting rights are set forth in Section C(2)(a)(iii) of the Existing Certificate of Incorporation. These special voting rights grant the holders of the Series A Preferred Stock the ability to influence or block certain material decisions affecting the Company, including a future sale of the Company. These special voting rights remain in effect for so long as at

least 1,010,925 shares of Series A Preferred Stock remain outstanding (which is equivalent to approximately 50% of the shares of Series A Preferred Stock that are issued and outstanding as of the date of this Form C). Such share number takes into account and has been adjusted for the Stock Reclassification but is subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock. These special voting rights apply to:

(1) Any amendment, alteration or repeal of any provision of the Company's certificate of incorporation that adversely affects any of the rights, privileges, or preferences of the Series A Preferred Stock or any merger, consolidation or recapitalization that adversely affects any of the rights, privileges, or preferences of the Series A Preferred Stock;

(2) Any alteration or change relating to the preferences or privileges of the Series A Preferred Stock;

(3) Any Deemed Liquidation Event to which the Company or any subsidiary of the Company is a party (including any agreement by the Company or any subsidiary with respect to a Deemed Liquidation Event); and

(4) Any dissolution, liquidation or winding up of the Company, or any consent of the Company to any of the foregoing.

(v) Separate Class Votes Pursuant to the DGCL. The DGCL provides that the holders of a class or series of capital stock of a Delaware corporation have the right to vote separately as a single class in certain circumstances. Section 242(b)(2) of the DGCL could require the holders of any of the outstanding shares of the Class A Common Stock or Series A Preferred Stock to vote separately as a single class in the following circumstances:

(1) If the Company amended its certificate of incorporation to increase or decrease the aggregate number of authorized shares of such class, then the holders of the shares of that class would be required to vote separately to approve the proposed amendment.

(2) If the Company amended its certificate of incorporation to increase or decrease the par value of the shares of a class of stock, then the holders of the shares of that class would be required to vote separately to approve the proposed amendment.

(3) If the Company amended its certificate of incorporation in a manner that altered or changed the powers, preferences, or special rights of the shares of a class of stock so as to affect them adversely, then the holders of the shares of that class would be required to vote separately to approve the proposed amendment.

## C. Non-Voting Stock

(i) Limited Voting Rights of the Class B Non-Voting Common Stock. The Class B Non-Voting Common Stock is the Common Stock into which the shares of Series CF Non-Voting Preferred Stock issued in any one or more Series CF Crowdfunding Offerings are convertible, as further described Section VIII of this Part I of this Addendum. Pursuant to the Existing Certificate of Incorporation (see Section B(2)(b) of Article IV of the Existing Certificate of Incorporation), the voting rights of the holders of Class B Non-Voting Common Stock are limited to the following:

(1) The holders of Class B Non-Voting Common Stock have the right to vote as a separate class on a Liquidation Event, or any recapitalization or reorganization, in each case in which shares of Class B Non-Voting Common Stock would receive or be exchanged for consideration different on a per share basis from consideration received with respect to or in exchange for the shares of Class A Common Stock or would otherwise be treated differently from shares of Class A Common Stock in connection with such transaction, provided that, shares of Class B Non-Voting Common Stock may, without any consent or vote of the holders of Class B Non-Voting Common Stock, receive or be exchanged for non-voting Company Securities which are otherwise identical on a per share basis in amount and form to the voting Company Securities received with respect to or exchanged for the Class A Common Stock so long as all other consideration is identical to that received by the Class A Common Stock on a per share basis.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

(2) The holders of Class B Non-Voting Common Stock have such voting rights as may be required by the first sentence of Section 242(b)(2) of the DGCL or any similar provision hereafter enacted; provided that, as permitted by the provisions of Section 242(b)(2) of the DGCL, the Existing Certificate of Incorporation contains provisions to eliminate the right of the holders of shares of Class B Non-Voting Common Stock to vote separately as a single class if the number of authorized shares of the Class B Non-Voting Common Stock is increased or decreased.

(3) The holders of Class B Non-Voting Common Stock have such voting rights, if any, as may be required by the DGCL or other applicable law (to the extent not addressed in subparagraphs (1) or (2) above), and which cannot be superseded by the provisions of the Existing Certificate of Incorporation.

As to the limited voting rights described above, the holders of the Class B Non-Voting Common Stock are entitled to one vote for each share of Class B Non-Voting Common Stock held at all meetings of stockholders (and written actions in lieu of meetings).

(ii) Limited Voting Rights of the Series B Non-Voting Preferred Stock. Pursuant to the Existing Certificate of Incorporation (see Section C(2)(b) of Article IV of the Existing Certificate of Incorporation), the voting rights of the holders of Series B Non-Voting Preferred Stock are limited to the following:

(1) The holders of Series B Non-Voting Preferred Stock have such voting rights as are provided to the holders of the Series B Non-Voting Preferred Stock (consenting or voting together separately as a single class) pursuant to section C(4)(c)(vii) (No Adjustment of Series B Conversion Price) of Article IV of the Existing Certificate of Incorporation. Such Section C(4)(c)(vii) addresses waivers of the price-based antidilution protection for the Series B Non-Voting Preferred Stock, which waivers can be approved (on behalf of all holders of Series B Non-Voting Preferred Stock) by the holders of a majority of the then outstanding shares of Series B Non-Voting Preferred Stock (voting separately as a single class).

(2) The holders of Series B Non-Voting Preferred Stock have such voting rights as are provided to the holders of the A/B Preferred Stock, as defined above in Section I of this Part 1 of this Addendum (consenting or voting together as a single class and not as separate series) pursuant to section C(3)(d) (Deemed Liquidation Event) and section C(4)(b)(i) (Automatic Conversion) of Article IV of the Existing Certificate of Incorporation. Such Section C(3)(d) permits the Requisite A/B Preferred Holders (as defined above in this Part I of this Addendum) to agree with the Company that an event otherwise qualifying as a Deemed Liquidation Event will not be treated as a Deemed Liquidation Event, thereby resulting in a waiver of the negotiated liquidation preferences contained in the Existing Certificate of Incorporation for all of the Preferred Stock (which includes not only the Company's Series A Preferred Stock and Series B Non-Voting Preferred Stock, but also the Company's Series CF Non-Voting Preferred Stock - which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings). Such Section C(4)(b)(i) entitles the Requisite A/B Preferred Holders to approve and effect the automatic conversion of all outstanding shares of all of the Preferred Stock (which includes not only the Company's Series A Preferred Stock and Series B Non-Voting Preferred Stock, but also the Company's Series CF Non-Voting Preferred Stock - which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings) into shares of Common Stock (Class A Common Stock in the event of conversion of shares of Series A Preferred Stock and Class B Non-Voting Common Stock in the event of conversion of shares of Series B Non-Voting Preferred Stock or Series CF Non-Voting Preferred Stock), based on the then-effective conversion rate (and such shares of Preferred Stock may not be reissued by the Company) at any time.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

(3) The holders of Series B Non-Voting Preferred Stock have such voting rights as may be required by the first sentence of Section 242(b)(2) of the DGCL or any similar provision hereafter enacted; provided that, as permitted by the provisions of Section 242(b)(2) of the DGCL, the Existing Certificate of Incorporation contains provisions to eliminate the right of the holders of shares of Series B Non-Voting Preferred Stock to vote separately as a single class if the number of authorized shares of the Series B Non-Voting Preferred Stock is increased or decreased.

(4) The holders of Series B Non-Voting Preferred Stock have such voting rights, if any, as may be required by the DGCL or other applicable law (to the extent not addressed in subparagraphs (1), (2) or (3) above), and which cannot be superseded by the provisions of the Existing Certificate of Incorporation.

As to the limited voting rights described above, other than the voting rights described above in subparagraph (2), the holders of the Series B Non-Voting Preferred are entitled to one vote for each share of Series B Non-Voting Preferred held at all meetings of stockholders (and written actions in lieu of meetings). As to the limited voting rights described above in subparagraph (2), each holder of Series B Non-Voting Preferred Stock is entitled to one vote for each share of Class B Non-Voting Common Stock into which such share of Preferred Stock could be converted. Fractional votes are not permitted, and any fractional voting rights available on an as-converted to Class B Non-Voting Common Stock basis will be rounded to the nearest whole number (with one-half being rounded upward).

(iii) Limited Voting Rights of the Series CF Non-Voting Preferred Stock. The Series CF Non-Voting Preferred Stock is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings. Pursuant to the Existing Certificate of Incorporation (see Section C(2)(c) of Article IV of the Existing Certificate of Incorporation), the voting rights of the holders of Series CF Non-Voting Preferred Stock are limited to the following:

(1) The holders of Series CF Non-Voting Preferred Stock have such voting rights as are provided to the holders of the Series CF Non-Voting Preferred Stock (consenting or voting together separately as a single class) pursuant to section C(4)(c)(viii) (No Adjustment of Series CF Conversion Price) of Article IV of the Existing Certificate of Incorporation. Such Section C(4)(c)(viii) addresses waivers of the price-based antidilution protection for the Series CF Non-Voting Preferred Stock, which waivers can be approved (on behalf of all holders of Series CF Non-Voting Preferred Stock) by the holders of a majority of the then outstanding shares of Series CF Non-Voting Preferred Stock (voting separately as a single class).

(2) The holders of Series CF Non-Voting Preferred Stock have such voting rights as may be required by the first sentence of Section 242(b)(2) of the DGCL or any similar provision hereafter enacted; provided that, as permitted by the provisions of Section 242(b)(2) of the DGCL, the Existing Certificate of Incorporation contains provisions to eliminate the right of the holders of shares of Series CF Non-Voting Preferred Stock to vote separately as a single class if the number of authorized shares of the Series CF Non-Voting Preferred Stock is increased or decreased.

(3) The holders of Series CF Non-Voting Preferred Stock have such voting rights, if any, as may be required by the DGCL or other applicable law (to the extent not addressed in subparagraphs (1) or (2) above), and which cannot be superseded by the provisions of the Existing Certificate of Incorporation.

As to the limited voting rights described above, the holders of the Series CF Non-Voting Preferred are entitled to one vote for each share of Series CF Non-Voting Preferred held at all meetings of stockholders (and written actions in lieu of meetings).

(iv) Separate Class Votes Pursuant to the DGCL. The DGCL provides that the holders of a class or series of capital stock of a Delaware corporation have the right to vote separately as a single class in certain circumstances:

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025
13

Section 242(b)(2) of the DGCL could require the holders of any of the outstanding shares of the Class B Non-Voting Common Stock, Series B Non-Voting Preferred Stock or Series CF Non-Voting Preferred Stock to vote separately as a single class in the following circumstances:

(1) If the Company amended its certificate of incorporation to increase or decrease the par value of the shares of a class of stock, then the holders of the shares of that class would be required to vote separately to approve the proposed amendment.

(2) If the Company amended its certificate of incorporation in a manner that altered or changed the powers, preferences, or special rights of the shares of a class of stock so as to affect them adversely, then the holders of the shares of that class would be required to vote separately to approve the proposed amendment.

As permitted by Section 242(b)(2) of the DGCL and as set forth in the Existing Certificate of Incorporation:

(1) The holders of shares of Class B Non-Voting Common Stock do not have the right to vote separately as a single class if the number of authorized shares of the Class B Non-Voting Common Stock is increased or decreased. Rather, the number of authorized shares of Class B Non-Voting Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by resolution adopted by the Company's Board of Directors and approved by the written consent or affirmative vote of the holders of a majority of the voting power of all outstanding shares of Class A Common Stock of the Company and all other outstanding shares of stock of the Company entitled to vote thereon.

(2) The holders of shares of Series B Non-Voting Preferred Stock do not have the right to vote separately as a single class if the number of authorized shares of the Series B Non-Voting Preferred Stock is increased or decreased. Rather, the number of authorized shares of Series B Non-Voting Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by resolution adopted by the Company's Board of Directors and approved by the written consent or affirmative vote of the holders of a majority of the voting power of all outstanding shares of Class A Common Stock of the Company and all other outstanding shares of stock of the Company entitled to vote thereon.

(3) The holders of shares of Series CF Non-Voting Preferred Stock do not have the right to vote separately as a single class if the number of authorized shares of the Series CF Non-Voting Preferred Stock is increased or decreased. Rather, the number of authorized shares of Series CF Non-Voting Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by resolution adopted by the Company's Board of Directors and approved by the written consent or affirmative vote of the holders of a majority of the voting power of all outstanding shares of Class A Common Stock of the Company and all other outstanding shares of stock of the Company entitled to vote thereon.

V. NO PRE-EMPTIVE RIGHTS OR SIMILAR RIGHTS

The Company's stockholders do not have pre-emptive rights or similar rights, which will cause them to experience dilution if the Company issues additional securities. For the holders of the Company's Preferred Stock, the magnitude of the dilution will depend upon whether the price-based anti-dilution for the Preferred Stock is triggered. See also the "Dilution" section of this Form C.

VI. DIVIDENDS AND DIVIDEND POLICY

A. Common Stock - Subject to and qualified by the rights, powers and preferences of the holders of the Preferred Stock, the holders of the Class A Common Stock and Class B Non-Voting Common Stock will be entitled to share equally, on a per share basis, in any dividends that the Company's Board of Directors may determine to issue from time to time; provided that (i) in the case of dividends or distributions payable in shares of Common Stock, or options, warrants or rights to acquire shares of such Common Stock, or securities convertible into or exchangeable for shares of such Common Stock, the shares, options, warrants, rights or securities so payable shall be payable in shares of, or options, warrants or rights to acquire, or securities convertible into or exchangeable for, Common Stock of the same class upon which the dividend or distribution is being paid and (ii) if such dividends or distributions consist of other voting securities of the Company, the Company shall make available to each holder of Class B Non-Voting Common Stock dividends

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

or distributions consisting of non-voting securities of the Company which are otherwise identical to the voting securities.

## B. Preferred Stock

### (i) Special Revenue Share Dividend, Reclamation Line of Business - Series CF Non-Voting Preferred Shares

Pursuant to the Existing Certificate of Incorporation (see Section C(1)(a) of Article IV of the Existing Certificate of Incorporation), a special dividend entitlement applies to issued shares of the Series CF Non-Voting Preferred Stock (whether issued in the Series CF Crowdfunding Offering #1, this Series CF Crowdfunding Offering #2, or any other Series CF Crowdfunding Offering) and no other shares or securities of the Company. The rights and terms of this special dividend (hereinafter referred to as the "Series CF Preferred Special Dividend(s)") are summarized in the separate Addendum 3 to this Exhibit A of this Form C.

### (ii) Other Dividends

(See Section C(1)(b) of Article IV of the Existing Certificate of Incorporation.) As used herein, "Other Dividends" means dividends or other distributions on shares of any class or series of capital stock of the Company, other than, if and as applicable, (A) dividends on shares of Common Stock payable in shares of Common Stock and (B) the Series CF Preferred Special Dividends. Other Dividends will be paid on the shares of the Series CF Non-Voting Preferred Stock, the shares of the Series B Non-Voting Preferred Stock, and the shares of the Series A Preferred Stock on an as-converted basis when, as, and if paid on the Common Stock of the Company. Other Dividends are payable only when, as and if declared by the Company's Board of Directors. All Other Dividends declared, paid or set aside on the shares of the Preferred Stock (which includes the Series CF Non-Voting Preferred Stock, the Series B Non-Voting Preferred Stock, and the Series A Preferred Stock) shall be declared, paid or set aside among such shares of Preferred Stock on a pari passu basis. If any Other Dividends to be declared, paid or set aside on shares of the Series CF Non-Voting Preferred Stock or the Series B Non-Voting Preferred Stock consist of voting Company Securities, the Company shall make available to each holder of Series CF Non-Voting Preferred Stock and/or Series B Non-Voting Preferred Stock, as applicable, dividends consisting of non-voting Company Securities which are otherwise identical to the voting Company Securities.

**Additional Provision Related to the Series CF Preferred Special Dividends.** Further, until all Accrued Reclamation Dividends are paid in full or any earlier termination of the Reclamation Dividend rights in accordance with Section C (1)(a) of Article IV of the Existing Certificate of Incorporation (as summarized in the separate Addendum 3 to this Exhibit A of this Form C), (x) no Other Dividends will be declared, paid or set aside during any period that Dividend Restrictions with respect to Accrued Reclamation Dividends exist and (y) Reclamation Revenues shall not be a source of revenues/income for Other Dividends. The terms "Accrued Reclamations Dividends," "Reclamation Dividends," and "Dividend Restrictions," have the meanings given to such terms in such Addendum 3.

## C. Dividend Policy

Historically, the Company has never declared or paid any dividends on its capital stock. With the exception of Series CF Preferred Special Dividends referred to above in subsection VI(B)(i) of this Part I of this Addendum and further described in the separate Addendum 3 to this Exhibit A of this Form C (it being noted that Series CF Preferred Special Dividends are not guaranteed and the calculation, declaration and payment of Series CF Preferred Special Dividends is subject to the terms and provisions of the Existing Certificate of Incorporation, as summarized in such Addendum 3): (i) the Company does not currently intend to declare or pay any dividends on any of its capital stock; (ii) for the foreseeable future, the Company intends to retain excess future earnings, if any, to support development and growth of its business; and (iii) any future determination to declare and pay dividends will be at the discretion of the Company's Board of Directors and will be dependent on the Company's financial condition, results of operations, cash requirements, plans for expansion, legal limitations, contractual restrictions and other factors deemed relevant by the Company's Board of Directors.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

# VII. LIQUIDATION RIGHTS / LIQUIDATION WATERFALL FOR A LIQUIDATION EVENT

Refer to Section I of this Part 1 of this Addendum for the definitions of "Liquidation Event" and "Deemed Liquidation Event."

It is noted that the Requisite A/B Preferred Holders (as defined in Section I of this Part I of this Addendum) are the only stockholders of the Company with the right to determine whether an asset sale, sale by merger, or other event described in the definition of "Deemed Liquidation Event" will or will not be treated as a "Deemed Liquidation Event" and "Liquidation Event" for purposes of the Existing Certificate of Incorporation, including triggering application of the liquidation waterfall below. Neither the holders of the Series CF Non-Voting Preferred Stock (which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings) nor any holders of the Company's Common Stock are entitled to participate in such determination. The Class B Non-Voting Common Stock is the security into which the Series CF Non-Voting Preferred Stock is convertible as described in Section VIII of Part I of this Addendum.

A. Common Stock - Subject to and qualified by the rights, powers and preferences of the holders of the Preferred Stock, in the event of any Liquidation Event, the holders of Class A Common Stock and Class B Non-Voting Common Stock shall be entitled to share equally, on a per share basis, all assets of the Company of whatever kind available for distribution to the holders of Common Stock.

B. Preferred Stock - In the event of any Liquidation Event, the proceeds available for distribution to the Company's stockholders (the "Available Proceeds") shall be paid as follows:

First, pay unpaid Accrued Reclamation Dividends (as defined in the separate Addendum 3 to this Exhibit A of this Form C), if and the extent this first tier of the liquidation waterfall applies. This first tier of the liquidation waterfall applies if a Liquidation Event occurs and there are unpaid Accrued Reclamation Dividends (as defined in such Addendum 3) outstanding immediately prior to such Liquidation Event, including with respect to any final Reclamation Dividends Period as determined pursuant to (and defined in) Section C(1)(a)(ii)(F)(II) of the Existing Certificate of Incorporation (as summarized in Section II(F)(II) of such Addendum 3) (collectively, the "Specified Dividends" and the holders entitled to payment of the Specified Dividends at such time, each an "Applicable Holder" and collectively, the "Applicable Holders"). In such case, the Applicable Holders shall be entitled to first payment of the Specified Dividends from the Available Proceeds. If upon any such Liquidation Event the Available Proceeds shall be insufficient to pay the Applicable Holders the full amount of the Specified Dividends: (x) the Specified Dividends will be sub-divided by each applicable Reclamation Dividends Period (as defined in the separate Addendum 3 to this Exhibit A of this Form C) relating to the Specified Dividends; (y) as between or among the applicable Reclamation Dividends Period(s), priority is based on chronological order of such Reclamation Dividends Period(s) with the first/earliest Reclamation Dividends Period having the highest priority; and (z) for any amounts paid under this first tier as to a particular Reclamation Dividends Period, such amounts will be shared ratably among the Applicable Holders entitled to the Specified Dividends with respect to that particular Reclamation Dividends Period.

Second, pay 1.0 times the Series B Original Issue Price (as defined below) plus all declared but unpaid Other Dividends, as defined above in subsection VI(B)(ii) of this Part I of this Addendum (if any) on each share of Series B Non-Voting Preferred Stock. If upon any such Liquidation Event, the Available Proceeds shall be insufficient to pay the holders of shares of Series B Non-Voting Preferred Stock the full amount to which they shall be entitled under this tier, the holders of shares of Series B Non-Voting Preferred Stock shall share ratably in any distribution of Available Proceeds in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

Third, pay 1.0 times the Series A Original Issue Price (as defined below) plus all declared but unpaid Other Dividends, as defined above in subsection VI(B)(ii) of this Part I of this

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

Addendum (if any) on each share of Series A Preferred Stock. If upon any such Liquidation Event, the Available Proceeds shall be insufficient to pay the holders of shares of Series A Preferred Stock the full amount to which they shall be entitled under this tier, the holders of shares of Series A Preferred Stock shall share ratably in any distribution of Available Proceeds in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

Fourth, pay 1.0 times the Series CF Original Issue Price (as defined below) plus all declared but unpaid Other Dividends, as defined above in subsection VI(B)(ii) of this Part I of this Addendum (if any) on each share of Series CF Non-Voting Preferred Stock. If upon any such Liquidation Event, the Available Proceeds shall be insufficient to pay the holders of shares of Series CF Non-Voting Preferred Stock the full amount to which they shall be entitled under this tier, the holders of shares of Series CF Non-Voting Preferred Stock shall share ratably in any distribution of Available Proceeds in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full.

Fifth, the balance of any proceeds shall be distributed exclusively the holders of Common Stock on a pro rata basis.

The "Series B Original Issue Price" means the original purchase price per share of the Series B Non-Voting Preferred Stock, which is $1.25 per share, subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series B Non-Voting Preferred Stock.

The "Series A Original Issue Price" means the original purchase price per share of the Series A Preferred Stock, which is currently $0.749512 per share (after adjustment for the Stock Reclassification), subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series A Preferred Stock.

The "Series CF Original Issue Price" means the original purchase price per share of the Series CF Non-Voting Preferred Stock, which is $2.50 per share, subject to appropriate adjustment in the event of any future stock dividend, stock split, combination or other similar recapitalization with respect to the Series CF Non-Voting Preferred Stock.

SPECIAL DEEMED CONVERSION PROVISION - Deemed conversion of Preferred Stock to Common Stock if a deemed conversion increases the liquidation preference amount payable upon a Liquidation Event pursuant to the second, third and/or fourth tier of the liquidation waterfall described above. Notwithstanding the foregoing liquidation preferences and liquidation waterfall, for purposes of determining the amount each holder of shares of Preferred Stock is entitled to receive with respect to a Liquidation Event pursuant to the second, third and/or fourth tier of the liquidation waterfall described above, as applicable, each such holder of shares of Preferred Stock shall be deemed to have converted (regardless of whether such holder actually converted) such holder's shares of Preferred Stock into shares of Common Stock (Class A Common Stock in the event of conversion of shares of Series A Preferred Stock and Class B Non-Voting Common Stock in the event of conversion of shares of Series B Non-Voting Preferred Stock or shares of Series CF Non-Voting Preferred Stock, as applicable) immediately prior to such Liquidation Event if, as a result of an actual conversion, such holder would receive, in the aggregate, an amount greater than the amount that would be distributed to such holder pursuant to the second, third and/or fourth tier of the liquidation waterfall described above, as applicable, if such holder did not convert such shares of Preferred Stock into shares of Common Stock. If any such holder shall be deemed to have converted shares of Preferred Stock into Common Stock pursuant to these deemed conversion provisions, then such holder shall not be entitled to receive any distribution pursuant to the second, third and/or fourth tier of the liquidation waterfall described above, as applicable, that would otherwise be made to holders of Preferred Stock that have not converted (or been deemed to have converted) into shares of Common Stock. A deemed conversion does not affect the first tier

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025
17

of the liquidation waterfall or the payment of any Specified Dividends to the relevant Applicable Holders pursuant to such first tier of the liquidation waterfall.

**NON-PARTICIPATING LIQUIDATION PREFERENCES.** The liquidation preferences of the Preferred Stock are "non-participating." This means that each holder of Preferred Stock will receive either (1) the applicable Preferred Stock liquidation preference described in the second, third and fourth tiers of the liquidation waterfall described above, or (2) such holder's pro rata share of the proceeds on an as-converted to Common Stock basis, whichever is greater; but not both.

## VIII. CONVERSION

A. Common Stock - Shares of the Company's Class A Common Stock and Class B Non-Voting Common Stock are not convertible into any other shares of the Company's capital stock.

B. Preferred Stock.

(i) Voluntary Conversion (Optional Conversion). (See Section C(4)(a) of Article IV of the Existing Certificate of Incorporation.) Each share of Preferred Stock is convertible at the option of the holder, at any time after the date of issuance of such share, into shares of Common Stock (Class A Common Stock in the event of conversion of shares of Series A Preferred Stock and Class B Non-Voting Common Stock in the event of conversion of shares of Series B Non-Voting Preferred Stock or Series CF Non-Voting Preferred Stock), as is determined by dividing the original issue price of the Preferred Stock by the conversion price in effect at the time of conversion for such Preferred Stock, subject to adjustments for stock dividends, splits, combinations and similar events as provided in the Existing Certificate of Incorporation. As of the date of this Form C, the conversion price for each of the Series CF Non-Voting Preferred Stock, the Series B Non-Voting Preferred Stock and the Series A Preferred Stock is equal to the original issue price of each such series of Preferred Stock, resulting in a conversion rate of 1:1.

**Additional Provision Related to the Series CF Preferred Special Dividends.** A voluntary conversion (optional conversion) of the Series CF Non-Voting Preferred Stock does not accelerate rights or obligations associated with, or grant any priority with respect to the payment of, unpaid Accrued Reclamation Dividends (as defined in the separate Addendum 3 to this Exhibit A of this Form C) to which a holder remains entitled at time of the conversion. The relevant unpaid Accrued Reclamation Dividends remain payable only at the times and in the amounts as originally payable in accordance with the applicable provisions of Section C(1)(a) of Article IV of the Existing Certificate of Incorporation (as summarized in such Addendum 3) prior to the time of conversion.

(ii) Automatic Conversion. (See Section C(4)(b) of Article IV of the Existing Certificate of Incorporation.) Each share of Preferred Stock shall automatically be converted into shares of Common Stock (Class A Common Stock in the event of conversion of shares of Series A Preferred Stock and Class B Non-Voting Common Stock in the event of conversion of shares of Series B Non-Voting Preferred Stock or Series CF Non-Voting Preferred Stock), based on the then-effective conversion rate (and such shares of Preferred Stock may not be reissued by the Company) at any time upon the earlier of (a) the written consent or affirmative vote of the Requisite A/B Preferred Holders (as defined in Section I of this Part I of this Addendum), or (b) immediately upon the closing of a public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale of Common Stock for the account of the Company in which (1) the per share price is at least $3.50 (as adjusted for stock splits, dividends, recapitalizations after 25 October, 2022 (the date the Existing Certificate of Incorporation was filed with the Delaware Secretary of State); such $3.50 per share price already takes into account and has been adjusted for the Stock Reclassification), and (2) the gross cash proceeds to the Company (before underwriting discounts, commissions and fees) are at least $25,000,000.

It is noted that, as to any automatic conversion of all of the Preferred Stock (including the Series CF Non-Voting Preferred Stock, which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings) to occur by vote or consent of Company stockholders, the Requisite A/B Preferred Holders (as defined in Section I of this Part I of this Addendum) are the only stockholders of the Company with the right to elect an automatic conversion. The holders of the Series CF Non-Voting Preferred (which is the security reserved for offer, sale and/or issuance, as the case may be, in the Series CF Crowdfunding Offerings) are not entitled to participate in such election.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

Additional Provision Related to the Series CF Preferred Special Dividends. Any unpaid Accrued Reclamation Dividends (as defined in the separate Addendum 3 to this Exhibit A of this Form C) outstanding immediately prior to an automatic conversion of the Preferred Stock, including with respect to any final Reclamation Dividends Period for the automatic conversion as determined pursuant to Section C(1)(a)(ii)(F)(II) of Article of Article IV of the Existing Certificate of Incorporation (as summarized in Section II(F) of such Addendum 3), shall be paid in cash to the holders entitled thereto by the Company as soon as practicable after the effectiveness of the automatic conversion.

## IX. PRICE-BASED ANTI-DILUTION PROTECTION

A. Common Stock - The Common Stock does not have price-based anti-dilution protection.

B. Preferred Stock

Each of the Series A Preferred Stock, the Series B Non-Voting Preferred Stock and the Series CF Non-Voting Preferred Stock will receive broad-based weighted average anti-dilution protection if the Company issues (or is deemed to issue) Common Stock, Options (as defined below) or Convertible Securities (as defined below) after 25 October, 2022 (the date the Existing Certificate of Incorporation was filed with the Delaware Secretary of State) and for consideration less than the original issue price for the Series A Preferred Stock, the Series B Non-Voting Preferred Stock or the Series CF Non-Voting Preferred Stock, respectively. If the anti-dilution protection for the Series A Preferred Stock, the Series B Non-Voting Preferred Stock and/or the Series CF Non-Voting Preferred Stock, as the case may be, is triggered, the applicable conversion price then in effect will be subject to a broad-based weighted-average adjustment to reduce dilution. (See Section C(4)(c) of the Existing Certificate of Incorporation.)

As used herein: (i) "Convertible Securities" means any evidences of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options; and (ii) "Option" means rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.

Price-based anti-dilution adjustments are not applicable to issuances or deemed issuances of "Exempted Securities," as defined in Section C(4)(c)(i) of Article IV of the Existing Certificate of Incorporation, which include:

1) shares of Common Stock, Options or Convertible Securities issued as a dividend or distribution on any shares of Preferred Stock or concurrently with or in connection with the issuance of any shares of Preferred Stock;

2) shares of Common Stock, Options or Convertible Securities issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock that is covered by Sections C(4)(d) (Adjustment for Stock Splits and Combinations), C(4)(e) (Adjustment for Certain Dividends and Distributions), C(4)(f) (Adjustment for Other Dividends and Distributions) or C(4)(g) (Adjustment for Merger or Reorganization, etc.) of Article IV of the Existing Certificate of Incorporation;

3) shares of Common Stock, Options or Convertible Securities issued to employees or directors of, or consultants or advisors to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Company's Board of Directors;

4) shares of Common Stock actually issued upon the exercise of warrants that were outstanding as of 25 October, 2022, the date the Existing Certificate of Incorporation was filed with the Delaware Secretary of State;

5) shares of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of Common Stock actually issued upon the conversion or exchange of Convertible Securities (including Preferred Stock), in each case provided such issuance is pursuant to the terms of such Option or Convertible Security; or

6) shares of Common Stock, Options or Convertible Securities issued (a) pursuant to the acquisition of another corporation by the Company by merger, consolidation, purchase of substantially all of the assets or similar business combination, (b) in connection with sponsored research, collaboration, technology

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025
19

license, development, OEM, marketing or other similar agreements or strategic partnerships approved by the Company's Board of Directors or (c) to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Company's Board of Directors.

## X. NO REDEMPTION RIGHTS

There are no redemption or sinking fund provisions applicable to (1) the shares of Series CF Non-Voting Preferred Stock that are offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, (2) the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described in Section VIII of this Part I of this Addendum, or (3) any other securities of the Company.

## XI. NO REGISTRATION RIGHTS

None of the stockholders of the Company have registration rights with respect to any securities of the Company, and the Series CF Crowdfunding Offering Investors will not acquire any such rights as part of any Series CF Crowdfunding Offering.

The Company's securities, including the shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, and the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described Section VIII of this Part I of this Addendum, have not been, nor will be, registered under the Securities Act of 1933, as amended, or under any state securities laws, and the Company is under no obligation to register any of its securities.

## XII. INFORMATION AND INSPECTION RIGHTS

A. Common Stock - The holders of the Company's Common Stock do not have information or inspection rights beyond what is provided to stockholders under the DGCL and subject to information provided pursuant to the financial reporting requirements of Regulation Crowdfunding, so long as the Company is and remains subject to such requirements.

B. Series A Preferred Stock - The holders of the Company's Series A Preferred Stock have expanded information and inspection rights as provided in Section 6 of the Stockholder Agreement.

C. Series B Non-Voting Preferred Stock - The holders of the Company's Series B Non-Voting Preferred Stock have expanded information and inspection rights as provided in Section 7 of the Stockholder Agreement.

D. Series CF Non-Voting Preferred Stock - The holders of the Company's Series CF Non-Voting Preferred Stock do not have information or inspection rights beyond what is provided to stockholders under the DGCL and subject to information provided pursuant to the financial reporting requirements of Regulation Crowdfunding, so long as the Company is and remains subject to such requirements.

See also Part III of this Addendum ("Stockholder Agreement"; pp. 23-30 of this Addendum).

## XIII. WAIVER OF THE PREFERRED STOCK RIGHTS AND PREFERENCES SET FORTH IN THE EXISTING CERTIFICATE OF INCORPORATION - MAJORITY VOTE EFFECTS WAIVER

(See Section C(5) of Article IV of the Existing Certificate of Incorporation.)

### A. Series A Preferred Stock

Any of the rights, powers, privileges, preferences and other terms of the Series A Preferred Stock set forth in the Existing Certificate of Incorporation (whether applicable to the Series A Preferred Stock as a separate series or as part of the Preferred Stock as a single class) may be waived on behalf of all holders of Series A Preferred Stock by the affirmative written consent or vote of the holders of a majority of the shares of Series A Preferred Stock then outstanding (voting together separately as a single class, and on an as-converted basis).

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

## B. Series B Non-Voting Preferred Stock

Any of the rights, powers, privileges, preferences and other terms of the Series B Non-Voting Preferred Stock set forth in the Existing Certificate of Incorporation (whether applicable to the Series B Non-Voting Preferred Stock as a separate series or as part of either the A/B Preferred Stock as a single class or the Preferred Stock as a single class, if and to the extent otherwise applicable) may be waived on behalf of all holders of Series B Non-Voting Preferred Stock by the affirmative written consent or vote of the holders of a majority of the shares of Series B Non-Voting Preferred Stock then outstanding (voting together separately as a single class, and, where applicable, on an as-converted basis). For clarity, this waiver provision does not expand the voting rights of the holders of Series B Non-Voting Preferred Stock, which voting rights are limited as provided in Section C(2)(b) of Article IV of the Existing Certificate of Incorporation.

## C. Series A/B Preferred Stock

Any of the rights, powers, privileges, preferences and other terms of the A/B Preferred Stock set forth in the Existing Certificate of Incorporation may be waived on behalf of all holders of A/B Preferred Stock by the affirmative written consent or vote of the holders of a majority of the shares of A/B Preferred Stock then outstanding (voting together separately as a single class, and, where applicable, on an as-converted basis) (provided that, for so long as any shares of Series A Preferred remain outstanding, such majority of the outstanding shares of A/B Preferred Stock shall include the holders of at least 20% of the outstanding shares of Series A Preferred). For clarity, this waiver provision does not expand the voting rights of the holders of Series B Non-Voting Preferred Stock, which voting rights are limited as provided in Section C(2)(b) of Article IV of the Existing Certificate of Incorporation.

## D. Series CF Non-Voting Preferred Stock

Any of the rights, powers, privileges, preferences and other terms of the Series CF Non-Voting Preferred Stock set forth in the Existing Certificate of Incorporation (whether applicable to the Series CF Non-Voting Preferred Stock as a separate series or as part of the Preferred Stock as a single class) may be waived on behalf of all holders of Series CF Non-Voting Preferred Stock by the affirmative written consent or vote of the holders of a majority of the shares of Series CF Non-Voting Preferred Stock then outstanding (voting together separately as a single class, and, where applicable, on an as-converted basis). For clarity, this waiver provision does not expand the voting rights of the holders of Series CF Non-Voting Preferred Stock, which voting rights are limited as provided in Section C(2)(b) of Article IV of the Existing Certificate of Incorporation.

## XIV. TRANSFER AGENT AND REGISTRAR

Prior to the May 2020 launch of the Initial Crowdfunding Offering, the Company acted as its own transfer agent and registrar. In connection with such launch of the Initial Crowdfunding Offering, the Company retained, and continues to retain as of the date of this Form C, the services of Colonial Stock Transfer Company, Inc. to act as the Company's transfer agent and registrar for the Company's capital stock, including the shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, and the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described Section VIII of this Part I of this Addendum. Colonial Stock Transfer Company, Inc. is registered as a transfer agent with the U.S. Securities and Exchange Commission.

## XV. RESTRICTIONS ON TRANSFERABILITY

The shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described Section VIII of this Part I of this Addendum, and all other securities of the Company, are subject to substantial legal and contractual restrictions on transfer, including restrictions on resale. For additional information on the transfer restrictions applicable to the Company's securities, including the shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, and the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described Section VIII of this Part I of this Addendum, see the risk factors contained in this Form C and next Parts II ("Transfer Restrictions"; p. 22 of this Addendum) and III ("Stockholder Agreement"; pp. 23-30 of this Addendum).

# PART II - TRANSFER RESTRICTIONS

For purposes of this Part II, (i) the term "Applicable Crowdfunding Securities" means, collectively, the shares of Series CF Non-Voting Preferred Stock that are offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings and the shares of the Class B Non-Voting Common Stock issuable upon conversion of such shares of Series CF Non-Voting Preferred Stock as described in Section VIII of Part I of this Addendum, and (ii) other capitalized terms used but not defined in this Part II have the meanings given to such terms on p. 1 of this Addendum or in Part I, Section I of this Addendum ("Description of Capital Stock; Certain Definitions"; pp. 1-5 of this Addendum).

## Restrictions under Securities Laws

The Applicable Crowdfunding Securities are offered and sold without registration under the Securities Act of 1933, as amended (the "Securities Act"), by reason of the exemption from the registration requirements of the Securities Act set forth in Section 4(a)(6) thereof and Regulation Crowdfunding ("Regulation CF") promulgated thereunder, and exemptions from registration or qualification under the securities laws of the states or other jurisdictions in which such Applicable Crowdfunding Securities may be offered or sold. We are under no obligation to register any of the Applicable Crowdfunding Securities, now or in the future. Because the Applicable Crowdfunding Securities have not been registered under the Securities Act or under the securities laws of any state or non-United States jurisdiction, the Applicable Crowdfunding Securities have transfer restrictions under applicable securities laws and cannot be resold in the United States except pursuant to (i) exemptions provided by Rule 501 of Regulation Crowdfunding (U.S. federal securities law exemption) and (ii) applicable securities or "blue sky" laws in the state of residence of the seller or in the state or other jurisdiction where sales/transfers are being effected.

As to Regulation CF, any Applicable Crowdfunding Securities sold pursuant to Regulation CF may not be transferred by any purchaser of such Applicable Crowdfunding Securities during the one-year holding period beginning when the Applicable Crowdfunding Securities were issued, unless such Applicable Crowdfunding Securities were transferred: 1) to the Company, 2) to an accredited investor, as defined by Rule 501(d) of Regulation D of the Securities Act, 3) as part of an offering registered with the U.S. Securities and Exchange Commission or 4) to a member of the family of the purchaser or the equivalent, to a trust controlled by the purchaser, to a trust created for the benefit of a family member of the purchaser or the equivalent, or in connection with the death or divorce of the purchaser or other similar circumstances. "Member of the family" as used herein means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse or spousal equivalent, sibling, mother/father/daughter/son/sister/brother-in-law, and includes adoptive relationships.

Remember that although you may legally be able to transfer the Applicable Crowdfunding Securities under applicable securities laws, the Applicable Crowdfunding Securities will remain subject to the contractual restrictions on transfer discussed below. Limitations on the transfer of the Applicable Crowdfunding Securities may adversely affect your ability to find another party willing to purchase them and the price that you might be able to obtain for the Applicable Crowdfunding Securities in a private sale.

## Certificate of Incorporation

The Applicable Crowdfunding Securities will be held by the purchaser thereof subject to all of the provisions of the Existing Certificate of Incorporation, and any amendments or supplements thereof, or restatements thereof, and will bear a restrictive legend to that effect. A copy of the Existing Certificate of Incorporation is attached as Exhibit F to this Form C.

## Bylaws

The Applicable Crowdfunding Securities will be held by the purchaser thereof subject to all of the provisions of the Existing Bylaws, and any amendments or supplements thereof, or restatements thereof, and will bear a restrictive legend to that effect. A copy of the Existing Bylaws are available to prospective investors in any applicable Series CF Crowdfunding Offering upon request to the Company.

## Stockholder Agreement

The Applicable Crowdfunding Securities will be held by the purchaser thereof subject to all of the provisions of the Existing Stockholder Agreement, and any amendments or supplements thereof, or restatements thereof, and will bear a restrictive legend to that effect. The sale, pledge, hypothecation or transfer of the securities of the Company, including the Applicable Crowdfunding Securities, is subject to, and in certain cases prohibited by, the terms and conditions of such stockholder agreement. A copy of the Existing Stockholder Agreement is attached as Exhibit G to the Form C. See Part III of this Addendum ("Stockholder Agreement"; pp. 23-30 of this Addendum).

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

# PART III - STOCKHOLDER AGREEMENT

The following is a summary of certain provisions of the Existing Stockholder Agreement, as in effect on the date of this Form C and as it is expected to be in effect at the completion of this Series CF Crowdfunding Offering #2 (provided, however, that nothing in this Form C prevents or limits the Company, with any requisite Board of Director and stockholder approvals, from amending, restating, supplementing or otherwise modifying the Existing Stockholder Agreement in accordance with its terms after the date of this Form C). This summary does not purport to be complete and is qualified in its entirety by the provisions of the Existing Stockholder Agreement, a copy of which is attached as Exhibit G to the Form C, and to the applicable provisions of Delaware law.

Capitalized terms used but not defined in this Part II have the meanings given to such terms on p. 1 of this Addendum or in Part I, Section I of this Addendum ("Description of Capital Stock; Certain Definitions"; pp. 1-5 of this Addendum).

All of the Company's existing stockholders and holders of outstanding warrants are parties to the Existing Stockholder Agreement. As a condition to the issuance of any shares of Series CF Non-Voting Preferred Stock in any Series CF Crowdfunding Offering, each prospective Series CF Crowdfunding Offering Investor is required to become a party to and be bound by the Existing Stockholder Agreement.

**Note - Current categories of stockholders for purposes of the Existing Stockholder Agreement:** There are currently three categories of stockholders in the Stockholder Agreement. The first category is the Company's founder, IX Power LLC. The second category is a group of stockholders defined as the "Investors"; this group includes, currently, the Seed Round Investors, the Series A Investors and the Series B Investors but does not include any of the Series CF Crowdfunding Offering Investors or any other existing or future Crowdfunding Investors (as defined in Section I of Part I of this Addendum). All Series CF Crowdfunding Offering Investors will join the Stockholder Agreement as stockholders in the third category, which is the group of stockholders defined as "Additional Stockholders." In addition to Crowdfunding Investors (including all Series CF Crowdfunding Offering Investors), other types of stockholders contemplated to be included in the "Additional Stockholders" group include, without limitation, persons who acquire Company stock in the future through the exercise of equity incentive awards, such as stock options, or for consideration other than cash investment in the Company (for example, among others, vendors, strategic partners, financial institutions or lessors). The rights of stockholders in the "Additional Stockholders" category are more limited than the rights of stockholders in the "Investors" category. Additional persons can be added to these categories, and the categories can be modified, in the future, if the Existing Stockholder Agreement is amended (see paragraph 12 below for the provisions governing amendments of the Existing Stockholder Agreement).

The principal terms of the Existing Stockholder Agreement are:

1) Voting Agreements - Composition of Board of Directors (Sec. 3.2). There are agreements in place for the holders of voting stock of the Company to vote such stock to achieve a particular structure of the Company's Board of Directors. These agreements are set forth in Section C(2) of Article IV of the Existing Certificate of Incorporation and in Section 3.2 of the Existing Stockholder Agreement. See the discussion of these voting agreements in subsection IV(B)(iii) of Part I of this Addendum (p. 10 of this Addendum).

Neither the shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more of the Series CF Crowdfunding Offerings, nor the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described Section VIII of this Part I of this Addendum, have the right to vote in the election of the Company's directors, and therefore such shares, and the holders thereof (which includes the Series CF Crowdfunding Offering Investors) are not included in these voting agreements.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025

2) Drag-Along Provision (Sec. 3.1). The Existing Stockholder Agreement contains a drag-along provision binding upon all holders of the Company's capital stock (including options, warrants and convertible securities) (hereinafter in this Part III of this Addendum, "Company stock") who are party to the Existing Stockholder Agreement. The drag-along provisions can be triggered in connection with a "Sale of the Company," as defined below, and, if triggered, require all of the Series CF Crowdfunding Offering Investors and all other holders of the Company's capital stock who are party to the Existing Stockholder Agreement to participate and cooperate with the Company and the "Selling Stockholders" (defined below) to carry out the terms of the Sale of the Company as further described in Section 3.1 of the Existing Stockholder Agreement.

The drag-along provisions may be triggered by election of (i) the holders of a majority of the outstanding shares of voting stock of the Company, currently the Class A Common Stock and the Series A Preferred Stock (voting together as a single class) and (ii) the holders of a majority of the outstanding shares of Class A Common Stock (voting together as a single class) (collectively, the "Selling Stockholders"). The additional approval of the Company's Board of Directors is not required except to the extent required by applicable law.

A "Sale of the Company" means either: (x) a transaction or series of related transactions in which a person, or a group of related persons, acquires from stockholders of the Company shares representing more than fifty percent (50%) of the then outstanding voting power of the Company; or (y) a Deemed Liquidation Event (as defined in the Company's certificate of incorporation; see also the definitions on p. 2 of this Addendum in Section I (Certain Definitions) of Part I, "Description of Capital Stock", of this Addendum.

3) Contractual Restrictions on Transfer; Right of First Refusal Provisions (Sec. 2.1). All of the Company's capital stock (including options, warrants and convertible securities) that are held by a stockholder who is a party to the Existing Stockholder Agreement (including, currently, not only the Series CF Crowdfunding Offering Investors but also the Founder, each Seed Round Investor, each Series A Investor, each Series B Investor, and each Initial Crowdfunding Offering Investor) is subject to the contractual restrictions on transfer set forth in the Existing Stockholder Agreement, including the right of first refusal provisions contained in Section 2.1 of the Existing Stockholder Agreement.

With the exception of the Exempt Transfers described in Section 2.3 of the Existing Stockholder Agreement (see paragraph 6 below), and subject to compliance with all applicable securities laws and so long as the proposed transferee is not a prohibited transferee (see paragraph 5 below), none of the stockholders party to the Existing Stockholder Agreement may transfer Company stock held by them without first complying with the right of first refusal provisions contained in Section 2.1 of the Existing Stockholder Agreement.

The Company has the first right to exercise such right of first refusal provisions. If the Company does not elect to exercise its right of first refusal in full, the stockholders of the Company who have the second right to exercise such right of first refusal provisions (including rights of over-subscription if the secondary refusal right is not exercised in full by the relevant eligible stockholders) depends upon whether the shares of capital stock to be transferred are voting stock or non-voting stock:

- If the proposed transfer involves voting stock, then the "eligible stockholders" are (i) the Founder and (ii) those stockholders holding voting stock (Class A Common Stock or Series A Preferred Stock) who qualify as an accredited investor at the time of the proposed transfer (as verified in a manner satisfactory to the Company) and who the Company's Board of Directors has not reasonably determined has become a Non-Qualified Person (as defined in paragraph 4 below); and the rights are exercised pro rata in proportion to the voting stock held by them.
- If the proposed transfer involves non-voting stock (including the shares of Series CF Non-Voting Preferred Stock offered, sold and/or issued, as the case may be, in any one or more Series CF Crowdfunding Offerings, and the shares of Class B Non-Voting Common Stock into which such shares of Series CF Non-Voting Preferred Stock are convertible as described in Section VIII of Part I of this Addendum), then the "eligible stockholders" are: (i) the Founder; and (ii) any other Stockholder (regardless of the type of capital stock or other securities of the Company held) who meets all of the following requirements at the time of the relevant proposed transfer: (A) the

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025
24

stockholder is either (I) a stockholder in the "Investors" category under the Existing Stockholder Agreement (currently, the Seed Round Investors, Series A Investors and Series B Investors, but not the Series CF Crowdfunding Offering Investors or any other Crowdfunding Investors) or (II) only if and to the extent expressly approved and designated by the Company's board of directors for a particular proposed transfer, one or more of stockholders in the "Additional Stockholders" category under the Existing Stockholder Agreement (which could include all or certain of the Series CF Crowdfunding Offering Investors); (B) the stockholder qualifies as an accredited investor at the time of the proposed transfer (as verified in a manner satisfactory to the Company); and (C) the Company's Board of Directors has not reasonably determined that the stockholder has become a Non-Qualified Person (as defined in paragraph 4 below); and the rights are exercised pro rata in proportion to the capital stock held by them (including both voting stock and non voting stock).

The Company and the relevant eligible stockholders must exercise their rights of first refusal for all of the shares of Company stock proposed to be transferred; otherwise, such rights are forfeited for that particular transfer.

The Company stock acquired and held by Series CF Crowdfunding Offering Investors will be subject to the right of first refusal provisions contained in the Existing Stockholder Agreement, but the Series CF Crowdfunding Offering Investors will generally not qualify as "eligible stockholders" who can exercise right of refusal provisions under the Existing Stockholder Agreement.

4) Definition of "Non-Qualified Person" (Sec. 1). A "Non-Qualified Person" is defined as any person who is (i) directly or indirectly engaged in any business which the Company's Board of Directors determines, in good faith, to be competing with any business of the Company (or any subsidiaries of the Company if the Company has subsidiaries), (ii) an adverse party in any significant (as determined in good faith by the Company's Board of Directors) legal or arbitration proceeding with the Company (or any subsidiaries of the Company if the Company has subsidiaries), or (iii) an affiliate of any person described in clauses (i) or (ii).

5) Prohibited Transferees (Sec. 2.4). In no event may any stockholder who is a party to the Existing Stockholder Agreement (including, currently, not only the Series CF Crowdfunding Offering Investors but also the Founder, each Seed Round Investor, each Series A Investor, each Series B Investor, and each Initial Crowdfunding Offering Investor), transfer any of the shares of Series CF Non-Voting Preferred Stock issued in any one or more Series CF Crowdfunding Offerings (or any other securities of the Company that may be later acquired), including, without limitation, pursuant to an exempted transfer under Section 2.3 of the Existing Stockholder Agreement as described in paragraph 6 below), to (i) any Non-Qualified Person (as defined in paragraph 4 above) or (ii) any customer, distributor or supplier of the Company, if the Company's Board of Directors should determine that such transfer would result in such customer, distributor or supplier receiving information that would place the Company at a competitive disadvantage with respect to such customer, distributor or supplier; provided, however, that the foregoing does not prohibit a sale of the Company's securities (including the Series CF Non-Voting Preferred Stock acquired by Series CF Crowdfunding Offering Investors in any one or more Series CF Crowdfunding Offerings and, if applicable, shares of Class B Non-Voting Common Stock issued upon conversion of such Series CF Non-Voting Preferred Stock as described Section VIII of Part I of this Addendum), pursuant to the drag-along provisions contained in the Section 3.1 of the Existing Stockholder Agreement and described in paragraph 2 above.

6) Exempt Transfers (Sec. 2.3). The transfers exempt from the right of first refusal provisions are as follows; provided, however, that any exempt transfer must still comply with all applicable requirements of Section 10.10 of the Existing Stockholder Agreement (which sets forth additional conditions and requirements for transfers of Company stock and a stockholder's rights and obligations under the Existing Stockholder Agreement, including, without limitation, any requirements relating to securities laws), and may not involve a transfer to a prohibited transferee as described in paragraph 5 above.

IX Power Clean Water, Inc. - Addendum 2 to Exhibit A of the Form C filed 8 April 2025
25

**Time limit hit – remaining pages or documents were skipped.**

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Is this an amendment?** Yes

**Nature of Amendment:** Second extension of offering deadline from July 8, 2025 to September 8, 2025

**Name of Issuer:** IX Power Clean Water, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 09-17-2014

**Physical Address:** 17301 WEST COLFAX AVENUE, SUITE 110, GOLDEN, CO, 80401

**Issuer Website:** https://ixwater.com

**Is there a Co-Issuer?:** No

**Intermediary Name:** STARTENGINE PRIMARY LLC

**Intermediary CIK:** 0001725012

**Intermediary File Number:** 008-70060

**Intermediary CRD Number:** 000291773

### Offering Information

**Compensation to Intermediary:** $10,000 plus a fee of 7.5% of the total amount of investments raised in the offering, collected from the issuer. In addition, a fee up to 3.5% of the total investment amount, collected from the investor.

**Financial Interest in Issuer:** At conclusion of the offering, intermediary will receive a number of shares being offered along the same terms as investors equal to 1% of the total amount of investments raised in the offering.

**Type of Security Offered:** Other

**Other Description of Security:** Series CF Non-Voting Preferred Stock

**Number of Securities Offered:** 8000

**Price per Security:** $2.50

**Target Offering Amount:** $20,000.00

**Oversubscription Accepted:** Yes

**Oversubscription Allocation Type:** Other

**Description of Oversubscription:** At issuer's discretion with priority given to StartEngine Venture Club members

**Maximum Offering Amount:** $2,750,000.00

**Deadline to Reach Target Amount:** 09-08-2025

### Annual Report Disclosure Requirements

**Current Number of Employees:** 1.00

**Total Assets (Most Recent Fiscal Year):** $242,484.00

**Total Assets (Prior Fiscal Year):** $317,853.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $12,573.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $10,292.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $6,520.00

**Short-Term Debt (Most Recent Fiscal Year):** $828,329.00

**Short-Term Debt (Prior Fiscal Year):** $561,676.00

**Long-Term Debt (Most Recent Fiscal Year):** $29,156.00

**Long-Term Debt (Prior Fiscal Year):** $96,332.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $100,000.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $167,890.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-333,140.00

**Net Income (Prior Fiscal Year):** $-513,714.00

**Jurisdictions Offered:**

ALABAMA, ALASKA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, NORTH DAKOTA, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PR, RHODE ISLAND, SOUTH CAROLINA, SOUTH DAKOTA, TENNESSEE, TEXAS, UTAH, VERMONT, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN, WYOMING

### Signatures

**Issuer:** IX Power Clean Water, Inc.

**Signature:** John R. (Grizz) Deal

**Title:** CEO, Principal Executive Officer and Director

---

**Signature:** John R. (Grizz) Deal

**Title:** CEO, Principal Executive Officer and Director

**Date:** 06-16-2025

---

**Signature:** Randall (Randy) Wilson

**Title:** CFO, Principal Financial Officer, Principal Accounting Officer and Director

**Date:** 06-16-2025

---

**Signature:** John Michael (Michael) Bell

**Title:** Director

**Date:** 06-16-2025